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CHAPTER 1  
 
Introduction and Objective of the Thesis 
 
 
 
 
 
 
 
Abstract: 
Liposomes have been studied more than 40 years for various applications. Industrial 
liposomal products entered the cosmetic field first and several years later the field of 
tumor therapy. The favorable properties of these colloidal drug carriers include active 
targeting, ability for drug loading and biocompatibility. Many techniques are used to 
prepare liposomes also in an industrial production process. However, stabilization and 
storage problems are still major concerns for the development and approval of such 
products. Nowadays numerous liposomal products are available on the market either as 
suspensions or as lyophilized dosage forms. If storage as a liquid form is not feasible 
due to stability problems, a drying process is required. So far, all dry products are 
lyophilized due to the lack of sophisticated alternatives. There is a need to further 
develop new stabilization technologies for large scale production of liposomes to 
circumvent the time and cost intensive freeze-drying process which is limited in 
scalability.  
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1. INTRODUCTION 
Liposomes are artificial membranes, in most cases composed of phospholipids like 
phosphatidylcholines (PC), phosphatidylethanolamines (PE) and phosphatidylserines 
(PS), enclosing an aqueous compartment. They form spontaneously when phospholipids 
are placed in an aqueous environment, because of their dual preference to solvents, 
which was first described by Bangham and Horne in 1962 [1]. Amphiphilic lipids consist 
of one lipophilic part that is soluble in nonpolar solvents and a hydrophilic part soluble in 
polar solvents. Liposomes can be classified according to their structural properties or to 
their preparation method [2,3].  
Table 1: Overview of commercially available liposomal products [4] 
trade name  
(FDA approval) 
product/drug substances 
type of dosage form phospholipids and drug/lipid ratio liposome type  
particle size 
Abelcet®  
(1995) 
Amphotericin B 
liposomal suspension DMPC:DMPG 7:3 molar ratio 
drug/lipid 1:1 molar ratio 
MLV 
< 5 µm 
 
AmBisome®  
(2001) 
Amphotericin B 
freeze-dried liposomes 213 mg hyd. soy phsophatidylcholine  
84 mg distearoylphosphatidylglycerol 
52 mg cholesterol, 0.64 mg α tocopherol 
drug/lipid 1:1 [w/w] 
SUV 
< 100 nm 
 
DaunoXome® 
(1996) 
Daunorubicin citrate 
liposomal suspension distearylphospatidylcholine/ 
cholesterol, 2:1 molar ratio 
lipid/drug 18.7:1 [w/w] 
SUV 
∼ 45 nm 
Doxil® 
(1999) 
Doxorubicin liposomes 
liposomal suspension  
ready to use  
3.19 ml/ml MPEG-DSPE 
9.58 mg/ml HSPC 
3.19 mg/ml cholesterol 
drug/lipid 1:6 [w/w] 
LUV  
100 nm 
Myocet®  
(2006) 
Doxorubicin liposomes 
liposomal suspension 
 
Egg-Pc/cholesterol 1:1 molar ratio 
drug/lipid 1:1 molar 
OLV 
180 nm 
Visudyne® 
(2001) 
Verteporfin® for injection 
Benzoprophyrin liposomes 
freeze-dried  
liposomes 
Egg phosphatidyl glycerol 
Dimyristoyl phosphatidylcholine 
Ascorbyl palmitate and butylated 
hydroxytoluene, 15 mg DS/vial 
DS/PL 1:7.5-15 weight ration 
SUV 
∼ < 100nm 
Junovan® 
(expected 2007) 
Muramyltripeptidephosphatidy
l-ethanolamine (MTP-PE) 
freeze-dried  
 
POPC/DOPS 7:3 [w/w] 
DS/lipid 1:250 [w/w] 
tert. butanol 
MLV 
2-5 µm 
 
An advantage, making liposomes an efficient drug delivery system, is the possibility that 
both hydrophilic and lipophilic molecules can be entrapped either into the aqueous core 
or into the lipid bilayer [5]. Due to their structure and the employed lipid molecules, 
liposomes are biocompatible, biodegradable and relatively non-toxic [6]. The application 
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of liposomes as drug carriers and pharmaceutical products depends on their colloidal 
stability, chemical composition, microencapsulating and surface properties. A 
classification of liposomal products ranges from drug-dosage forms [7] over cosmetic 
formulations [8] to diagnostics [9] and various applications in the food industry [10]. In 
drug delivery applications they have been extensively investigated for the delivery of 
anti-tumor substances [11], antimicrobial agents for treatments of bacterial [12], viral 
[13] and parasitic induced diseases [14], as well as for the use as immunological 
adjuvants for vaccines [15]. Other studies demonstrated the entrapment of genes [16] 
and DNA [17] into liposomal systems. Currently, many clinical studies for liposomal 
preparations are under investigations and several products have already entered the 
market (Tab 1). 
 
2. LIPOSOMAL PREPARATION 
Since the introduction of liposomes as drug delivery vehicles in the 1970s a 
comprehensive knowledge on strategies improving stability and on interaction 
characteristics between drugs and lipid membranes has been gained. The cosmetic 
industry was the first to launch a product containing liposomes in 1986. It took almost 
ten more years until the first pharmaceutical product Abelcet® reached the market in 
1995. Although the successful development of many products has been achieved and 
extensive investigations have been made over decades, the production and stabilization 
of liposomal formulations for long term storage is still a major concern.  
Particularly the industrial manufacturing of liposomes at a large scale is very challenging, 
as the production process is complex and consists of several steps. The procedure is 
based on several production steps, which are varying in complexity and are generally 
well described. Figure 1 provides an overview on a standard large scale production 
process for liposomes. As a first step the compounds will be dissolved in an appropriate 
solvent depending on the properties of the used lipids and drugs. The residual solvent 
concentration in the formulation must be reduced by an elimination step before 
continuing the processing of the liposomal formulation. A variety of hydration and 
homogenization steps can be used. Finally, the sterilization step and the stabilization are 
important to achieve a stable product. For invasive administration in humans by the 
parenteral route a sterilization of the liposomal formulations is essential. The most 
common method is sterile filtration using a 0.2 µm membrane [18]. Also gamma-
irradiation [19], heat sterilization of the end product by autoclaving at 121°C [20] or 
steam sterilization [21] has been used for the sterilization of liposomes.  
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Figure 1: Schematic diagram for a large-scale liposome facility. Adopted from Redziniak et al. 1995 [22]. 
 
During the last two decades many of these process steps were further investigated and 
optimized. One approach described in literature is the introduction of new components or 
solvents for the preparation of solutions during the production of liposomes [23]. Organic 
solvents are often employed in liposomal production processes to solubilize either the 
lipids or the drug. The elimination of such organic solvents and the removal of non-
encapsulated drugs are often required for the purification of the final product. In several 
cases this represents the limiting factor for scalability of the process. Additionally, to 
avoid stability problems like sedimentation or leakage of liposomes over the storage time 
the manufacturing with uniform liposomal size distributions by homogenization is 
particularly important [24]. For certain applications it is necessary to achieve certain 
liposome sizes e.g. multi-lamellar (MLV), small uni-lamellar (SUVs), large uni-lamellar 
(LUVs) or multi-vesicular vesicles (MVVs). The effect of liposome size can be important in 
respect of drug loading [25] or the circulation time accumulation behavior after 
application to the patient [26].  
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A simplification of the homogenization method has been another optimization goal within 
the last years. Therefore, preparation techniques were optimized for example the use of 
supercritical gases as solvents [27]. Based on the ethanol injection technique new 
approaches to control the local lipid concentration at the injection point were developed 
which result in spontaneous formation of homogenous liposomes [28]. Furthermore, new 
techniques like the jet disperser were introduced to optimize the homogenization step 
[29].  
Another issue, which has to be overcome, is the prevention of physical or chemical 
reactions occurring during manufacturing or long term storage. Chemical stability is 
directly dependent on the composition of the liposomes. Lipid peroxidation and hydrolysis 
are the most common processes of chemical degradation. Physical processes can be the 
loss of bilayer compounds due to desorption, leakage of entrapped material, vesicle 
fusion and aggregation. A possible approach to stabilize the liposomal formulations is the 
removal of water and the production of a dried formulation. Only freeze-drying was used 
so far as dehydration process for approved products on the market. 
 
3. LIPOSOMAL FORMULATIONS CONTAINING PACLITAXEL 
Paclitaxel is an antineoplastic drug used in the treatment of breast and ovarian cancer 
[30] derived from the bark of Taxus brevifolia a natural complex diterpene with an 
extended side chain necessary for activity on C13 [31]. The major concern of Paclitaxel 
in formulation development is its low solubility of 1 µg/ml in aqueous media, which 
makes its formulation challenging [32]. The commercially available formulation Taxol® 
contains 6 mg Paclitaxel, dissolved in 527 mg of the surfactant Cremophor® EL 
(polyethoxylated castor oil) and is finally filled up with water-free ethanol ad 1 ml [33]. 
Cremophor® EL and ethanol are used to improve the solubility of Paclitaxel. A further 
dilution step with a physiological solution is necessary as described by Straubinger et al. 
(1995) prior to administration, which often results in a Paclitaxel precipitation [34]. To 
circumvent irritations for the patient by precipitated material, a filter is placed between 
the infusion bag and the injection port. Additionally, serious side affects are known for 
Paclitaxel in combination with Cremophor® EL because of an increased toxicity and 
hypersensitivity reactions [35]. Studies to overcome this drawback by using the solubility 
enhancer Pluronic®, a block co-polymer [36], or by the preparation of emulsions [37] 
revealed no advantages with respect to precipitation and crystallization. The approach of 
an oral administration of Paclitaxel (Paxene®) failed, due to the low absorption and the 
reduced bioavailability [38]. As an alternative to Cremophor® EL based formulations, 
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liposomal preparations were developed to overcome some of these drawbacks which are 
summarized by Haas (2005) [39] and Holvoet et al. (2007) [40].  
The formulation EndoTAG®-1, which is used for our studies is based on cationic liposomes 
developed as delivery system for neovascular targeting of Paclitaxel inserted into the lipid 
bilayer [41]. For this formulation the solubility and loading approach was extensively 
discussed by Gruber in 2004 [42]. The lipid complex is composed of the two lipids N-[1-
(2.3-Dioleoyloxy)propyl]-N,N,N,-trimethylammonium chloride (DOTAP-Cl) and 1,2-
Dioleoyl-sn-glycero-3-phosphatidyl choline (DOPC). DOTAP-Cl is a synthetic lipid with a 
positively charged headgroup, whereby DOPC is a zwitterionic natural phospholipids. The 
mechanism of action in the neovascular cancer therapy of the so called vascular-
disrupting agents (VDA) can be described as a specific targeting of blood vessels [43]. In 
this way the tumor tissue compartment and the newly formed endothelial tumor 
vasculature are affected. This lead to thrombus formation with a subsequent occlusion of 
the tumor blood vessel, which may cause a reduction or even a collapse of such vessels 
[44]. The consequence is a reduced or even hindered tumor supply with nutrients and 
oxygen [45]. The lipids used for EndoTAG®-1 exhibit an overall positive surface charge of 
the liposome. Due to the negatively charged surface of proliferating or activated 
endothelial cells in the tumor blood vessels and the positive charge of the liposomes a 
certain targeting effect of the Paclitaxel loaded liposomes can be achieved [46]. This 
specific charged phospholipid headgroup of the liposomes itself interacts through 
electrostatic interactions with negative charges of phospholipid headgroups, which are 
preferentially expressed on the tumor endothelial cells [47]. The intracellular uptake may 
occur via endocytosis and/or membrane fusion, but it is not yet fully understood as 
described by Michaelis and Haas (2007). To approve the unique mode of action, clinical 
phase II studies are currently carried out [48].  
 
4. STABILIZING OF LIPOSOMAL FORMULATION 
In early studies up to the 1990s typically large multi-lamellar vesicles in the micrometer 
range were employed. More recent investigations revealed an advantage of homogenous 
uni-lamellar vesicles in the size range of 50 to 200 nm. Liposome stability decreases with 
increasing size and shows an optimum at a size between 80 and 200 nm. The selection of 
an appropriate size is always a compromise between loading efficiency, which increases 
with liposome size, and the resulting decline in stability [49]. Physical and chemical 
stability of liposomes can be strengthened by choosing a homogenous size, the optimum 
encapsulation efficiency and by the addition of diverse excipients like antioxidants (e.g. 
alpha- or gamma tocopherhol) or chelating agents (e.g. like ethylenediaminetetraacetic 
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acid (EDTA) or diethylene triamine pentaacetic acid (DTPA)). Furthermore, by the 
optimization of the size and the formulation conditions, liquid formulations can be stable 
for several years like DauXome®, Doxil® or Myocet®. With the addition of appropriate 
cryoprotectants and lyoprotectants, liquid formulations can also be frozen or lyophilized 
to enhance the stability. As already mentioned, freeze-drying is exclusively employed as 
dehydration process for industrial manufacturing and stabilization of approved liposomal 
products up to the present. Freeze-drying (FD) is extensively discussed as a standard 
method to stabilize liposomal formulations [50,51,52] and will be discussed more in 
depth in chapter 2 of this thesis. Besides the commercial Paclitaxel containing liposomal 
formulations AmBisome® and Visudyne® are freeze-dried. Other techniques like spray-
drying (SD) of liposomal products have been demonstrated to be feasible in several 
publications for regular manufacturing of dried liposomal formulations especially for the 
stabilization of lipophilic drugs [53,54,55,56]. 
The current manufacturing process of the Paclitaxel loaded liposomal formulation 
EndoTAG®-1 was described by Michaelis and Haas (2007). The formulation comprises 
3 mol% Paclitaxel in a 10 mM DOTAP-Cl/DOPC lipid matrix dissolved in ethanol. 
Polydisperse liposomes are formed during the ethanol injection of the Paclitaxel 
containing lipid stock solutions into an aqueous trehalose phase. The size of the 
liposomes is adjusted to 200 nm using consecutive extrusion steps through a membrane 
with pore size of 0.2 µm followed by a sterile filtration step. However, the liquid 
formulation is not suitable for long term storage over several months due to the 
crystallization tendency of Paclitaxel. To achieve sufficient storage stability and to avoid 
Paclitaxel crystallization the formulation is finally lyophilized. This process was developed 
by Gruber (2004) to achieve a stable product for at least two years.  
The major goal of this thesis was to overcome the limitations related to the liposome 
formation process and the freeze-drying cycle during the preparation of the EndoTAG®-1 
formulation. Several extrusion cycles are necessary to achieve homogenous liposomes. 
The blocking of the membrane is a frequent problem related to the extrusion process 
especially at large scale and can only be overcome by an exchange of the blocked 
membrane. With filling volumes of 25 ml in a single vial the freeze-drying process takes 
about one week. For the application to the patient a large volume of the EndoTAG®-1 
needs to be injected and therefore, several vials are combined to achieve the application 
volume. Instead of the classical lyophilized cake, free flowable bulk material would be 
beneficial to simplify the dosing for the patient. A scale-up of the so far used production 
process is related to tremendous difficulties. Due to the mentioned obstacles in the 
current production process of the EndoTAG®-1 formulation, alternative large scale 
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production methods for liposome formation and drying of bulk particles should be 
investigated.  
 
5. OBJECTIVE OF THE THESIS 
In this thesis alternative techniques that can be scaled up to industrial scale for the 
drying and stabilization of the liposomal Paclitaxel formulation EndoTAG®-1 should be 
explored and compared for their ability to achieve an ideal stabilizing effect. The primary 
goal was to identify possible techniques to preserve the physical and chemical stability of 
the liposomes and to study the effect of process parameters on the product without 
performing major changes in the formulation. Furthermore, we focused on particulate 
drying processes to benefit from the advantages of the free flowing bulk material and 
flexibility in dosing. The combination of the engineering part, designing new processes 
with the product quality after the drying was the major task. Several drying techniques 
were included into the thesis, all with the same liquid formulations but with different 
approaches to achieve a dry product (Fig 2). Furthermore, to overcome the complex 
preparation of liposomes a new technique should be developed that allows the formation 
of homogeneous liposomes within a single process step. With such a process some of the 
preparation steps described in figure 1 could be replaced and the complexity of an 
industrial process could be reduced.  
  
Figure 2: Schematic pressure-temperature diagram with the triple point (TP) and the critical point (CP) and the 
different phases. The investigated drying pathways from the liquid phase over solid (freeze-drying, spray 
freeze-drying, percolative vacuum-drying) and supercritical phase (supercritical fluid-drying) and the direct 
evaporation (spray-drying and inert spray-drying) are shown.  
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To gain further information on the existing formulation and production process, the 
freeze-drying (FD) process should be studied and optimized in chapter 2. Although 
freeze-drying is the accepted production technique the process is very time consuming. 
Therefore, we wanted to increase the efficiency of the lyophilization process by different 
approaches. One approach was to shorten the drying process by optimizing the 
sublimation rate. Furthermore, the approach to increase the filling volume for an 
enhanced productivity was to be tested. Finally, the cake geometry should be varied to 
investigate the heat and mass transfer properties.  
 
In chapter 3 spray freeze-drying (SFD) should be evaluated as a method to stabilize 
liposomes in free flowable dry granules. As no SFD equipment is available at our 
department, suitable set-ups should be planned and technically implemented, which 
allow the controlled production of different particle sizes. The impact of process 
conditions on the particle properties like size and morphology, as well as the liposomal 
integrity and the drying speed compared to the conventional freeze-drying process 
should be studied. 
 
In chapter 4 a new drying method the percolative vacuum-drying (PVD), which 
combines several aspects of spray freeze-drying, vacuum-drying and atmospheric freeze-
drying should be tested as an approach to further enhance the drying process, with 
special focus on a decrease in drying time. The first task was the implementation of a 
technical set-up for this non standard process. Generally, the limitations for the 
sublimation of water are the relatively low driving force of heat and mass transfer 
resulting in very time consuming processes. The idea was to overcome these limitations 
and to enhance the sublimation rate by the introduction of a percolation gas streaming 
through the particle layer. The process parameter should varied to gain deeper 
knowledge of this new drying-method 
 
Processes like spray-drying (SD) require high drying temperatures but result in a rather 
quick evaporation of the aqueous content. Therefore, in chapter 5 such a fast technique 
should be tested for the manufacturing of small and dry particles from the liposomal 
formulations. Variations in the solid content and process parameters, like liquid flow rate, 
nozzle type or temperature and the related physico-chemical properties of the dried 
powder, as well as the liposomal integrity should be evaluated. These experiments should 
give insight into the overall preservation of the liposomal integrity during spray drying. 
An important goal was to perform first studies with Paclitaxel loaded liposomes to test 
the integrity of Paclitaxel formulations after SD.  
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During the evaluation of the spray-drying process the idea of using the shear forces of a 
nozzle to prepare homogenous liposomes originated with the aim to avoid a consecutive 
extrusion process of multi-lamellar vesicles (MLV). While atomizing the liquid feed by a 
conventional two-fluid nozzle, the shear forces not only induced a droplet break-up but 
also exhibited the ability to reduce the size of the liposomes. Based on this assumption 
we wanted to develop a new liposome preparation technique to obtain small and 
homogenously distributed liposomes in a single step by an inline extrusion at high 
pressure followed by an atomization step. The development of such a process, as well as 
underlying mechanistic explanations are described in chapter 6.  
 
Furthermore, our aim was to transfer the single step liposome formation of chapter 6 into 
a conventional pilot scale spray-drying apparatus, to subsequently stabilize the formed 
liposomes by drying. A feasibility study to investigate the liposomal formation in 
combination with the drying step should be performed, which is the topic of chapter 7. 
By testing several drying conditions an optimum working range, which results in 
appropriate particle properties and liposomal qualities should be identified. 
 
The results from spray-drying revealed that the temperature exposure during the drying 
step was in some cases to high resulting in degradation products. For the reduction of 
the heat capacity necessary to dry the liposomal formulations our intention was to 
evaluate the addition of organic solvents to the aqueous formulation, which is described 
in chapter 8. Spray-drying of formulations with more than 10 % organic solvent 
requires special equipment due to the risk of explosion. A closed inert loop spray-drying 
system allows the processing of organic solvents at all selected temperature. Different 
organic solvents should be employed to reduce the drying temperature and their impact 
on the liposomes quality should be analyzed. The idea of the single step liposome 
formation as described in chapter 5 should be tested in this set-up as well. Furthermore, 
our aim was to use a molecular disperse solution of lipids and excipients to overcome the 
spontaneous polydisperse liposome formation by ethanol injection and to further simplify 
the production method.  
 
The relatively new and promising technology of sub- and supercritical fluids should be 
tested to dry aqueous liposomal suspension. The main advantages of these techniques 
are the gentle drying conditions at low temperature around the critical point (chapter 
9). Several technical set-ups and the impact of the working conditions like pressure, flow 
rate and co-solvents on the particle characteristics and the liposomal integrity should be 
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tested. The solubility of lipids in supercritical fluids was an additional challenge to be 
overcome in order to preserve the integrity of the liposome. 
 
One of the main objectives of the thesis was to finally compare all developed and tested 
processes for their feasibility to function as an alternative optimized production method 
for the EndoTAG®-1 formulations. In chapter 10 we therefore intended to give a 
comprehensive comparison of the processes with respect to product quality and 
scalability as well as an outlook into necessary investigations. 
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CHAPTER 2 
 
Optimizing the Freeze-Drying Process of Liposomal Paclitaxel Formulation 
 
 
 
Abstract : 
The aim of the study was to optimize the existing lyophilization process for a liposomal 
Paclitaxel formulation and to reduce the drying time by improving the process 
parameters, increasing the filling volume and changing the cake geometry. The effect of 
freezing rate, shelf temperature and pressure on primary-drying time was investigated. 
Furthermore, the filling volume was increased from 25 to 80 ml and the cake geometry, 
as well as surface structure was modified. By selecting a freezing shelve temperature 
below the Tg` (-47.0°C) and shelve temperatures between -10 and 0°C during the 
primary drying, the drying time could be significantly reduced compared to the existing 
lyophilization process, without any quality loss of liposomal properties. Changes of the 
lyophilization protocol decreased the primary-drying time by about 20 hours. Increasing 
the filling volume was feasible at least up to 50 ml without causing lipid or Paclitaxel 
degradation.  
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1. INTRODUCTION  
Freeze-drying (FD) is a well established standard method for the stabilization of 
liposomal formulations [1,2,3]. However, the time consuming and expensive freeze-
drying processes are the major drawbacks. To develop an economical freeze-drying 
process the formulations need to be optimized to withstand a high temperature during 
drying, which can reduce the drying time [4]. Many approaches are feasible for 
developing and optimizing a conventional freeze-drying cycle, e.g. changes in the 
excipient composition, use of different primary packaging material, variations of filling 
volumes or changes in the process conditions. Freeze-drying comprises three different 
stages, beginning with the freezing procedure, followed by the removal of the frozen 
water (ice) at low temperatures and high vacuum via sublimation (primary-drying) [5]. 
Finally, absorbed water is further removed at ambient temperature and low vacuum 
(secondary-drying) [6]. The success and efficiency of each stage of the freeze-drying 
cycle depends on process variables such as pressure, shelf-temperature and duration [7]. 
Changing the freezing process can play a major role in determining the product quality. 
The ice formation process is impacted by several factors like shelf temperature, ramp 
rate, composition of the formulation in the vial, concentration, fill volume/depth and the 
interior surface properties of the vial itself. By altering the ice crystal size, the ice 
distribution pattern across fill volume, the ice interconnection and ice crystal habit, the 
progress of the subsequent drying steps, as well as the final product appearance can be 
influenced [8]. Liposome bilayer membranes can be damaged during the freezing step, 
by mechanical stress during ice crystal formation or chemical stress due to the increased 
solute concentration. Cryoprotectants have been shown to prevent vesicle fusion and 
leakage induced by the described processes and to ensure the physical integrity of the 
liposomes during storage [9]. Non-crystallizing cryoprotectants form amorphous matrices 
upon freezing. During freezing the transition from a viscous gel to a hard glass with a 
reduced molecular mobility is referred to as the glass transition temperature of the 
maximally freeze-concentrated solution. During freeze-drying the product needs to be 
frozen below Tg’. Accordingly, when amorphous matrices have to be dried, the product 
temperature during primary drying needs to be kept below Tg´, which consequently can 
lead to longer drying cycles. The macroscopic collapse temperature of the formulation 
(Tc) is the temperature above which the freeze-dried cake loses macroscopic structure 
and collapses during freeze-drying. Tc is usually about 2°C higher than Tg´. The collapse 
temperature equals the eutectic temperature (Teu), if solutes are crystallizing in the 
frozen solution. In order to produce an acceptable freeze-dried product, it is in most 
cases required to freeze-dry a formulation at a product temperature below Tc. 
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Trehalose is used as cryoprotector in the formulation with the advantage of having a high 
collapse temperature that allows faster drying rates at higher product temperatures [10]. 
For the protection of liposomes sugars like trehalose or sucrose are employed in a 
concentration between 5 and 20 %. They protect the liposomes by interacting directly 
with the lipid membranes, probably via hydrogen bonding [11]. In order to develop an 
economical freeze-drying cycle, it is crucial to minimize the process time, especially the 
primary-drying step. Thereby, the ice sublimation rate is the most important parameter. 
The sublimation rate is a direct result of the selected parameters (freezing process, 
temperature, pressure, etc.). First, the freezing process has a deep impact on the surface 
area of the freeze-dried product and with it the sublimation rate [12]. The ice crystal 
formation and growth occurs spontaneously and is hard to predict. In general, fast 
freezing leads to smaller ice crystals, whereas slow freezing results in larger crystals and 
pores. The larger porosity leads to higher sublimation rates during primary-drying. 
During primary-drying the solvent is removed from the product and transferred to the 
condenser. Limitations during lyophilization are mainly induced by the mass transfer 
through the dried cake structure under high vacuum. Other aspects like stopper and 
chamber resistance can be neglected. During the last stage of the lyophilization cycle, 
the secondary-drying step, adsorbed water will be removed and the optimum residual 
moisture content for long time storage is adjusted. Higher shelf temperatures for a short 
time should be preferred because of the drastic water desorption deceleration over time 
[13].  
Within in this study the formulation was kept constant and only changes in process 
parameters, filling volume and cake geometry were evaluated. The current standard 
freeze-drying process used for the drying of the liposomal Paclitaxel formulation is very 
time consuming: the primary-drying requires about 90 hours. For storage stability and 
product quality reasons residual moisture contents below 3 % have to be reached and 
maintained during storage. Various process conditions for freezing and drying were used 
in this study and their impact on primary-drying time and product quality was evaluated. 
Furthermore, the influence of cake structure and filling volume was investigated. Drying 
of high fill volumes presents additional challenges, due to longer cycle times, which can 
result in heterogeneity of the cake and non-elegant cake appearance. Another approach 
evaluated within the study was to modify the cake geometry and with it the resulting 
surface area with the goal to improve the freeze-drying process.  
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2. MATERIAL AND METHODS 
2.1 LIPOSOME PREPARATION 
The ethanol injection technique was used for preparing placebo and drug containing 
liposomes. Briefly, for the placebo formulation a lipid stock solution of 400 mM DOTAP-Cl 
(1,2-dioleoyl-3-trimethylammonium-propane-chloride) and DOPC (1,2-dioleoyl-sn-
glycero-3-phosphocholine) in ethanol was prepared (Merck, Darmstadt, Germany). 25 ml 
of this lipid stock solution were subsequently injected under stirring into 975 ml 
10.5 % [w/v] trehalose solution to result in a total final lipid concentration of 10 mM. The 
ethanol injection was followed by five cycles of extrusion through a 0.2 µm polycarbonate 
membrane. The liposomal Paclitaxel containing formulation consisted of molar 
concentrations 50/47/3 of DOTAP-Cl/DOPC/Paclitaxel (Natural Pharmaceuticals Inc., 
Beverly, MA, USA) and was prepared in the same way. The liposomal suspension was 
filled into 100H vials (Schott, Mainz, Germany) with a filling volume between 25 and 
80 ml. 
 
2.2 FREEZE-DRYING METHOD 
Lyophilization was performed with the freeze-dryer Epsilon 2-12D special (Martin Christ, 
Osterrode, Germany). The refrigeration system consists of two 4 KW (5.5 hp) generators 
with an ice capacity of 12 kg. The ice condenser capacity is limited with 10 kg per 24 
hours and a minimum ice condenser temperature of -85°C can be reached. The ice 
condenser has a volume of 35 liters and the drying chamber a size of 350 * 450 * 
420 mm and a volume of 150 liters. The vacuum pump has a specific power of 20 m3/h. 
For each run a total number of 108 100H vials filled with volumes between 25 and 80 ml 
were dried. Two of the three shelves were used with a total size of 0.472 m2. Several 
lyophilization cycles were investigated and compared with the conventional lyophilization 
process for vial freeze-drying (Fig. 1). 
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Figure 1: Standard freeze-drying cycle used so far for the liposome drying. 
 
  FREEZE-DRYING 
 
 
 
  
 
19
2.3 LIPID ANALYSIS 
The concentration of the lipids DOTAP-Cl and DOPC was analyzed by a gradient RP-HPLC 
using UV/VIS detection at 205 nm. Separation and quantification of the components was 
carried out using a C8 Luna 5 µm 100 RP-selected A column (150 x 2 mm). The mobile 
phase consisted of acetonitrile with 0.1 % TFA and water with 0.1 % TFA (Merck, 
Darmstadt, Germany). Aliquots of the samples were diluted 1:3 with acetonitrile:water 
mixtures prior the measurement. The flow rate was set to 0.4 ml/min at an oven 
temperature of 45°C. 
 
2.4 PACLITAXEL ANALYSIS 
Paclitaxel content was analyzed by RP-HPLC using UV/VIS detection at 229 nm. 
Separation and quantification of the drug was carried out using a LiChroCart 250-4 
LiChrospher 60, RP-select B (5 µm) column. The mobile phase of 
Acetonitril/THF/Ammoniumacetat 32/12/56 (v/v/v) 2 mM was adjusted to pH 5 with 
acetic acid (Merck, Darmstadt, Germany). Aliquots of the samples were diluted 1:3 with 
2 mM Acetonitril/THF/Ammoniumacetat 48/18/34 (v/v/v) and the pH was adjusted to 5 
with acetic acid prior the measurement. The flow rate was set to 1 ml/min at an oven 
temperature of 35°C. 
 
2.5 RESIDUAL MOISTURE 
Residual moisture in freeze-dried cakes was determined by a coulometric Karl Fischer 
titrator with a Head-Space oven (Analytic Jena AG, Jena, Germany). Sealed dried 
samples were heated in the oven chamber to 80°C. The vaporized water from the 
particles was transported into the Karl Fischer chamber via a needle-flexible tube system. 
 
2.6 DIFFERENTIAL SCANNING CALORIMETRY ANALYSIS 
DSC was used to study Tg’ and Tg of the formulations. Approximately 20 mg of the 
solution were analyzed in crimped Al-crucibles. For Tg´ the samples were cooled down 
from 20°C to -70°C and reheated to 20°C with a scanning rate of 10 K/min in a Netzsch 
DSC 204 Phoenix® (Selb, Germany), calibrated with Indium. For the glass transition 
temperature DSC was preformed using a scanning rate of 10 K/min over an appropriate 
temperature range. Tg’ and Tg (onset and point of inflection) and crystallization (onset, 
peak and enthalpy) of the excipients were determined during the heating scan. 
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2.7 ANALYSIS OF CAKE MORPHOLOGY  
Wide angle X-ray powder diffraction (XRD) was used to study the morphology of the 
lyophilized products at the Angstrom scale. The X-ray diffractometer XRD 3000 TT 
(Seifert, Ahrensburg, Germany) equipped with a copper anode (40 kV, 30 mA, 
wavelength 0.154178 nm) and a scintillation counter was used. About 10 to 30 mg of the 
freeze-dried product was placed in the sample carrier and analyzed in the angular range 
from 5-40 ° 2-Θ, with steps of 0.05 ° 2-Θ and duration of 2 s per step. 
 
2.8 SIZE MEASUREMENTS OF LIPOSOMES 
For each measurement a complete vial was reconstituted with the necessary amount of 
water to reach the starting concentration. The particle size (z-average) and 
polydispersity index (PI) of the liposomes was analyzed by photon correlation 
spectroscopy (PCS) using a Malvern Zetasizer Nano (Malvern Instruments; UK). Each 
sample was diluted 1:10 with a sterile filtered 10.5 % [w/v] trehalose solution and 
measured after an equilibration time of 3 minutes. A viscosity of 1.3 cP and refractive 
index of 1.348 was used for the aqueous phase. The Zetasizer Nano is operating with a 
4 mW He-Ne-Laser at 633 nm and non invasive back-scatter technique (NIBS) at a 
constant temperature of 25°C. The measurements were conducted in the manual mode 
using 20 sub runs of 10 seconds. The size distribution by intensity and volume was 
calculated from the correlation function using the multiple narrow mode of the Dispersion 
Technology Software version 4.00 (Malvern, Herrenberg, Germany). Thereby, the 
resulting size distributions show the hydrodynamic diameter. 
 
2.9 RESIDUAL ETHANOL CONTENT 
The residual ethanol content was determined using a DANI 6000 static headspace gas 
chromatography (HS-GC) equipped with a HS 850 automated headspace sampler and a 
flame ionization-detector (FID) (DANI, Monza, Italy). All data were acquired with a HP 
3396 series integrator. A DB-WAX (J&W) capillary column 60 m * 0.32 mm i.d. and 
0.5 µm film thickness was used (Agilent Technologies, Waldbronn, Germany). The carrier 
gas was helium at a flow rate of 5.0 ml/min. Injection was carried out in split mode, with 
a total spilt of 1 ml/min (1:1). The injector temperature was 160°C and the detector 
temperature was set to 240°C. The oven temperature remained constant at 60°C. All 
samples were provided in a 20 ml headspace vial conditioned in the headspace oven at 
80°C under continuous gentle shaking for 2 h. The loop temperature was 110°C with a 
transfer line temperature of 120°C. Pressurization time for the vial, loop equilibrium and 
 
  FREEZE-DRYING 
 
 
 
  
 
21
the injection time were adjusted to 0.16 min. For the quantification methanol was used 
as internal standard. Furthermore, a calibration curve of 6 reference solutions containing 
ethanol was set up at the beginning of each run. The calibration curve was calculated by 
the least square method using the relative areas of ethanol.  
 
 
3. RESULTS AND DISCUSSION 
3.1 FREEZE-DRYING METHOD WITH MODIFIED CAKE GEOMETRY 
During the development of the formulation the optimization of the freeze-drying protocol 
is often neglected. For the given liposomal formulation diverse filling volumes were 
investigated to identify the optimum between the drying process parameter and the 
filling volume inside a single vial (Fig 2, (A)). Another technical approach to improve the 
efficiency of the lyophilization process is to raise the filling volume inside the vials with 
the same or even longer drying cycles. However, the increased load per drier may 
overcompensate the process time increase and lead to an optimized economical process 
with a higher throughput. Freeze-drying of such products usually requires a longer cycle 
time and can result in product quality problems due to a higher intravial heterogeneity 
during freezing and drying and unaesthetic cake appearance [14]. Additionally, the cake 
geometry was modified, because it is obvious that the filling height and the cake 
thickness have an impact on the drying time (Fig 2, (B)). The so formed thinner shells 
with a hollow centre could be compared to a sort of spin freezing [15]. By further 
variations of freezing temperature and freezing rate, the effect of ice crystal formation on 
product quality was investigated. Finally, the vacuum and the shelf temperature during 
primary-drying were varied to optimize the drying time. A reduced vacuum will allow the 
formulations to be dried at higher shelf temperatures and an enhanced heat transfer 
without compromising the cake appearance [16].  
 
  
Figure 2: Model of freezing and drying behavior with the sublimation front of a conventionally filled vial (A) and 
of a vial with an increased surface area (modified cake) by using a removable stick during freezing (B). 
 
CHAPTER 2   
 
 
 
  
 
22 
3.2 DETERMINATION OF THE GLASS TRANSITION TEMPERATURE (TG´) 
The Tg’ of the formulations was measured by DSC. A 10.5 % [w/v] trehalose solution, 
trehalose liposome placebo and the Paclitaxel containing liposomal formulation 
with/without ethanol were investigated. During liposome formation the lipids were 
dissolved in ethanol and injected into the aqueous phase, which introduced a small 
amount of organic solvent into the formulations. To investigate the influence of ethanol 
on the glass transition, different ethanol concentrations were added to the formulation 
and the Tg’ measured by DSC. At a scanning rate of 10°C/min the point of infliction, 
which marks the Tg’ was -28.5°C for trehalose (Fig 3, left). The combination of trehalose 
with lipids and also with Paclitaxel itself had no influence on the Tg´. Ethanol however led 
to a significant reduction of Tg’ from -28.5°C without ethanol, to -33.5°C with 2.0 g/l 
ethanol, to -43.5°C at 7.5 g/l ethanol and finally to -47.0°C at the standard 
concentration ethanol of 13.8 g/l (Fig 3, right).  
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Figure 3: DSC heating scans of trehalose solution, lipid mixtures and lipid/drug mixture with ethanol (left) and 
the influence of the ethanol content on the Tg’ (right). 
 
During lyophilization it is important to freeze the solution below the Tg’ to assure a 
complete solidification of the frozen matrix. The product temperature during the primary-
drying has to be adjusted in this range, as well. Potential quality problems in the product 
can be seen for the used liposomal formulation relatively straightforward, as this would 
result in leakage and fusion of the liposomes and a variation in the size distribution 
 
3.3 STUDIES TO OPTIMIZE THE FREEZE-DRYING CYCLE FOR PLACEBO FORMULATIONS 
In the standard freeze-drying process used so far, the freezing shelf temperature of        
-40°C is held for 4 hours for 25 ml product. During primary-drying the shelf temperature 
is raised to -16°C at a chamber pressure of 0.1 mbar and kept for 95 hours. For the 
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secondary-drying step the shelf temperature is raised to 20°C at a vacuum of 0.009 
mbar (Fig 1).  
Based on the results of the Tg´ determination by DSC, which revealed a Tg´ of -47°C for 
Paclitaxel loaded liposomes, the shelf temperature during freezing was reduced to -50°C 
to assure complete freezing and solidification. The product temperature during primary-
drying was kept below the Tg’ by selecting a vacuum of 0.045 mbar. Further changes of 
the freezing, primary-drying (PD) and secondary-drying (SeD) temperatures are 
summarized in table 1. By the faster freezing ramp which is realized when the freezing 
temperature is set to -50°C instead of -40°C, faster primary-drying rates were achieved 
with a total primary-drying time of 87 hours. In combination with increased shelf 
temperature during primary-drying, enhanced heat transfer rates with respect to the 
higher vacuum during primary-drying resulted in faster sublimation rates [17]. 
Table 1: Summarized process conditions for the first optimization round. 
drying 
run  
No. 
freezing 
temp 
[°C] 
freezing 
ramp 
[°C/min] 
primary 
drying temp 
[°C] 
vacuum 
PD 
[mbar] 
product 
temp 
[°C] 
secondary-
drying temp 
[°C] 
vacuum 
SeD 
[mbar] 
1 -40 0.18 -16 0.1 -30 20 0.01 
2 -65* 0.28 -16 0.1 -35 20 0.009 
3 -50 0.30 -16 0.045 -34 20 0.009 
4 -50 0.31 -10 0.045 -35 20 0.009 
5 -50 0.31 -5 0.045 -35 20 0.009 
6 -50** 0.30 -5 0.045 -34 20 0.009 
* two step freezing to -50°C hold for two hours than down to -65°C; ** annealing step (-20°C / 2h) 
 
When increasing the shelf temperature during primary-drying from -16°C to -5°C the 
lyophilization time could be reduced from 87 hours down to 68 hours without affecting 
liposome size and polydispersity (Fig 4, right). A higher vacuum during primary-drying 
results in an optimized pressure difference between the vapor pressure of ice and the 
partial pressure of water in the chamber [18]. A compromise between a high sublimation 
rate and a homogenous heat transfer was necessary, and a combination of higher shelf 
temperature and a higher vacuum was preferred. This could be achieved by freezing 
down to -50°C and increasing the shelf temperature during primary-drying from -16 to   
-10 and -5°C. The primary-drying time was reduced from 87 hours at -16°C to 68 hours 
at -5°C, a decline of 23 %. Additionally, with increasing the primary-drying shelf 
temperature the residual moisture decreased and reached the lowest value of 0.3 % at a 
shelf temperature of -10°C and a vacuum during PD of 0.045 mbar (Fig 4, left). During 
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secondary-drying the absorbed water is removed by the high vacuum of 0.009 mbar. The 
liposome properties after the different drying protocols are shown in figure 4 (right). 
Favorable liposome properties with polydispersity indices of 0.16 and 0.14 were obtained 
for the lyophilization cycle with a very low freezing temperature of -65°C (drying run 
no. 2) and the lyophilization cycle with a freezing temperature of -50°C and a shelf 
temperature primary-drying of -10°C (drying run no. 4). An annealing step resulted in 
liposomes with a high polydispersity index indicating fusion and aggregation of 
liposomes. Furthermore, more favorable liposome properties with a polydispersity index 
of 0.16 were obtained when drying at a reduced product temperature of -35°C compared 
to -30°C at a changed vacuum.  
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Figure 4: Primary-drying time and residual moisture (left) and the corresponding liposome size and 
polydispersity index (right) for the drying runs described in table 1. 
 
The first optimization studies resulted in more advantageous process conditions 
regarding process time, compared to the conventional freeze-drying cycle. The 
combination of a decreased freezing temperature of -50°C and optimized mass transfer 
at higher vacuum of 0.045 mbar during primary-drying were responsible for the result 
[19,20]. The higher shelf temperature of -10°C or -5°C reduced the primary-drying time 
by about 14 respectively 20 hours. A further increase in shelf temperature can result in 
too high vaporization rates, at which the solvent permeates through the already dried 
layer above the solvent-vapor front [21]. 
 
3.4 INCREASING THE FILLING VOLUME TO OPTIMIZE THE FD PROCESS 
As a second approach to increase the efficiency of the lyophilization cycle, experiments 
with increasing filling volume were conducted. The filling volume of the 100H vial was 
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raised from the initial 25 ml to 80 ml for placebo formulations and freeze-drying was 
performed with two different freezing procedures (Tab 2).  
Table 2: Process conditions used for lyophilization of variable filling volumes of placebo formulation. 
freezing 
temp. (F) 
[°C] 
primary-drying 
temp. (PD) 
[°C] 
vacuum 
PD 
[mbar] 
secondary-
drying temp. 
[°C] 
vacuum 
SeD 
[mbar] 
filling 
volume 
[ml] 
-40 -5 0.045 20 0.009 25 – 80 
-50 -5 0.045 20 0.009 25 – 60 
 
3.4.1 Primary-drying time and residual moisture 
The primary-drying time of the placebo formulations depends on the freezing 
temperature and on the filling volume of the vials (Fig. 5, left). When using the lower 
shelf temperature of -50°C during freezing, the primary-drying time was reduced by 
about 30 hours. This is indicative for an increased sublimation rate compared to the shelf 
temperature of -40°C. At -40°C the product is not completely solidified and the 
temperature increase during primary-drying resulted in unstable matrix with higher 
mobility and higher resistance, due to closed pores. With higher filling volumes, the 
duration of primary-drying increased drastically due to the rising dry layer resistance of 
the higher cakes. Although drying time increased with filling volume the processes were 
more efficient. When comparing the calculated time required to dry one ml of the 
formulation at different filling volumes (Fig 5, right) the higher efficiency of the process 
becomes obvious. For freezing down to -50°C an improvement of 20 % could be 
achieved compared to the conventional process.  
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Figure 5: Duration of primary-drying with increasing filling volumes (left) and the process improvement  
compared to the conventional freeze-drying process (right) for freezing temperatures of -40 and -50°C and 
primary-drying at shelve temperature of -5°C and a vacuum of 0.045 mbar. 
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The residual moisture of the dried products ranged below 1.5 % for filling volumes up to 
60 ml for both studied freezing protocols (Fig. 6). When the filling volume exceeded 
60 ml the residual moisture level stepped up above 3 %. Additionally, at a higher 
freezing rate of 0.3°C/min, when setting the shelf temperature during freezing down to -
50°C, larger ice crystals can form when crystal growth is more rapid than ice nucleation. 
Such a freezing procedure, especially at high filling volumes can create heterogeneity in 
solute distribution [22]. When the rate of the nuclei formation is greater than the ice 
crystal growth, nearly instantaneous ice crystal formation occurs throughout the sample, 
which leads to a uniform intravial distribution of solutes in the vial [23]. With a 
homogenous ice crystal distribution the sublimation was enlarged also for high filling 
volumes. So far the optimum can be described with a high freezing rate and filling 
volumes up to 50 ml.  
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Figure 6: Residual moisture of the freeze-dried products dried with freezing temperatures of -40 and -50°C and 
primary-drying at a shelf temperature of -5°C and a vacuum of 0.045 mbar. 
 
3.4.2 Cake morphology 
The morphology of the dried placebo formulations was analyzed by powder X-ray 
diffraction. Amorphous samples were obtained for filling volumes up to 60 ml when using 
the freezing shelf temperature of -40°C and -50°C (data not shown) and primary-drying 
conditions of -5°C shelf temperature at a vacuum of 0.045 mbar (Fig 7, left). Only when 
the filling volume was increased to 70 and 80 ml distinct peaks of crystalline trehalose 
were detected. The crystallization can be attributed to the increased residual moisture 
level in these cakes, which can facilitate crystallization (Fig 7, right) [24].  
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Figure 7: X-ray diffraction pattern of lyophilized placebo formulations using freezing shelf temperature of -40°C 
and primary-drying at -5°C at a vacuum of 0.045 mbar (left) and comparative X-ray diffraction pattern of 
crystalline and amorphous trehalose (right). 
 
3.4.3 Liposome properties with increased filling volume 
Liposome size and polydispersity in the placebo formulations were neither affected by the 
freezing-drying protocol nor by the filling volume (Fig. 8, left). The liposome size was 
about 100 nm with a polydispersity between 0.2 and 0.25, which was comparable to the 
values before lyophilization with a size of 120 nm and a PI of 0.19. After 12 months 
storage at 5°C, the liposome size of about 100 nm could be retained for both freezing 
protocols and all filling volumes (Fig. 8, right). The polydispersity on the other hand 
remained more stable for products using the freezing temperature of -50°C. No obvious 
disadvantage could be determined for the high filling volumes of 70 and 80 ml, although 
they exhibited higher residual moisture levels and crystallization after lyophilization.  
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Figure 8: Liposome size and polydispersity for the reconstituted cakes at filling volumes between 25 and 80 ml 
after lyophilization using freezing shelf temperatures of -40°C and -50°C, primary-drying temperature of -5°C 
at a vacuum of 0.045 mbar (left) and after 12 months storage at 5°C (right).  
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3.5 INVESTIGATION OF THE OPTIMIZED FILLING VOLUME 
To overcome the limitations of mass transfer in conventional cakes with high filling 
volumes a modified cake geometry was evaluated. An enlarged surface area could be 
assigned to the cakes with the modified geometry. This modification in cake geometry 
and the related change in drying behavior could help to clarify the impact of surface area 
on drying behavior and mass transfer. Moreover, it will be an alternative approach to 
optimize the lyophilization time. The filling volume of a 100H vial was raised from the 
initial 25 ml to 80 ml for a conventional cake and directly compared to the cakes with 
modified cake geometry for Paclitaxel loaded formulations (Tab 3)  
Table 3: Process conditions: freezing temperature and shelf temperatures during primary- and secondary-
drying with variable filling volumes of Paclitaxel formulation. 
freezing 
temp (F) 
[°C] 
primary 
drying temp (PD) 
[°C] 
vacuum 
PD 
[mbar] 
secondary-
drying temp 
[°C] 
vacuum 
SeD 
[mbar] 
conventional cake 
filling volume 
[ml] 
modified cake 
filling volume 
[ml] 
-50 -10 0.045 20 0.009 25 - 80 - 
-50 -5 0.045 20 0.009 25 - 80 30 - 80 
-50 0 0.045 20 0.009 25 - 80 30 - 80 
-50 0 0.009 20 0.009 25 - 80 30 - 80 
 
The thermal contact and therefore the heat transfer between the shelf surface and the 
vial is known to be small, because only a limited area of the vial has direct contact with 
the shelf surface. Based on this consideration, Pikal et al. (1984) observed a preferential 
sublimation of ice from the wall of the vial into the centre [18]. With the additional cake 
surface the distribution and sublimation of ice would change and should result in an 
enhanced drying process. 
 
3.5.1 Characterization of primary-drying 
The product temperature profiles are exemplarily shown for the process with a freezing 
shelf temperature of -50°C, primary-drying temperature of 0°C at a vacuum of 
0.045 mbar. The remarkable differences in the temperature profile between the 
processes when using the conventional cake (Fig 9, left) and when using the modified 
cake geometry (Fig 9, right) can be assigned to the changed drying behavior related to 
the different sublimation interface. Conventional cakes basically dry from the top to the 
bottom with simultaneous minor drying from the wall into the centre. The temperature 
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profiles obtained by the thermocouples reveal a constant temperature increase already at 
the beginning of the primary-drying step. With the modified cake an enlarged ice-vapor 
interface and a thinner layer were present leading to a later but steeper increase in 
product temperature.  
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Figure 9: Freeze-drying process temperature profiles obtained from the same drying cycle with product 
temperature during the drying stages at filling volume of 30, 50 and 80 ml by the conventional cake (left) and 
the modified cake (right).  
 
Depending on shelf temperature and chamber pressure the drying time increased with 
increasing filling volumes for the conventional cake structure at all conditions (Fig 10, 
left). Compared to the conventional drying process for almost all conditions and filling 
volumes the drying time could be reduced (Fig 10, right). Depending on vacuum and 
shelf temperature time savings up to 60 % were achieved. An optimum filling volume of 
50 ml per vial could be suggested, because a further increase did not substantially 
improve the process efficiency.  
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Figure 10: Primary-drying time of different processes for conventional cakes (left) and process improvement 
during primary-drying compared to the conventional process (right). 
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With the modified cake geometry the primary-drying time increased with filling volume 
comparable to the conventional cake structure (Fig 11, left). Only at a chamber pressure 
of 0.009 mbar a significant reduction of the primary-drying time was achieved for all 
filling volumes (Fig 11, right). At the other process conditions only a minor time saving 
could be achieved due to the additional surface area.  
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Figure 11: Primary-drying time of different processes for the modified cakes (left) and process improvement 
during primary-drying compared to the conventional process (right). 
 
The primary-drying time is influenced by sublimation rate, heat and mass transfer. 
During the drying progress of a conventional cake, the heat transfer into the centre of 
the cake levels down because of the reduced heat conductivity of the dried regions [25]. 
With the introduction of the hole within the modified cake the maximum distance, which 
has to be overcome by the heat transfer is reduced with the consequence of a reduced 
primary-drying time. This effect is most pronounced when the sublimation rate is low e.g. 
at a high vacuum of 0.009 mbar or a low shelf temperature of -10°C. At sufficient high 
heat transfer rates at a shelf temperature of 0°C and a vacuum of 0.045 mbar primary-
drying time was not reduced for the modified cakes. This indicates that the thickness of 
the drying layer does not primarily influence the sublimation rate, which is in agreement 
with Ybema et al. (1995) [26]. For this reason, the heat transfer and the heat 
conductivity are the more relevant factors for the drying speed of high filling volumes.  
 
3.5.2 Residual moisture and organic solvent content 
Generally, the residual moisture of a freeze-dried product should be as low as possible 
[27]. It became obvious when comparing the residual moisture levels of the dried 
products that water vapor transfer rates were affected by the cake geometry. The 
residual moisture content of the conventional cakes increased with the filling volume (Fig 
12, left). For the cakes with modified cake geometry the residual moisture could be kept 
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below 0.5 % even for the higher filling volumes of 70 and 80 ml (Fig. 12, right), whereas 
residual moistures of about 1 % were obtained at regular conditions.  
Considering the replacement theory by Tsvetkova et al. (1998) sugars can replace water 
molecules bound to the lipid headgroups after drying [28]. At a higher residual moisture 
content a larger amount of water molecules can still interact with the lipid headgroups. 
This can result in significantly improved storage stability and the assumption that a 
certain amount of water is beneficial, which is around 0.5 %.  
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Figure 12: Residual moisture of products produced by different processes at conventional cake (left) and at 
conditions with modified cake geometry (right). 
 
Since the liposomal formulations contain ethanol, it is important to determine the 
residual ethanol content after lyophilization. Organic solvents like ethanol are known for 
their incomplete evaporation from the freeze-dried product during secondary-drying 
[29,30]. According to the ICH Guidelines, ethanol is a class 3 solvent with low toxicity 
potential, but the solvent concentration should nevertheless as low as possible [31]. The 
residual amount of ethanol after freeze-drying was investigated for the different drying 
processes and cake geometries. The residual ethanol content was only marginally 
affected by freezing temperature, shelf temperatures or vacuum applied during the 
process. Apparently, a residual ethanol concentration of about 5500 ppm was retained in 
the lyophilized product for filling volumes between 25 and 80 ml (Fig 13, left). Moreover, 
different pressures during primary-drying and variations in secondary-drying could not 
reduce the retention of ethanol in the cake. For the residual ethanol content of the 
samples dried at a vacuum of 0.045 mbar and a shelf temperature of 0°C a reduction of 
the ethanol content to about 3500 to 4000 ppm was achieved by the modified cake 
geometry (Fig. 13, right). However, the residual ethanol content varied between 4500 
and 6000 ppm within the conventional cake.  
 
 
CHAPTER 2   
 
 
 
  
 
32 
20 30 40 50 60 70 80
0
1000
2000
3000
4000
5000
6000
7000
8000
 
 
et
h
an
o
l 
co
n
te
n
t 
[p
p
m
]
filling volume [ml]
 F: -50°C PD:-10°C, vacuum: 0.045mbar
 F: -50°C PD:  0°C,  vacuum: 0.045mbar
 F: -50°C PD:  0°C,  vacuum: 0.009mbar
20 30 40 50 60 70 80
0
1000
2000
3000
4000
5000
6000
7000
8000
 
 
et
h
an
o
l 
co
n
te
n
t 
[p
p
m
]
filling volume [ml]
 F: -50°C PD:-5°C,  vacuum: 0.045 mbar
 F: -50°C PD:  0°C,  vacuum: 0.045 mbar
 F: -50°C PD:  0°C,  vacuum: 0.009 mbar
 
Figure 13: Residual ethanol content of products produced by different processes at the conventional cake (left) 
and at conditions with modified cake geometry (right).  
 
The relatively high retention levels of ethanol after lyophilization indicate a specific 
binding of ethanol to the used excipients and components. Especially the high amount of 
trehalose in the lyophilized product can be responsible for this effect. The retention of 
ethanol in amorphous sugars is ascribed to intermolecular hydrogen bonding between the 
sugar molecules and ethanol during lyophilization [32]. To verify this assumption, 
trehalose formulations with increasing ethanol concentrations were lyophilized with the 
process shown in figure 14 (left). The data suggested that more ethanol remained bound 
to the amorphous trehalose when increasing the initial ethanol concentration (Fig 14, 
right). Furthermore, a saturation/retention level of ethanol was observed between 5000 
and 10000 ppm, which was in agreement with the residual ethanol concentration 
measured for the varied drying processes. Even after grinding of freeze-dried material 
the organic volatiles remained entrapped in microregions [33]. However, it was feasible 
to also dry the high ethanol concentration (> 10 %) without any indications of collapse, 
although such formulations are known to be difficult to dry [34].  
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Figure 14: Freeze-drying process for varied ethanol concentrations (left) and the residual ethanol and moisture 
content of freeze-dried trehalose with increased ethanol content in the formulation (right)  
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3.5.3 Cake morphology and effects on storage stability 
DSC and X-ray diffraction were used to characterize the morphology of the freeze-dried 
products. The morphology of the cakes was analyzed, as it can affect the storage stability 
of the formulations and affect liposome integrity and fusion [35]. To characterize the 
amorphous phase the glass transition temperature was determined by DSC for 
conventionally lyophilized cakes and cakes with modified geometry. The glass transition 
temperature was around 75°C for the majority of the studied formulations. With 
increasing filling volumes the Tg remained constant (Fig 15). Lower Tg values of about 
40°C on the other hand were determined for conventional cakes dried at a shelf 
temperature of -5°C and a vacuum of 0.045 mbar due to the high residual moisture 
content. 
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Figure 15: Glass transition temperature (Tg) of lyophilized conventional cakes (left) and at conditions with 
modified cake geometry (right). 
 
To a great extent the amorphous state of the conventional cakes was assured after the 
studied processes (Fig. 16). The XRD diffraction pattern of a freeze-dried sample 
displayed a maximum in the range from 17 to 25° 2-Theta with the maxima at about 20 
and 24° 2-Theta, corresponding to lattice spacings of about 4.4 and 3.7 Å, respectively. 
At a shelf temperature of -5°C and a vacuum of 0.045 mbar during primary-drying some 
peaks indicate the presence of crystalline trehalose (Fig 16, (B)). The higher residual 
moisture content resulted in a crystalline structure during the storage, especially at 
moisture content above 4 % (compare chapter 9).  
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Figure 16: X-ray diffraction pattern of conventional lyophilized cakes at primary-drying of -10°C and a vacuum 
of 0.045 mbar (A), primary-drying of -5°C and a vacuum of 0.045 mbar (B), primary-drying of 0°C and a 
vacuum of 0.045 mbar (C) and primary-drying of 0°C and a vacuum of 0.009 mbar (D). 
 
XRD confirmed the results from DSC. Overall amorphous structures were obtained for the 
cakes with the modified cake geometry (Fig 17). The presence of an amorphous halo and 
the absence of peaks of any other form of trehalose in the XRD patters suggested an 
amorphous state. The DSC measurements already indicated amorphous structures by the 
high glass transition temperatures.  
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Figure 17: X-ray diffraction pattern of lyophilized cakes with modified cake geometry at primary-drying of -5°C 
and a vacuum of 0.045 mbar (A), primary-drying of 0°C and a vacuum of 0.045 mbar (B) and primary-drying 
of 0°C and a vacuum of 0.009 mbar (C). 
 
3.5.4 Liposome properties at increased filling volume  
Various process variables affect the efficiency of freeze-drying. Product temperature and 
mass transfer are the most important factors because the sublimation rate is generally 
faster at higher temperatures [36]. The appearance of the cake and the reconstitution 
behavior depend on the lyophilization cycle and the filling volume. With raised filling 
volumes and higher shelf temperatures of 0°C the cakes collapsed marginally from the 
wall and the top. Finally, the reconstitution time was slowed down slightly for such cakes 
(data are not shown).  
The direct interaction of trehalose with lipid head groups is described to preserve the 
liposomes [37,3]. However, liposome size and polydispersity index in the conventional 
cakes were affected by the process parameters and the filling volume. The tendency of 
slightly increased liposome sizes at higher filling volumes was obvious for all tested 
conditions (Fig 18). Under the regular drying conditions and for the normal cake 
morphology the polydispersity index increased above 0.4 when the filling volume 
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exceeded 50 ml. This is indicative for a loss of structural integrity of the liposomes and a 
potential crystallization of Paclitaxel. The process of liposomal damaging was further 
induced by raising the shelf temperature from -10 to 0°C (Fig 18, (A to C)). Only at the 
most gentle drying conditions with a shelf temperature of 0°C and a vacuum of 
0.009 mbar the polydispersity remained constant also for the filling volumes above 50 ml 
(Fig 18, (D)). The very time consuming and gentle process showed macroscopically a 
homogenous cake appearance. Due to the very high vacuum the product temperature 
and the heat transfer through the cake were reduced.  
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Figure 18: Liposome size and polydispersity index after reconstitution of conventional cakes at primary-drying 
of -10°C and a vacuum of 0.045 mbar (A), primary-drying of -5°C and a vacuum of 0.045 mbar (B), primary-
drying of 0°C and a vacuum of 0.045 mbar (C) and primary-drying of 0°C and a vacuum of 0.009 mbar (D). 
 
With the modified cake geometry, no change in cake appearance and no macroscopically 
collapsed structures were visible for all processes and filling volumes. The liposomes size 
and the polydispersity indices stayed constant for all investigated conditions. Here the 
liposome size varied between 120 and 150 nm with acceptable polydispersity indices 
around 0.4 (for Paclitaxel loaded liposomes) (Fig 19). Again the gentle and very time 
consuming drying process at a vacuum of 0.009 mbar resulted in the most favorable 
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liposome properties with a size of about 120 nm and polydispersity below 0.4. Compared 
to the conventional cake conditions the additional surface of the cakes and the related 
drying performance preserved the liposomal structure during the faster drying process 
and led to a reduced heat exposure due to the overall thinner layer thickness.  
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Figure 19: Liposome size after reconstitution of optimized cake conditions at primary-drying of -5°C and a 
vacuum of 0.045 mbar (A), primary-drying of 0°C and a vacuum of 0.045 mbar (B) and primary-drying of 0°C 
and a vacuum of 0.009 mbar (C). 
 
3.5.5 Effect of filling volume and process parameters on the lipid recovery 
Before lyophilization the formulation contained 5 mM DOTAP-Cl and 4.7 mM DOPC, which 
was determined by RP-HPLC. The lipid recovery of DOTAP-Cl and DOPC after the different 
freeze-drying processes remained constant. In addition no variations were found for the 
vials with increased filling volumes (Tab 4).  
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Table 4: Lipid recovery values for filling volumes between 25 and 80 ml prepared with the conventional cake 
structure at varied freeze-drying programs.  
DOTAP-Cl recovery [mM] DOPC recovery [mM] 
filling volume [ml] filling volume [ml] 
conventional 
cake before 
25 30 40 50 60 70 80 
before 
25 30 40 50 60 70 80 
F:-50°C 
PD:-10°C 
0.045mbar 
5.1 5.4 5.4 5.3 5.2 5.2 5.2 5.3 4.8 5.0 5.1 5.1 5.0 5.0 5.0 5.0 
F: -50°C  
PD:-5°C 
0.045mbar 
5.0 - 5.0 4.9 - - - 4.8 4.7 4.6 - 4.7 4.7 - - - 
F: -50°C 
PD:0°C  
0.045mbar 
5.0 5.5 5.3 5.1 5.2 - 5.2 5.3 4.8 5.0 5.2 5.1 4.9 5.0 - 5.0 
F: -50°C 
PD:0°C 
0.009mbar 
5.0 4.8 5.0 5.0 5.0 4.9 4.9 4.9 4.7 4.5 4.8 4.7 4.7 4.7 4.7 4.7 
 
The lyophilized vials with the changed cake geometry showed similar lipid recoveries as 
the conventional cakes. No decomposition or degradation of the lipids could be 
determined (Tab 5). The data revealed that lyophilization with high filling volumes and 
with harsher conditions e.g. shelf temperature of 0°C resulted in a good lipid recovery 
and the absence of degradation products.  
 
Table 5: Lipid recovery values for filling volumes between 25 and 80 ml prepared with the additional surface 
cake structure at varied freeze-drying programs. 
DOTAP-Cl recovery [mM] DOPC recovery [mM] 
filling volume [ml] filling volume [ml] 
optimized  
cake before 
25 30 40 50 60 70 80 
before 
25 30 40 50 60 70 80 
F: -50°C 
PD:-5°C 
0.045mbar 
5.3 - 5.7 5.7 5.6 5.6 5.4 5.5 5.0 - 5.4 5.4 5.4 5.4 5.3 5.3 
F :-50°C  
PD:0°C  
0.045mbar 
5.0 5.3 5.4 5.3 5.3 5.1 - 5.2 4.8 5.0 5.1 5.0 5.0 4.8 - 5.0 
F: -50°C  
PD:0°C 
0.009mbar 
5.0 4.9 5.0 5.0 5.0 5.0 - 4.9 4.7 4.7 4.8 4.7 4.7 4.7 - 4.7 
 
3.5.6 Effect of the filling volume on the Paclitaxel recovery 
The Paclitaxel content after lyophilization and the content of the degradation product 7-
Epipaclitaxel was determined for conventional cakes and cakes with modified geometry. 
The values determined for the products dried at the higher shelf temperature of 0°C were 
comparable for both cake geometries. The degradation and crystallization of Paclitaxel 
from lipid membranes is known to be very sensitive. However, no loss of Paclitaxel out of  
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the membrane occurred for both cake structures and during all drying processes (Fig 20). 
The different freeze-drying conditions and especially the high filling volumes did not lead 
to a crystallization of Paclitaxel.  
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Figure 20: Paclitaxel recovery after varied freeze-drying conditions for the conventional cakes (left) and 
modified cake geometries (right). 
 
Before lyophilization no 7-Epipaclitaxel was determined. The content of this degradation 
product after freeze-drying ranged between 1.3 to 2.2 % for all process conditions, for 
the conventional cakes and increasing filling volume (Fig 21, left). By using the modified 
cake geometry a significant reduction of the impurity below 1 % was obtained at the 
primary-drying temperature of -5°C and a vacuum of 0.045 mbar (Fig 21, right). The 
values determined for the products dried at the higher shelf temperature of 0°C were 
comparable for both cake geometries. Although the shelf temperature during primary-
drying was increased up to 0°C and the heat transfer thereby enhanced, the degradation 
products remained in acceptable values below 3 %.  
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Figure 21: Impurities of 7-Epipaclitaxel after varied freeze-drying conditions for the conventional cakes (left) 
and modified cake geometry (right). 
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4. CONCLUSIONS 
The goal to increase the efficiency of the lyophilization process was achieved either by 
reducing the process time, by increasing the filling volume or by changing the cake 
geometry to higher surfaces. The change of the freezing step to a freezing temperature 
below Tg´ resulted in enhanced solidification of the products, which shortened the 
primary-drying step. This can be ascribed to enhanced sublimation rates, which resulted 
in a 10 to 25 % reduction in primary-drying time. Furthermore, the faster freezing ramp 
and the resulting formation of larger ice crystals can make primary drying more efficient. 
An increased shelf temperature of -5°C and higher vacuum of 0.045 mbar enhanced the 
difference in relative vapor pressure between the solvent in the product and the 
atmosphere above the sublimation front, intensifying the driving force for sublimation. 
However, compared to the lowering of the freezing temperature, the impact on primary 
drying time was less pronounced.  
When using such an optimized lyophilization cycle the filling volume can be successfully 
raised to at least 50 ml per vial without cake shrinkage and collapse. The drying behavior 
of vials filled up to 80 ml, combined with modified cake geometry was studied for 
Paclitaxel loaded formulations. A process improvement saving up to 60 % time compared 
to the conventional process and filling volume of 25 ml could be achieved in this way.  
With the modified cake geometry primary-drying could be shortened, especially for filling 
volumes up to 40 ml. The sublimation rate, which is generally limited by the heat 
transfer, was enhanced due to the additional surface. At filling volumes above 50 ml the 
additional surface did not improve the drying time as efficient as compared to the 
conventional cakes. Thus, it can be concluded that the heat transfer through the dry 
layer of the cake is a more limiting factor for sublimation than the product resistance. Up 
to a filling volume of 50 ml liposomal integrity, reflected in size and PI, as well as 
Paclitaxel loading was preserved for both, conventional cakes and those with modified 
geometry. Overall, the cakes with modified geometry exhibited lower moisture contents, 
more homogenous liposome properties and faster drying rates. Although it was possible 
to optimize the lyophilization cycle and increase the efficiency, the resulting processes 
are still rather time and energy consuming. 
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Abstract : 
Spray freeze-drying (SFD) was evaluated as a method to prepare and stabilize particles 
of placebo liposomal formulations with the lipids DOTAP-Cl/DOPC in a molar range of 
50/50, as well as of drug loaded formulations made up from DOTAP-Cl/DOPC/Paclitaxel 
in the molar range 50/47/3. The SFD process consists of two separate processing steps: 
spray-freezing to produce the particles and a subsequent lyophilization to dry the 
product. With the SFD technology particle sizes between 10 and 3000 µm can be 
obtained. The drying speed and the physicochemical properties of such particles were 
comparable to conventional freeze-drying. After reconstitution of the particles the 
liposome size distribution was not influenced. Lipid and drug content stayed constant 
during the freezing and drying procedure. The main advantage of SFD is the resulting 
free flowable spherical product. Due to the particle formation and the drying process at 
low temperatures heat exposure could be circumvented. 
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1. INTRODUCTION  
Spray freeze-drying (SFD) is a relatively new method for the preparation of particles and 
microparticles [1,2,3]. SFD is widely used for the production of biopharmaceuticals and 
different applications for protein therapeutics [4]. Nutropin Depot® a recombinant human 
growth hormone (hGH) from Genentech and Alkermes was prepared with the so called 
ProLease® process as a first product using spray freeze-drying technology [5]. An 
overview of studies on SFD and their applications is provided by Maa and Costantino 
(2004) [6]. SFD is often used because of the high porosity of the product and the 
controlled particle size distribution which make such a process an alternative to the 
conventional techniques like spray-drying [7,8].  
The spray freeze-drying process can be isolated into two separate processing steps: the 
spray-freezing into a cryogenic liquid and the lyophilization step. As cryogenic liquids, 
liquid nitrogen or liquid carbon dioxide are preferred [9]. Two freezing techniques are 
commonly used to prepare particles, the spray-freezing directly into liquid nitrogen (SFL) 
and spray freeze-drying (SFD) above the cryogenic surface. The SFL process can be used 
if a contact of the drug solution with the atmosphere needs to be circumvented [10]. In 
SFL the liquid solution is sprayed directly into the liquid nitrogen through a fine orifice 
nozzle (capillary peak) equipped with a pressure system. Such a capillary peak nozzle 
generates high velocities and the droplets produced thereby are frozen instantly [11]. We 
used a SFD process where the solutions are sprayed above the liquid surface to obtain 
fine or small particles. An alternative for the formation of larger particles is to spray first 
into a cold vapour phase over a cryogenic liquid. Such a process was first described by 
Gusman and Johnson (1990) [12] for ceramic powders and by Gombotz et al. (1991) for 
carbohydrates and proteins. While falling through the cold vapour the formed droplets 
begin to freeze, but the main freezing process takes place upon contact of the prefrozen 
droplets with the cryogenic liquid phase [13]. Atomized droplets during SFD maintain 
their spherical shape and size upon freezing and the subsequent drying process [14,15]. 
The main advantage of the SFD method is the absence of heat exposure during the 
particle formation and the drying process contrary to spray-drying [16,17]. The 
limitations of the method are the use of expensive cryogenic fluids, which is technically 
impractical, and the need of the time consuming lyophilization step. A freeze-dried cake 
in a vial is still the typical form for currently marketed biopharmaceuticals [18,19]. 
However, SFD is widely used in the field of protein stabilization to achieve a particulate 
system. The use of this technique for the stabilization of liposomes was not yet 
extensively discussed in literature. One example is the manufacturing of a liposomal 
powder formulation containing ciprofloxacin for pulmonary drug delivery [20]. During 
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reconstitution of the powder, spontaneous in vitro formation of liposomes in aqueous 
media occurred. The main advantage of such a process is the improved mass median 
aerodynamic diameter.  
The objective of this study was to investigate spray freeze-drying as a method to 
stabilize liposomal formulations as dry solid particles. With the SFD technology free 
flowable particles with controlled size could be achieved under gentle process conditions.  
 
2. MATERIAL AND METHODS 
2.1 LIPOSOME PREPARATION 
The ethanol injection technique was used for preparing placebo and drug containing 
liposomes. Briefly, for the placebo formulation a lipid stock solution of 400 mM DOTAP-Cl 
(1,2-dioleoyl-3-trimethylammonium-propane-chloride) and DOPC (1,2-dioleoyl-sn-
glycero-3-phosphocholine) in ethanol was prepared (Merck, Darmstadt, Germany). 25 ml 
of this lipid stock solution were subsequently injected under stirring into 975 ml 
10.5 % [w/v] trehalose solution to result in a total final lipid concentration of 10 mM. The 
ethanol injection was followed by five cycles of extrusion through a 0.2 µm polycarbonate 
membrane. The liposomal Paclitaxel containing formulation consisted of molar 
concentrations 50/47/3 of DOTAP-Cl/DOPC/Paclitaxel (Natural Pharmaceuticals Inc., 
Beverly, MA, USA) and was prepared in the same way.  
 
2.2 SPRAY-FREEZING METHODS 
Two different technical set-ups were applied to spray-freeze small and large particles. 
Small particles were atomized using a two-fluid nozzle by direct spraying above the liquid 
nitrogen (Fig 1, (A)). The two-fluid nozzle was operated at atomizing air volumetric flow 
rate (vaa) of 120 and 470 l/h with a liquid feed volumetric flow rate (vlf) of 2.7 ml/min for 
all experiments. The so formed droplets freeze rapidly after contact with the cryogenic 
nitrogen. To generate large particles the liposome suspension was pumped through an 
orifice nozzle to produce a uniform stream of droplets. Depending on the liquid feed rate 
the droplet size could be varied in the range of 10 to 3000 µm. In this set-up the droplets 
begin to freeze while falling through a cold gaseous phase of vaporized nitrogen in a pre-
freezing vessel (Fig 1, (B)). Due to the pre-stabilization, the large partially frozen 
droplets do not rupture when they immerse into the liquid nitrogen, where the major 
freezing step takes place. In both set-ups the liquid nitrogen was stirred during the 
process to avoid agglomeration of the freezing particles.  
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Figure 1: Schematic constructions of the SFD by direct spray-freezing in liquid nitrogen for fine and small 
particles (A) and the developed spray-freezing with pre-freezing vessel for large particles (B). 
 
2.3 FREEZE-DRYING METHOD 
The particles frozen in liquid nitrogen were transferred either into a lyoguard R&D 
container (W.L. Gore, Newark, USA) or into 10R glass vials (Schott, Mainz, Germany). 
The vials were stored in a -80°C freezer until the liquid nitrogen evaporated. Afterwards, 
the lyoguard/vial containing the frozen particles was loaded onto the pre-cooled shelves 
(-40°C) of the conventional freeze-dryer Epsilon 2-6D (Martin Christ, Osterrode, 
Germany). After loading, the vacuum was set to 0.045 mbar and the shelf temperature 
was increased to -16°C for primary drying and held for 36 h. For secondary drying, the 
shelf temperature was increased to 20°C and held for 12 h (Figure 2, left). The process 
used for conventional vial freeze-drying of the liposomal formulation is shown in Figure 2 
(right) with a freezing step to -50°C and comparable primary– and secondary-drying 
steps. 
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Figure 2: Freeze-drying cycle for the particles prepared by the spray-freezing method (left), and for the 
conventional vial freeze-drying with a process including the freezing step (right). 
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2.4 FREEZE-DRYING VELOCITY 
Weight loss and drying rate were investigated by a microbalance (Martin Christ, 
Osterode, Germany). The microbalance was placed on a shelf inside the freeze-drying 
chamber. A single vial filled with an equal volume of liposomal suspension respectively of 
pre-frozen particles was placed onto the holding-arm of the microbalance. Every 
3 minutes, the holding-arm moves upwards and thereby lifts the vial for weighing. The 
lifting and weighing step takes ∼10 s. The microbalance was connected via a co-axial 
cable through a sealed flange in the chamber wall to a computer. Microbalance 
programming and data evaluation were performed using Christ's proprietary software.  
 
2.5 ANALYSIS OF PELLET MORPHOLOGY 
Images of the products were obtained by scanning electron microscopy (SEM) to study 
pellet morphology and size. Conductive double sided tape was used to fix the pellets onto 
the specimen holder before sputtering them with a thin layer of carbon under vacuum. 
Scanning electron microscopy images were obtained using a Philips XL-Series XL20 
(Philips, Netherlands). 
Pellet size distribution was determined with a He-Ne laser beam equipped laser 
diffraction analyzer (Mastersizer X, Malvern, Herrenberg Germany). The small-volume-
presentation-unit was used to pump the powder suspension into the sample cell. About 
20 mg of SFD powder were dispersed in 10 ml Migylol 812 containing 1 % Span 85. 
Background alignment with pure dispersion was performed before the pellet medium was 
added. Laser light scattering intensity was evaluated by Fraunhofer analysis using a 
polydisperse mode.  
 
All further methods used in this chapter are already described before.  
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3. RESULTS AND DISCUSSION 
3.1 PARTICLE FORMATION PROCESSES 
With the spray freeze-drying methods used in this study the modifications of the freezing 
set-up allowed a production of small and large particles with size distributions between 
10 and 3000 µm (Figure 3). At both spray freeze-drying set-ups the formed droplets 
maintained their spherical shape and size upon immediate freezing. In addition, the 
subsequent drying process did not affect the particle shape or size. Depending on the 
droplet size and the spraying technique the freezing time varied for small and large 
particles. Freezing of fine and small droplets by spraying directly above liquid nitrogen 
resulted in high cooling rates, although the aqueous droplets floated some seconds on 
the liquid nitrogen [21]. This phenomenon can be described by a boiling of the cryogen in 
contact with the droplets as a result of the Leidenfrost effect [22]. The larger droplets, 
which were pre-frozen in gaseous nitrogen by the described method (Fig 1, (B)) exhibit a 
much lower freezing rate due to their tenfold size and their different freezing process. 
Before the droplets were completely solidified in the liquid nitrogen, they floated for 
almost 20 seconds on the surface of the liquid nitrogen before sinking, which is indicative 
for a complete freezing [23]. With the pre-freezing step no fragmentation or clustering of 
the particles occurred. Compared to freeze-drying with a freezing step over several 
hours, the very high cooling rates employed in SFD inhibit ice crystal growth after 
nucleation, leading to small ice crystals and a large ice crystal surface area by Burke 
et al. (2004).  
 
 
Figure 3: Spray freeze-dried small particles (left) produced by set-up A with direct spraying into liquid nitrogen, 
and large particles (right) produced by set-up B including a pre-freezing step. 
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3.2 DRYING VELOCITY 
The primary drying behavior of a regular freeze-drying cake and SFD particles were 
compared using the microbalance to elucidate how the different freezing protocols affect 
the drying velocity. Although the samples were frozen with different techniques and 
freezing rates, the drying behavior during primary-drying was quite similar for the 
studied FD cake (Fig 4, left) and fine SFD particles (Fig 4, right). The initial drying rate 
for the freeze-dried cake was slightly higher than for the fine SFD particles. This can be 
assigned to the more efficient heat transfer into the cake structure [24]. However, in 
both cases the water loss faded out after 24 hours. With the additional surface of the 
porous particles the drying speed was not improved, although other authors suggested a 
shorter drying time of highly porous SFD particles [25]. They proposed that the short 
conduction and diffusion length and the resulting low heat and mass transfer resistance 
are responsible for the shorter drying cycle.  
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Figure 4: Drying rate during primary drying in the lyophilization process of cake structure (left) and spray 
freeze-dried of fine particles (right). 
 
3.3 PARTICLE YIELD AND RESIDUAL SOLVENT CONTENT 
Within vial freeze-drying no product loss occurred and a 100 % yield was achieved. For 
the SFD particles the yield varied between 63 % for fine and 97 % for large particles 
(Tab 1). The large material loss for the fine particles was assigned to the Leidenfrost 
effect, as the particles disappeared to the wall or out of the stainless steel container. 
Handling of liquid nitrogen, as well as the collection and transfer of particles into the 
drying chamber was more complicated for the fine particles and resulted in a greater 
material loss.  
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Table 1: Yield of particles prepared with the different set-ups and residual ethanol content in comparison to the 
conventional freeze-dried cake.  
spray freeze-drying 
parameter 
freeze-drying 
cake fine particles small particles large particle 
yield  
[%] 
100.0 ± 0.0 63.0 ± 5.2 93.0 ± 2.8 97.0 ± 1.5 
residual ethanol  
[ppm] 
4120 ± 254 397 ± 85 1007 ± 128 1845 ± 104 
 
FD cakes contained residual ethanol contents above 4000 ppm. Two possible 
explanations for the high residual ethanol content after lyophilization were already 
discussed in chapter 2: the retention of ethanol by hydrogen bonding to trehalose and 
the entrapment of ethanol in microregions within the freeze-dried cake. Especially for the 
fine particles a tremendous decrease in residual ethanol down to 397 ppm compared to 
the larger particles with 1845 ppm was determined (Tab 1). The fine porous structure 
improved the extraction of ethanol out of the particles. The formation of so called 
microregions could be reduced due to the very fast freezing process. Furthermore, an 
extraction of ethanol during the freezing step by liquid nitrogen should be considered as 
well and further studies are necessary to prove this assumption.  
 
3.4 PARTICLE SIZE DISTRIBUTION 
The major advantage of the SFD technique is the ability to control particle size 
characteristics. By varying liquid feed and with it the atomization rate and the droplet 
formation, the particle size can be adjusted. The SFD process rendered particles with a 
mean size d[4,3] of 37.5 µm for the fine particles compared to 485 µm for small particles 
and 2915 µm for large particles (Fig 5).  
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Figure 5: Volume-based size distribution of fine, small and large particles prepared with the different spray 
freeze-drying set-ups.  
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Without a pre-freezing vessel a controlled size distribution could not be achieved for large 
particles, due to the rupture of the droplets upon contact with the liquid nitrogen surface. 
However, due to the Leidenfrost effect an agglomeration of droplets occurred dependent 
on the size, although the liquid nitrogen bath was stirred. Such agglomeration resulted in 
larger agglomerated particles, especially for the small particle fraction. With direct 
spraying of the liquid feed into the liquid nitrogen this effect can be overcome as 
described by Yu et al. (2004).  
A pre-freezing step, as it was described for the larger particles in set-up (B), would also 
avoid such coalescence effects on the liquid nitrogen surface. However, direct spraying 
into the used freezing vessel was not feasible in our laboratory due to technical 
limitations. Scanning electron microscopy revealed a more porous structure for the fine 
particles (Fig 6, left), as compared to the larger particles which exhibit a solid interior 
(Fig 6, right). The porous structure of the small particles can be explained by the very 
fast freezing and hence the formation of small ice crystals within the frozen droplets. A 
denser structure was obtained for the large particles due to the pre-freezing of the outer 
shell in the pre-freezing vessel followed by the complete freezing in the liquid nitrogen.  
 
   
Figure 6: Scanning electron micrographs of fine porous particles (left), small spray freeze-dried particle 
(middle) and large compact spray freeze-dried particle (right). 
 
3.5 RESIDUAL MOISTURE 
A low residual moisture content of 1.0 % was achieved for the freeze-dried cakes. The 
almost similar residual moisture of SFD small particles was 1.8 and 1.5 % for fine and 
larger particles (Tab 2). The heat transfer into particles was reduced compared to the FD 
cake, due to the large convective gas layer between the particles. Although reduced 
residual moisture levels were expected for the greater surface to mass/volume ratio of 
smaller particles [26], the water evaporation was not more efficient with the increasing 
particle surface compared to the freeze-dried cake.  
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Table 2: Yield of particles prepared with the different set-ups, residual moisture and residual ethanol content in 
comparison to the conventional freeze-dried cake.  
spray freeze-drying 
parameter 
freeze-drying 
cake fine particles small particles large particles 
residual moisture  
[%] 
1.0 ± 0.12 1.5 ± 0.2 1.8 ± 0.3 1.5 ± 0.4 
 
3.6 PARTICLE MORPHOLOGY 
The particle morphology of the SFD particles was analyzed by DSC and XRD and 
compared to regular FD cakes. A glass transition temperature at about 40°C for small 
and 44.5°C for the larger particles compared to 65.7°C for the freeze-dried samples was 
measured by DSC (Fig 7, left). The glass transition temperatures were indicative for an 
amorphous state of the spray freeze-dried products. The lower Tg of the SFD particles 
can be attributed to the higher residual moisture contents.  
To confirm the amorphous state of the products X-ray powder diffraction was performed. 
The scattering curve of a freeze-dried sample displayed a broad maximum in the range 
from 17 to 25° 2-Theta with two maxima at about 20 and 24° 2-Theta, corresponding to 
a lattice spacings of about 4.4 and 3.7 Å, respectively (Fig 7, right). It was expected that 
these were due to the packing of the amorphous trehalose matrix. The spray freeze-dried 
samples displayed a slightly different pattern and mainly the broad halo was less 
pronounced. This behavior was particularly obvious for the small particles, which were 
directly frozen in the liquid nitrogen. The data suggested that the fundamental structure 
of the trehalose matrix was amorphous and similar for the large spray freeze-dried 
particles and the freeze-dried samples.  
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Figure 7: Glass transition temperature (Tg) of small and large SFD particles and the FD cake (left) and wide-
angle X-ray diffraction pattern for SFD small and large particles and the FD cake (right).  
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3.7 LIPOSOME CHARACTERIZATION 
Preformed placebo and drug loaded liposomal formulations were used for spray freeze-
drying and the freeze-drying experiments. After SFD the dry free flowable particles 
exhibited excellent redispersibility characteristics in an aqueous medium, better than the 
FD product, due to the enlarged surface area. For the placebo formulations the liposome 
size decreased by 22 % for fine particles and by 17 % for large particle after SFD as 
compared to the initial solution before processing. The polydispersity index on the other 
hand increased from 0.16 to 0.20 for small particles and to 0.19 for large particles. No 
changes in liposomes size and polydispersity were determined for the lyophilized sample 
(Fig 8, left). Freeze-drying of Paclitaxel loaded liposomal formulations affected the 
liposomal polydispersity in all investigated cases (compare chapter 2). For the Paclitaxel 
formulations the liposome size and polydispersity index increased only slightly for SFD 
particles (Fig 8, right). For the freeze-dried Paclitaxel formulation the liposome size 
remained constant. However, the polydispersity index significantly increased to 0.34 after 
the freeze-drying process.  
0.0
0.1
0.2
0.3
0.4
before FD cake SFD fine SFD small SFD large
0
50
100
150
200
250
300
 
z-
av
er
ag
e
 size  polydispersity
 p
o
ly
d
is
p
er
si
ty
 i
n
d
ex
0.0
0.1
0.2
0.3
0.4
before FD cake SFD fine SFD small SFD large
0
50
100
150
200
250
300
 
z-
av
er
ag
e
 size  polydispersity
 p
o
ly
d
is
p
er
si
ty
 i
n
d
ex
 
Figure 8: Liposome size before processing compared to the freeze-dried cake and the spray freeze-dried fine, 
small and large particles of placebo formulations (left) and Paclitaxel loaded formulations (right). 
 
The very fast freezing in the SFD process improved the preservation of the liposomes, 
which was very pronounced for the Paclitaxel formulation probably due to the formation 
of smaller ice crystals compared to freeze-drying. Because of the fast freezing no phase 
separation within the droplets between the pure ice and the frozen eutectic liquid 
occurred [27]. The Paclitaxel remained associated to the membrane structure of the 
liposomes as before processing, which is a major advantage of using SFD for the 
stabilization of these formulations.  
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3.8 LIPID AND PACLITAXEL RECOVERY  
The lipid recovery in placebo and Paclitaxel formulations was completely preserved for 
the freeze-dried cake and the larger spray freeze-dried particles (Tab 3). A significant 
reduction in lipid content by about 30 and 50 % for placebo and Paclitaxel formulations 
was determined for the fine particles. Such tremendous changes in lipid recovery can be 
explained by the particle loss resulting from the Leidenfrost effect during the contact of 
the fine aqueous droplets with the liquid nitrogen. The boiling of cryogenic liquid nitrogen 
caused stress to the particles, which led to decomposition and the variation in lipid 
content by extraction or phase separation.  
Table 3: Lipid recovery of placebo and Paclitaxel loaded formulations of the lyophilized cakes and fine, small 
and large particle after spray freeze-drying and reconstitution. 
DOTAP-CL DOPC  DOTAP-CL  DOPC  lipid recovery 
[%] placebo  Paclitaxel loaded 
FD cake 102.5 ± 2.5 101.8 ± 1.9 101.3 ± 2.3 98.2 ±3.1 
SFD large particles 103.0 ± 3.7 101.0 ± 2.2 97.4 ± 5.4 96.3 ± 5.2 
SFD small particles 101.0 ± 2.1 102.2 ± 2.8 93.5 ± 3.5 93.2 ± 2.4 
SFD fine particles 71.0 ± 2.1 71.5 ± 2.8 44.0 ± 6.4 47.1 ± 6.1 
 
Quantification of Paclitaxel in the formulations revealed almost 100 % recovery of the 
drug for the freeze-dried cake and after spray freeze-drying for small and large particles. 
A decrease in Paclitaxel concentration of about 10 % was observed for fine particles (Fig 
9, left). During all processes the degradation product 7-Epipaclitaxel was formed, with 
1.4 % for the freeze-dried cake, 1.0 % for large and small particles and 1.2 % for fine 
particles (Fig 9, right). The faster freezing rates during spray freeze-drying resulted in 
the optimized stabilization of Paclitaxel in the membranes of the liposomes, which is 
indicative by the slightly lower content of 7-Epipaclitaxel.  
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Figure 9: Paclitaxel concentration of lyophilized cake and the particles after spray freeze-drying and 
reconstitution (left) and the 7-Epipaclitaxel concentrations (right). 
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4. CONCLUSIONS 
The presented study demonstrates that liposome stabilization by spray freeze-drying is a 
feasible alternative to the so far used freeze-drying process. An advantage of SFD is that 
a bulk of free-flowable particles is obtained, which can be used for flexible dosing and 
filling to various primary packaging. Particle size can be adjusted in a wide rage between 
20 µm and 3 mm by the selection of an appropriate nozzle type and the applied spraying 
conditions, e.g. liquid feed rate and atomization pressure. In general, higher atomizing 
air flow rates led to smaller particles in the final product. During spray freeze-drying the 
spherical shape and size of the particles was maintained for large particles upon pre-
freezing in gaseous nitrogen and for small particles also by direct freezing in liquid 
nitrogen. For larger particles the application of the developed pre-freezing vessel was 
essential to obtain intact particles and to avoid disintegration. While all deployed lipid 
was recovered for larger particles, a loss of about 60 % occurred for fine particles which 
can be ascribed to the Leidenfrost effect. To avoid the Leidenfrost effect spray-freezing 
into liquid nitrogen could be alternatively tested.  
One draw back of SFD is the complicated handling of the liquid nitrogen during the 
transfer from the spray-freezing equipment to the freeze-dryer. Other than expected the 
drying velocity of the spray-frozen particles was comparable to conventional vial freeze-
drying although the surface area of the particles was larger. The residual moisture 
content could be reduced by decreasing the droplet size and ranged between 1.8 % and 
1.5 %. Determination of liposome size and polydispersity index revealed a stabilization 
effect of spray freeze-drying. Most importantly, an almost complete recovery of Paclitaxel 
was achieved for the small and large particles after reconstitution of the dried product. 
Less degradation products of Paclitaxel were formed as compared to conventional vial 
freeze-drying.  
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Chapter 4  
 
Development of a Percolative Vacuum-Drying Process  
 
 
 
Abstract : 
The newly developed percolative vacuum-drying (PVD) method combined the principles 
of several techniques, such as spray freeze-drying, vacuum-drying and atmospheric 
freeze-drying in one set-up. Due to this combination the drying of frozen particles 
prepared by spray-freezing was significantly accelerated. The introduction of a 
percolation gas enhanced the heat transfer into the particle layer and improved the 
sublimation rates. Dry free flowable particles were obtained with adjusted particle size by 
spray-freeze particle size distributions. The liposome size and loading efficiency was only 
affected in a minor way although a crystallization of the excipient trehalose occurred 
within the powder.  
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1. INTRODUCTION  
Freeze-drying (FD) is one of the most useful techniques for drying of thermolabile 
compounds, which are unstable in aqueous solution. Spray freeze-drying (SFD) is a 
relatively new method for the preparation of particles where the particles are frozen in 
liquid nitrogen followed by a conventional drying process under vacuum. Both processes 
consist of two steps where the product is first frozen as a cake or as particles and the 
water is then subsequently removed as vapor from the frozen state in the dehydration 
step. To achieve sublimation of water/ice from the solid phase directly into the gaseous 
phase it is necessary to keep vapor pressure and temperature below the triple point 
(Fig 1). However, as already described in chapter 2 for freeze-drying and chapter 3 for 
spray freeze-drying the low temperature and the high vacuum only resulted in marginal 
driving forces for heat and mass transfer. The drying rates during SFD were very low and 
the process was therefore very time consuming. During SFD the drying time could not be 
shortened although the surface areas of SFD particles were significantly increased 
compared to cakes from conventional vial freeze-drying.  
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Figure 1: Phase diagram for water and the corresponding phase-transition processes.  
 
Freeze-drying processes are generally performed by applying a vacuum to the system. 
However, the presence of a strong vacuum is not obligatory to induce sublimation. Only 
the partial pressure of water vapor in the drying medium must be kept low enough to 
provide a driving force for mass transfer and water vapor removal from the frozen 
sample. To further improve drying processes and to reduce drying time and with it the 
costs, technologies like atmospheric spray freeze-drying [1], fluid bed freeze-drying [2,3] 
or vacuum assisted drying [4] were developed. Some of these processes use cold gas to 
foster the water removal and as heat source to achieve sublimation close to atmospheric 
pressure. 
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Our newly developed percolative vacuum-drying (PVD) method combines several of the 
described approaches to improve heat and mass transfer between the circulation drying 
medium and the frozen sample. A vacuum was maintained during the drying process 
while a drying gas percolated through a cooled static particle bed [5,6]. By the 
application of a vacuum the thawing of the frozen particles during the drying process was 
inhibited. To produce particles the spray-freezing set-ups as described in chapter 3 for 
the production of small or large particles were used. The objective of this study was to 
evaluate the feasibility of the percolative vacuum-drying technique for the stabilization of 
liposomal formulations. The focus was set on the influence of operation variables on the 
quality of the dried particles and the integrity of the liposomes. 
 
2. MATERIAL AND METHODS 
2.1 LIPOSOME PREPARATION 
The ethanol injection technique was used for preparing placebo and drug containing 
liposomes. Briefly, for the placebo formulation a lipid stock solution of 400 mM DOTAP-Cl 
(1,2-dioleoyl-3-trimethylammonium-propane-chloride) and DOPC (1,2-dioleoyl-sn-
glycero-3-phosphocholine) in ethanol was prepared (Merck, Darmstadt, Germany). 25 ml 
of this lipid stock solution were subsequently injected under stirring into 975 ml 
10.5 % [w/v] trehalose solution to result in a total final lipid concentration of 10 mM. The 
ethanol injection was followed by five cycles of extrusion through a 0.2 µm polycarbonate 
membrane. The fluorescent probe Coumarin (Sigma-Aldrich, Darmstadt, Germany) was 
directly dissolved within the lipid stock solution with a final lipid concentration of 10 mM 
in total, and a final concentration of 15.4 µM Coumarin. 
 
2.2 FLUORESCENCE SPECTROSCOPY  
Fluorescence spectroscopy was performed using a Varian Cary Eclipse (Darmstadt, 
Germany). 2 ml of the solutions were measured in quartz cuvettes at a constant 
temperature of 20°C. For the determination of the Coumarin content in the samples a 
standard curve with 0 to 20 mg/l Coumarin in ethanol was measured. The excitation 
wavelength was 410 nm and the emission intensity was recorded at 520 nm. The 
emission and excitation slits were set to 5 nm and the voltage of the PMT detector was 
set to 800 V. After PVD drying the samples were reconstituted and centrifuged using 
Ultrafree® 0.5 centrifugal filter devices (Millipore, Bedford, MA, USA) with a cut-off off at 
10K to remove the free drug content.  
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2.3 PERCOLATIVE VACUUM-DRYING METHOD (PVD) 
Preliminary experiments were carried out using the technical set-up as shown in Figure 2. 
Small and large particles were prepared by spray-freezing a preformed liposome 
suspension which contained trehalose as stabilizer. The frozen particles were loaded with 
liquid nitrogen into the pre-chilled drying chamber at a temperature of below -20°C. To 
maintain the temperature below the freezing point inside the percolation drying chamber 
after the evaporation of the liquid nitrogen the double walled jacket was adjusted to 
temperatures between -40 and 10°C during the process. The temperature was controlled 
by an intercooler with a cooling agent or by using a self developed liquid nitrogen supply. 
The percolation medium was gaseous nitrogen in an open loop system. A percolation flow 
rate between 15 to 30 l/h nitrogen was used. The vacuum inside the drying chamber was 
maintained between 1 and 4 mbar by a vacuum pump duo 10 (Pfeiffer, Assler, Germany) 
with a total capacity of 10 m3/h.  
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Figure 2: Schematic construction of the percolation drying apparatus to spray-freeze particles.  
 
All further methods used in this chapter are already described before.  
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3. RESULTS AND DISCUSSION 
3.1 THE PERCOLATIVE DRYING CONCEPT 
To obtain dry PVD powders, the frozen solvents must be sublimated. Compared to 
freeze-drying with a freezing step over several minutes or hours, the high cooling rates 
in SFD inhibit ice crystal growth after nucleation, leading to small ice crystals with a large 
ice crystal surface area [7]. These small ice crystals produce a very fine microporous 
structure in the particles and affect the water vapor permeability during the drying 
process. However, a direct comparison of the drying rates measured during SFD and FD 
of a cake revealed no enhanced water sublimation rates for the SFD product.  
In literature it is often referred to that liposomal fusion, aggregation and a collapse of the 
samples can be avoided by selecting drying conditions (product temperatures) below the 
glass transition temperature of the maximally freeze concentrated solution (Tg´) [8,9]. 
However, we found a so called no collapse range (Tnc) above the Tg´ of the formulation 
which was at -47°C (Fig 3).  
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Figure 3: Product temperature of the applied vacuum [10] with the glass transition temperature of the 
liposomal formulation. The assumed temperature range without any collapse and the product temperature 
induced by the vacuum are shown. 
 
Depending on the heat transfer and drying rate no macroscopic collapse of the cake 
occurred in this Tnc range above approximately -47°C. As upper limit of the non collapse 
region the Tg´ of pure trehalose at -28°C was estimated. However, the non collapse 
region reaches probably to even higher temperature, which was not tested so far. 
Furthermore, only minor effects on the liposomal properties were determined. Therefore, 
we assumed that this Tnc range can be used as a working area for the PVD process. The 
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lowest applied vacuum was 1.5 mbar which can be assigned to a product temperature of 
-18°C. The applied vacuum and the great temperature difference between the product 
and the percolation gas resulted in a high sublimation rate. This led to an evaporative 
cooling effect of the product. Additionally, the heat and mass transfer were raised by a 
continuous increase of the chamber temperature.  
The gas inlet temperature during the percolative process was about 15°C, which is 
clearly above the eutectic temperature and the temperature of the ice-vapor interphase 
of the frozen sample. Although the percolation gas temperature was relatively high the 
particles almost retained their structure and size during the process. The very fast 
sublimation rates, as well as the vacuum (Tvaccum) and the chamber temperature (Tchamber) 
preserved the material due to the cooling effect induced by the sublimation. The frozen 
particles were placed into liquid nitrogen, with a temperature of -196°C in the drying 
chamber and the drying process occurred ideally within the described product 
temperature range (Tproduct) (Fig 4).  
 
Figure 4: Schematic drying profile during percolative-drying of the spray freeze-dried particles of the liposomal 
formulation.  
 
Simultaneously, the thermal treatment during the warming of the product resulted in a 
continuous annealing and drying process. The conventional annealing processes during 
lyophilization use the effect of crystal growth during the annealing step and result in 
faster sublimation rates during primary drying [11]. The percolative gas flow through the 
particle layer further enhanced the heat transfer into the product and the sublimation of 
ice. Furthermore, the gas temperature raised the product temperature, which should 
result in a balance between heat transfer and drying rate at a certain vapor pressure. 
The formed dry layers on the particles, which are known to increase the product 
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resistance, did not influence the heat transfer. The low heat conductivity of dried material 
and the layer resistance can be neglected in such a percolation drying processes 
compared to freeze-drying of a solid cake under vacuum because of the percolation of 
the drying gas, which further strengthens the movement of the vapor phase. The major 
challenge of this process is to achieve a gap where the mobile water which is present 
above the Tg´ is removed before collapse occurs (Fig 4). 
To avoid controlled collapse and/or crystallization an optimum product temperature 
profile defined by the percolation rate and the gas temperature is essential for the drying 
process. Therefore, the process parameters must be selected in the no collapse area 
(Tnc). The fact the Tg´ raises with the drying status of the product support this 
assumption [12]. The crystallization of the powder during the process (compare 3.3) 
indicated that this range was not yet found sufficiently.  
 
3.2 RESIDUAL MOISTURE  
The residual moisture content varied between 4.0 % for large and 2.6 % for small 
particles (Tab 1). During the drying process of the particles first weak bound surface 
water was removed followed by the water of the large capillaries and finally the capillary 
water out of the particle core. With the selected drying conditions and the applied 
vacuum the residual absorbed water could not be removed. 
During freeze-drying and spray freeze-drying ethanol could not be completely removed 
(compare chapter 2 and 3). After reconstitution of the particles produced by percolative 
drying no residual ethanol was detectable for all drying conditions (data not shown). This 
is a major advantage of this technique.  
Table 1: Process parameters during percolative drying at varied temperature and percolation gas flows in 
respect of process time and residual moisture.  
chamber 
temperature [°C] 
batch 
no. 
particle 
type 
start end 
percolation gas 
flow 
[l/h] 
vacuum 
[mbar] 
process 
time 
[h] 
residual 
moisture 
[%] 
1 large -40 15 14.8 4.5 4 2.8 
2 large -8 10 14.8 3.5 12 4.0 
3 large -1 9 22.2 2.5 4 3.5 
4 small -1 14 22.2 3.5 4 3.5 
5 small -1 9 22.2 1.5 2 2.6 
6 small -5 5 29.6 2.0 2 3.9 
7 small -1 9 29.6 2.0 2 2.7 
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3.3 PARTICLE MORPHOLOGY 
DSC and X-ray powder diffraction were used to characterize the morphology of the 
percolative dried particles. To characterize the amorphous phase the glass transition 
temperature was determined by DSC for percolative dried particles. The glass transition 
temperature was located at 49°C for the smaller particles (Fig 5, left). The X-ray 
diffraction pattern of percolative dried samples displayed crystalline peaks with higher 
intensities for the larger particles (Fig 5, right). The heat transfer and the temperature 
increase during the process were faster for smaller particles compared to larger particles 
at comparable percolation gas flow and chamber temperature. Although the small 
particles showed partially crystalline structure the liposome properties were preserved 
(compare 3.4). These data indicated that the temperature profile for the selected 
conditions passed the “Tg´ line” and the free water was not sublimated fast enough. This 
resulted in glassy material with a local structure similar to that in crystals. Only a 
minimal rearrangement was necessary for nucleation and crystal growth [13]. 
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Figure 5: Glass transition temperature (Tg) of percolative dried small particles (left) and wide-angle X-ray 
diffraction pattern for crystalline trehalose and large and small particles of percolative dried trehalose (right).  
 
3.4 LIPOSOME PROPERTIES AND DRUG LOADING 
The percolation vacuum-drying process showed a robust and very fast drying progress 
for spray-freeze particles. The primary goal of the developed drying process was the 
preservation of the liposome size distribution and the prevention of leakage and fusion. 
Liposome size and polydispersity were only slightly affected by the percolative drying 
process (Fig 6, left) although crystallization occurred. For example the size stayed 
constant and only the polydispersity index increased slightly from 0.21 to a maximum of 
0.22 for batch no. 6 (small particles). The drug loading studies with Coumarin as model 
substance did not reveal significant fusion or aggregation of the liposomes which would 
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result in a loss of the active compound after the percolation drying process (Fig 6, right). 
Only at high percolation gas flow rates the drug recovery decreased to about 90%.  
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Figure 6: Liposome size and polydispersity before and after percolative drying of small and large particles (left) 
and drug loading recovery of Coumarin in small and large particles (right).  
 
3.5 LIPID RECOVERY  
The lipid recovery for the percolative dried products depended on the particle size 
(Tab 2). Larger particles showed about 100 % recovery. The smaller particles showed a 
lipid loss between 10 and 15 %, where it is still unclear to which process step the loss 
could be ascribed. During SFD a lipid loss of about 7 % was determined for the small 
particles although they were dried with a more gentle SFD process. Due to the 
preservation of the lipids within the larger particles the assumption was made that the 
lipid loss occurred already during the spray-freezing process. Further investigations are 
necessary to identify this relation. No lipid degradation products were determined for all 
percolative drying processes (data not shown).  
Table 2: Lipid concentration of small and large particle after spray-freezing and percolative drying. 
lipid recovery [%] 
batch no. 
particle 
type DOTAP-CL  DOPC 
1 large 101.5 102.0 
2 large 99.8 100.4 
3 large - - 
4 small 87.1 87.7 
5 small 85.9 86.2 
6 small 90.5 90.2 
7 small - - 
 
 
 
 
  PERCOLATIVE VACUUM-DRYING 
 
 
 
  
 
67
4. CONCLUSIONS 
The presented investigations demonstrate that liposome stabilization by percolative 
vacuum-drying was feasible. It can be used as a fast alternative to the time consuming 
freeze-drying of spray-frozen particles, which was described in chapter 3. Only 120 
minutes were necessary to dry the same amount of particles compared to 24 hours with 
freeze-drying. Free-flowable particles were obtained, which could be handled as bulk 
material and used for flexible, individual filling to the desired primary packaging 
container. The residual moisture content was reduced to 2.6 % without any additional 
drying step. However, trehalose crystallization occurred during the drying process for all 
studied conditions. Nevertheless, a determination of liposome size and polydispersity 
index revealed a stabilizing effect of percolative vacuum-drying. The reduced lipid 
content or smaller particles most likely due to the Leidenfrost effect could not be solved 
in this chapter, as well. 
However, the results demonstrate a first feasibility study whether drying under the 
described percolative vacuum-drying conditions is possible. Further investigations and 
process variations are necessary to optimize the drying behavior of the particles. A first 
approach can be the reduction of the percolation gas temperature to decelerate the 
thawing process of the particles. In addition, higher vacuums or different chamber 
temperatures should be evaluated to determine the optimum product temperature during 
the drying process. A full understanding of the obtained sublimation rates is essential to 
further optimize this process. The knowledge of the maximum cooling effect induced by a 
specific sublimation rate is necessary to calculate the maximum heat capacity. Overall, 
the use of deeply frozen particles and their behavior during thawing seems to be a 
promising approach for an effective drying method.  
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CHAPTER 5 
 
Evaluation of Spray-Drying as a Stabilizing Technique for Liposomes 
 
 
 
Abstract:  
Spray-drying using a two-fluid nozzle was tested to dry liposome preparations, i.e. 
liposomes composed of DOTAP-Cl/DOPC with the molar ratio 50/50 at 10 mM total lipid 
concentration. Operating parameters such as drying air temperature and volumetric air 
flow were varied. Stable, flowable and dry powders with particle diameters in the range 
from 5 to 70 µm could be produced. Best results were obtained for an inlet air flow above 
473 l/h at a temperature of about 200°C, corresponding to a product temperature (outlet 
temperature) of about 100°C. No indication for chemical degradation of lipids was found 
under these conditions. The redispersability characteristics of the dry powders were 
excellent. The size distribution of the liposomes after reconstitution was remarkably well 
maintained, with a mean size (Zave) of about 130 nm and a polydispersity index (PI) 
mostly below 0.2. Residual moisture was about 2 % at the best conditions.  
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1. INTRODUCTION  
Spray-drying is an established method for the preparation of fine powders ranging from 
about 50 nm to several hundred µm. Its applicability for the drying of liposomal products 
has been demonstrated and it can also be used for regular manufacturing of dried 
liposomal formulations especially for the stabilization of lipophilic drugs [1,2,3,4]. 
However, the particular spray-dried product needs to be evaluated in respect of 
stabilization of the active ingredient and of liposomal integrity after the process. During 
spray-drying, particle formation and drying is achieved in a continuous single step. The 
driving force is the difference in vapor pressure between the drying air and the droplet 
surface. The process consists of (i) atomization of a liquid feed into a spray, (ii) the 
spray-air contact where the moisture evaporates and finally, (iii) the separation of the 
dried particles from the air [5]. A major concern in spray-drying of liposomes is the high 
processing temperatures, which may induce thermal degradation of the lipids and/or the 
active ingredient. Contrary to freeze-drying, the moisture levels should be decreased 
within seconds during the spray-drying process, whereby the moisture level is affected 
by the particle size and the used excipients. As crystallization during the process and 
during long term storage can be fostered by the presence of water, moisture content 
should be maintained at a low level. 
Depending on the design of the spraying nozzle different atomization procedures are 
possible. The most common approaches are two-fluid atomization, pressure atomization 
and electrostatic or ultrasonic atomization. Droplet size and the subsequent particle size 
are depending on the applied nozzle. With a two-fluid nozzle the feed solution is 
transported to the nozzle at relatively low flow rates and mixed with a velocity gas 
stream. Upon mixing, the air causes the feed to break up into a spray. The droplets are 
principally formed at the cap-orifice of the two-fluid nozzle. The droplet size is influenced 
by the surface tension, the viscosity of the feed solution and most importantly, by the 
fluid velocity at the nozzle orifice, as well as the air/liquid mass flow ratio [6]. An 
increase in liquid flow rate at constant atomizing air flow rate modifies the fluid break-up 
and results in larger droplets and hence larger particles [7]. Lipids can reduce the surface 
activity as well as energy and therefore can influence the droplet formation [8,9,10]. 
Trehalose acts as bulking agent in the formulation and plays an important role in 
increasing the surface area of the lipid mixture enabling successful hydration of spray-
dried products [11]. 
When processing heat labile materials, the spray-dryer should be operated in a co-
current manner, where the spray and the drying air pass through the drying chamber in 
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the same direction. Thereby, droplets remain at low temperatures at high moisture 
evaporation rates and the particles get in contact with the coolest air after drying.  
In this study the spray-drying technique (SD) using a two fluid nozzle was tested to dry 
cationic placebo liposomes, as well as liposomes loaded with the fluorescent dye 
Coumarin or the drug Paclitaxel. Two different spray-drying set-ups were tested for the 
spray-drying of preformed placebo and drug loaded liposomes in an aqueous-organic 
medium with trehalose as stabilizing excipient. Parameters like drying air temperature 
and atomizing air flow rate were varied. The morphology and physico-chemical properties 
of the spray-dried particles were analyzed after the process. After reconstituting the 
dried powders with water the liposomes were characterized.  
 
2. MATERIAL AND METHODS 
2.1 LIPOSOME FORMATION  
The ethanol injection technique was used for preparing placebo and drug containing 
liposomes. Briefly, for the placebo formulation a lipid stock solution of 400 mM DOTAP-Cl 
(1,2-dioleoyl-3-trimethylammonium-propane-chloride) and DOPC (1,2-dioleoyl-sn-
glycero-3-phosphocholine) in ethanol was prepared (Merck, Darmstadt, Germany). The 
fluorescent probe Coumarin (Sigma Aldrich, Steinheim, Germany) was used as model 
drug and dissolved within the lipid stock solution at a concentration of 31 µM. 25 ml of 
this lipid stock solution were subsequently injected under stirring into 975 ml 
10.5 % [w/v] trehalose solution to result in a total final lipid concentration of 10 mM. The 
ethanol injection was followed by five cycles of extrusion through a 0.2 µm polycarbonate 
membrane. The liposomal Paclitaxel containing formulation consisted of molar ratio 
50/47/3 of DOTAP-Cl/DOPC/Paclitaxel (Natural Pharmaceuticals Inc., Beverly, MA, USA) 
and was prepared in the same way.  
 
2.2 SPRAY-DRYING METHOD WITH BÜCHI MINI SPRAY-DRYER 
The liposome dispersion was spray-dried with a B-290 mini spray-dryer (Büchi, Flawil, 
Switzerland) combined with the dehumidifier LT mini (Much, Germany) and an improved 
(high resistance) cyclone. Such improved cyclone resistance results in a larger pressure 
drop due to a smaller radius of the cyclone chamber. A two-fluid nozzle equipped with a 
cap-orifice diameter of 0.7 mm was used for spray-drying. Cooling water of about 10°C 
circulated through the double jacket around the nozzle. After separation of the drying 
product the air passes a filter unit through the aspirator (Fig 1).  
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Figure 1: Schematic construction of the Büchi mini spray-dryer B-290 and the measuring points. 
 
The following process conditions were used. The drying air with a relative humidity of 
20 % and an inlet temperature (Tinlet) from 80 to 220°C resulted in a drying air outlet 
temperature (Toutlet) in the range from 40 to 120°C. The atomizing air volumetric flow 
rate (vaa) ranged from 240 to 750 l/h and the drying air volumetric flow rate (vda) was 
kept constant at a maximum of 37.8 m3/h. Finally, the liquid feed volumetric flow rate 
(vlf) was set to 2.7 ml/min for all experiments. In some cases the mass ratio of atomizing 
air to liquid feed (maa/lf) was calculated using equation 1. These conditions were chosen 
to achieve a sufficiently high enthalpy throughput of the system for most process 
conditions [12].  
Equation 1: Mass ratio of atomization air to liquid feed maa/lf was calculated [7]. 
]/[1000]/[10]/[10][min/60min]/[
]/[21.1]/[10]/[
aa/lfm 3333
333
mkglmmllhmlv
mkglmhlv
lf
aa
××××
×××
= −−
−
 
 
2.3 SPRAY-DRYING METHOD WITH A NIRO SD-MICRO 
Paclitaxel formulations were spray-dried using a SD-Micro (GEA-Niro, Copenhagen, 
Denmark) installed in an isolator safety cabinet. This scale-up apparatus allows a spray 
pattern comparable to full scale production units. The system was equipped with exhaust 
gas bag filters to increase the product recovery (Fig 3). Such filters allow the removal of 
fine particle fractions and to maintain the air flow rate constant. A 0.5 mm two fluid 
nozzle in the co-current mode with the following process conditions was used: drying air 
inlet temperature (Tinlet) from 67 to 142°C, resulting in the drying air outlet temperature 
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(Toutlet) in the range from 50 to 111°C, atomizing air volumetric flow rate (vaa) 2 and 
3.5 kg/h and a constant drying air volumetric flow rate (vda) of 30 kg/h. The liquid feed 
volumetric flow rate (vlf) was set from 106 to 977 g/h. An aliquot of the same batch of 
the spraying solution was lyophilized with conditions described in chapter 2 (drying run 
no.1).  
 
Figure 2: Schematic construction of the Niro Mobile Minor SD and the measuring points. 
 
2.4 VACUUM-DRYING  
A secondary vacuum drying (VD) step for 12 hours at 0.01 mbar and 20°C in the freeze-
dryer Epsilon 2-6D (Martin Christ, Osterode, Germany) was implemented for selected 
experiments. This additional drying step was found to be necessary to further reduce the 
residual moisture below 1 %. 
 
2.5 ANALYSIS OF PARTICLE MORPHOLOGY 
The size distribution of solid particles was determined with a laser diffraction analyzer 
(Mastersizer X, Malvern, Germany) and the small-volume-unit, which was used to pump 
the powder suspension into the sample cell. About 20 mg of SD powder were dispersed 
in 10 ml Migylol 812 (Sasol, Marl, Germany) containing 1 % Span 85. Background 
alignment with pure dispersion medium was performed prior to adding the particle 
medium. Laser light scattering intensity was evaluated by Fraunhofer analysis using a 
polydisperse mode. The data were expressed in terms of the particle size diameter at 10, 
50 and 90 % of the volume distribution (d[10], d[50] and d[90]). The span of the 
volume distribution, a measure of the width of the volume distribution relative to the 
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median diameter (d[50]) was derived from (d[90]-d[10])/d[50]. In addition, the mean 
diameter of the volume distribution (d[4,3]) was reported.  
 
2.6 VISCOSITY MEASUREMENTS 
The viscosity was determined by a cone-plate rheometer MCR 100 (Paar Physica, 
Germany). A 75 mm plate was used for the measurement. The computer based system is 
equipped with a Peltier element measurement system. The measurements were 
conducted at a constant temperature of 25°C. 
 
2.7 LIGHT OBSCURATION  
Subvisible particle ≥1 µm were determined by light obscuration measurement using 
PAMAS-SVSS-C Sensor HCB-LD-25/25 (Partikelmess- und Analysensysteme, Rutesheim, 
Germany).  
 
2.8 ZETA-POTENTIAL 
The zeta-potential was determined with the Zetasizer Nano (Malvern, Herrenberg, 
Germany). The measurements were performed in the automatic measurement mode 
using disposable capillary cells (Malvern DTS 1060). 
 
All further methods used in this chapter are already described before.  
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3. RESULTS AND DISCUSSION 
3.1 FEASIBILITY STUDY OF LIPOSOME SPRAY-DRYING 
3.1.1 Particle morphology  
The feasibility studies were performed using the Büchi mini spray-dryer and liposomal 
formulations without drug. Within the hot dehumidified drying air, which is produced by 
the dehumidifier and the heater, the particles dry very rapidly in the main drying 
chamber with drying times shorter than 1 second for spray droplets smaller than 100 µm 
as described by Masters (1991) [5]. The low relative humidity of the inlet air by the 
dehumidifier improved the drying capacity and raised the driving force for water removal 
[13]. The droplet size is affected by various parameters, e.g. liquid feed rate or 
atomizing air flow. The drying process can be divided in two phases beginning with a 
constant drying rate followed by a steadily decreasing drying rate. The particle shape and 
size correlates with the drying rate, which is determined by the liquid feed and basically 
by the outlet temperature described by Maa et al. (1997) [8]. The particle morphology of 
the spray-dried powders for the different atomizing air flows is shown in the scanning 
electron microscopy (SEM) photographs (Fig 3). In general, SEM of the spray-dried 
powders revealed smooth spherical surfaces of the particles for all conditions. At 246 l/h 
larger droplets were formed and the particles tended to partly agglomerate. This can be 
mainly attributed to the low atomization energy and the sticky nature of trehalose during 
spray-drying [14]. However, no rough surface structures or particle shrinkage were 
observed for all studied conditions.  
   
Figure 3: Scanning electron micrographs of spray-dried liposomes dried with atomizing air flows of 246 l/h, 
473 l/h and 742 l/h.  
 
3.1.2 Product temperature during the process 
The correlation between the inlet air temperature and the outlet temperature depends on 
various parameters, in particular the liquid feed, the atomizing air flow rate and the solid 
content in the fluid solution. During the early stage of the drying process the surface of a 
5 µm   5 µm 20 µm 
Tinlet 200°C, vaa 246 l/h Tinlet 200°C, vaa 473 l/h Tinlet 200°C, vaa 742 l/h 
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droplet remains moisture saturated with a temperature lower than Tinlet. This beneficial 
effect preserves the liposomes and the incorporated drug, as it is suggested that the 
majority of water is removed early on the top of the chamber. As the drying continues, 
the droplet temperature raises because the surface is not saturated with moisture due to 
reduced diffusion and convection rate. If the ratio of drying rate to diffusion of water to 
the particle surface is too high, a crusted surface or a viscous film forms, and the 
temperature increases above the so called wet bulb temperature (Twb). This can result in 
collapsed or burst structures due to the high interior vapor pressure and in higher 
residual moisture content [13]. Considering this, Toutlet can be used as the representative 
temperature of the drying droplet and finally the exposed temperature during the 
evaporation process [15]. For the tested trehalose concentrations the outlet temperature 
is plotted against the inlet temperature and the mass ratio of atomizing air and liquid 
feed, as these parameters influence the drying rate (Fig 4).  
A linear relation between outlet temperature and inlet temperature/maa/lf was found at a 
trehalose concentration of 5 % [w/v] for the studied conditions (Fig 4, (A)). At a 
trehalose content of 10.5 % [w/v] the outlet temperature increased at low mass ratio 
atomizing feed to liquid feed (Fig 4, (B)). A further increase in trehalose concentration 
led to a reduced Toutlet and suggested a faster evaporation of water (Fig 4, (C)). Here the 
viscosity and the increased mass ratio of atomized air and liquid feed resulted in different 
droplets sizes and finally a faster drying rate visible by the steeper decreased Toutlet.  
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Figure 4: Outlet temperature (Toutlet) at increasing trehalose concentration of 5 (A), 10.5 (B) and 15 (C) % 
[w/v], mass ratio of atomizing air to liquid feed (maa/lf) at an air inlet temperature of 100, 150 and 200°C.  
 
The high viscosity and solid content influenced the droplet formation and drying 
performance. More energy was required to evaporate the water and consequently the 
outlet temperature decreased. Already at 150°C Tinlet the product temperature revealed 
values of about 55°C and was further reduced below 40°C (Fig 4, (C)). To reduce the 
outlet temperature/product temperature a high mass ratio of atomized air and liquid feed 
or high trehalose concentrations are beneficial.  
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3.1.3 Particle size distribution 
The liquid break-up at the two-fluid nozzle is influenced by the viscosity of the 
formulation, the atomizing air flow and the drying temperature. Maury et al. (2005) 
showed a minor influence of varying liquid feed on the droplet velocity and droplet 
diameter, as compared to the atomizing airflow for trehalose solutions by measuring the 
droplets size distribution using the phase doppler analysis (PDA) [7]. The disintegration 
of the jet is significantly improved by the high velocity of the atomizing air and causes 
sufficient turbulences, which results in small droplets [16]. The atomization appeared to 
be the most important parameter for the size of the particles. The viscosity of trehalose 
solutions increased from 1.09 mPa s at 5% [w/v], to 1.33 mPa s at 10.5% [w/v] and to 
1.56 mPa s at 15% [w/v] trehalose compared to water (0.89 mPa s / 25°C). At 
5 % [w/v] trehalose and Tinlet of 100°C the mass ratio of atomizing air to liquid feed only 
had a minor effect on the particle size distribution. This indicated homogenous water 
evaporation from the droplets during the passing through the drying chamber (Fig 5, 
(A)).  
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Figure 5: Volume size distribution of spray-dried particles at increasing atomizing air flow 246, 473 and 742 l/h 
with different trehalose concentrations of 5 % [w/v] at Tinlet of 100°C (A), 150°C (B) and 200°C (C) for 10.5 % 
[w/v] at Tinlet of 100°C (D), 150°C (E) and 200°C (F) and for 15% [w/v] at Tinlet of 100°C (G), 150°C (H) and 
200°C (I). 
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When increasing the temperature to 150°C the drying speed rose at the high mass ratio 
of atomizing air to liquid feed (maa/lf) and resulted in smaller particles with narrow size 
distributions (Fig 5, (B)). However, for the studied liposomal formulations the particle 
size increased with temperature and drying speed (Fig 5, (C)), as well as with the 
viscosity (Fig 5, (D) to (E) and (G) to (J)). In literature it was already shown that the 
droplet size increases at higher liquid viscosities and results in larger particles shown by 
Adler and Lee (1999) [11] and by Bain et al. (1999) [17]. The increased mass ratio of 
atomizing air to liquid feed (maa/lf) in our study predominantly led to the smallest 
particles size distribution. The mass ratio of atomizing air to liquid feed at 200°C showed 
no significant differences in the particle size distribution. In addition, the span decreased 
from 2.5 to 1.5 (data not shown) with increased solid content, temperature and 
atomization air flow for all particle distributions. 
 
3.1.4 Residual moisture content  
The drying air volumetric flow rate (vda) affected the drying efficacy of the spray-dryer 
and the droplet/particle residence time within the drying chamber. Although the particle 
size increased at higher trehalose contents, the efficient atomization and the higher 
enthalpy throughput resulted in moisture contents below 3 % (Fig 6). A possible 
explanation can be increased hydrogen bonding, which occurs between the sugar and the 
lipids, when more trehalose was present in the liposomal formulations [18].  
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Figure 6: Residual moisture at 5 (A), 10.5 (B) and 15 % [w/v] trehalose (C), with atomizing air flow of 246, 
473 and 742 l/h, determined at an air inlet temperature of 100, 150 and 200°C. 
 
Residual moisture levels under reasonable spray-drying conditions generally range about 
3 to 5 %, which can be too high for a feasible long term stabilization of the formulation 
[19]. Within spray-drying, inlet temperature and the mass ratio of atomizing air to liquid 
feed (maa/lf) can be varied to achieve sufficiently low moisture contents. The residual 
moisture content of the particles decreased from 4.5 % at 58°C to 2.2 % at outlet 
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temperatures above 100°C (Fig 7). Above 100°C outlet temperature the drying capacity 
could be not further improved. However, the manufacturing efficiency is slowed down 
when reducing the vlf and the temperature exposure could affect the integrity of 
liposomes and drug. 
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Figure 7: Residual moisture of the particles after spray-drying at 473 l/h atomizing air flow and after the 
additional vacuum-drying step.  
 
Therefore, a secondary vacuum-drying process after spray-drying might be the helpful 
alternative to reduce the residual moisture within the spray-dried powder. With an 
additional vacuum-drying step of 12 hours at 0.01 mbar and 20°C (Fig 7) a level of 1 % 
residual moisture could be achieved for all samples. After the spray-drying process 
liposomal formulations furthermore contained no ethanol deriving from the ethanol 
injection. Using static headspace gas chromatography (HS-GC) no residual ethanol could 
be detected in the reconstituted spray-dried powders, indicating a complete removal 
during the process (data not shown). 
 
3.1.5 Particle yield  
A decline in yield during spray-drying can be induced by attachment of powder to the 
chamber wall and by reduced cyclone efficiency in collecting fine powders. Such fine 
particle fractions are retained by the back filter and cannot be calculated within this 
balance. However, to further reduce the material loss during spray-drying of the 
liposomal formulation a high resistance cyclone was used.  
The effect of drying temperature and the mass ratio of atomization air to liquid feed 
(maa/lf) on the powder yield was distinct and correlated with the drying behavior of the 
droplets. With increasing trehalose concentrations the product yield decreased for all 
selected conditions (Fig 8). The highest atomizing air flow rate of 742 l/h resulted in an 
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ideal particle distribution for spray-drying with a reduced loss of material at the wall of as 
fine particle fraction. For 5 and 10.5 % [w/v] trehalose concentration a product yield 
above 80 % was achieved at drying conditions of 150°C, which was the optimum inlet 
temperature. For 15 % [w/v] trehalose the solution viscosity resulted in a broader initial 
droplet size distribution. The initial droplet size which is induced by the vaa showed to be 
responsible for the product yield.  
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Figure 8: Product yield at 5, 10.5 and 15 % [w/v] trehalose, atomizing air flow (vaa) of 246, 473 and 742 l/h 
determined at air inlet temperatures of 100, 150 and 200°C. 
 
3.1.6 Liposome recovery  
3.1.6.1 Liposome size and polydispersity 
The liposome size was generally well retained after rehydration as measured by dynamic 
light scattering for all preparations. A slight decrease in liposome size by 20 nm to about 
130 nm could be determined after reconstitution of the dried product (Fig 9). This 
tendency was more pronounced at high trehalose concentrations, which might be due to 
the heat exposure. Higher drying temperatures induce more stress to the lipid bilayers, 
resulting in increased membrane fluidity with larger permeability for the entrapped 
material [20]. Coumarin was used as model drug to investigate this phenomenon. For all 
trehalose concentrations and process conditions a drug loading of about 95 % Coumarin 
could be preserved after the process (data not shown), although it is known that the 
permeability of phospholipids increases during the spray-drying process [21]. Trehalose 
was capable to prevent fusion and leakage of the liposomes during the spray-drying 
process and the rehydration step. As described recently, two stabilizing mechanisms of 
trehalose on the liposomal structure are feasible. At first the sugar preserves headgroup 
spacing in the dried state and thereby prevents the phase transition during rehydration 
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[22]. Secondly, the sugar replaces the water molecules bound to lipid headgroups in the 
hydrate state, when the water is removed by the spray-drying process [23]. 
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Figure 9: Liposome size at 5, 10.5 and 15 % [w/v] trehalose, atomizing air flow (vaa) of 246, 473 and 742 l/h 
determined at an air inlet temperature of 100, 150 and 200°C. 
 
Despite of the relatively constant liposome size, the polydispersity was affected 
depending on temperature and solid content (Fig 10). At higher trehalose concentrations 
the liposomes were preserved better because of efficient protecting properties of 
trehalose and the resulting lower outlet temperatures. At elevated heat exposures during 
our experiments the polydispersity index increased slightly. The preserving effect of 
trehalose depended on its concentration and finally on the droplet size. Although droplets 
containing only 5 % [w/v] trehalose showed a fast drying behavior, the ratio of 
liposomes to trehalose was not ideal. However, the polydispersity values were still in an 
acceptable range for all conditions and indicated preservation of the liposomal structure 
during the spray-drying process.  
5% 10% 15% -- 5% 10% 15% -- 5% 10% 15% -- 5% 10% 15% 
0.05
0.10
0.15
0.20
0.25
0.30
before processing
tinlet 200°Ctinlet 150°C
 
 
p
o
ly
d
is
p
er
si
ty
 i
n
d
ex
trehalose concentration [w/v]
 v
aa
 246 l/h  v
aa
 473 l/h  v
aa
 742 l/h
tinlet 100°C
 
Figure 10: Polydispersity index at 5, 10.5 and 15 % [w/v] trehalose, atomizing air flow (vaa) of 246, 473 and 
742 l/h determined at an air inlet temperature of 100, 150 and 200°C. 
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To study the general impact of temperature exposure on liposome size and polydispersity 
DLS of the liposomal dispersion was measured during a thermal scan from 20 and 70°C 
using steps of 5°C (Fig 11). The liposome size decreased with increasing temperature by 
about 20 % down to 100 nm at 70°C. The polydispersity index was marginally affected 
by the induced temperature and varied between 0.13 and 0.17. After cooling back to 
20°C the liposome size rose again slightly, but did not go back to the initial size before 
the thermal treatment. 
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Figure 11: Liposome size distribution and polydispersity index measured at temperatures between 20 and 70°C 
with DLS.  
 
No damage of the liposomes was detected during spray-drying, which indicated a 
stability of the liposomes to resist heat stress without any leakage. The subsequent 
vacuum-drying procedure showed no negative influence on liposome integrity (Fig 12). 
For all process conditions the liposome size and polydispersity was preserved and no 
fusion could be determined. 
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Figure 12: Liposome properties of the particles after spray-drying of 10.5 % [w/v] trehalose at 473 l/h 
atomizing air flow without and with the additional vacuum-drying step.  
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3.1.6.2 Liposome zeta-potential 
Before processing, the zeta-potential was 50 mV for the liposomal formulation stabilized 
with 10.5 % [w/v] trehalose, which confirmed the incorporation of charged lipids [24]. 
Spray-drying had no significant influence on the zeta-potential, which was not 
substantially changed for all conditions. The values varied between 45 and 51 mV (Fig 
13) and were least changed after the spray draying process in the formulations with 
15 % trehalose slightly. 
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Figure 13: Zeta potential after spray-drying at varied mass ratio of atomization air to liquid feed (maa/lf) 150°C 
Tinlet and increased trehalose content.  
 
The zeta-potential is an important and useful indicator to control the integrity of the 
liposomes. The more positive the zeta-potential the more stable is the liposomal 
membrane, because charged particles repel each another. High zeta potentials therefore 
imply more stable suspensions with less aggregation [25]. 
 
3.1.7 Physico-chemical characterization  
Besides the liposome integrity, the morphology of the dried particles was analyzed, as it 
can affect the storage stability of the formulations. The glass transition temperature, 
which is characteristic for an amorphous system was determined by DSC. The interaction 
of trehalose and lipids, plus the formation of a glassy product have a major impact on 
liposome preservation [26,27]. Here, the glass transition temperature of spray-dried 
trehalose–liposome formulations appeared to generally increase with the drying 
temperature depending on trehalose concentration. At 5 % trehalose the Tg varied from 
38°C at a inlet temperature of 100°C to 47.4°C at a inlet temperature of 200°C 
(Fig 14, (A)). For higher trehalose concentrations the effect was less pronounced, an 
increased Tg of 46°C at 200°C Tinlet was determined (Fig 14, (B-C)). The measured Tg 
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above 45°C is high enough to allow storage of the formulations at room temperature. 
Around and above Tg higher molecular mobility would facilitate fusion and leakage, which 
can result in increased vesicle size in the rehydrated dispersion [28]. Furthermore, a 
crystallization of trehalose indicated by the endothermic peak at about 100°C was 
distinct. The crystallization onset depended on the residual moisture content and the 
molecular structure [29]. The glass transition temperature rose up to 70°C when 
reducing the moisture content e.g by the additional vacuum-drying step (data not 
shown). Water is known to act as plasticizer, which decreases the Tg of formulations 
[30]. 
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Figure 14: DSC thermograms for different trehalose concentrations for spray-dried particles with 5 % (A), 
10.5 % (B) and 15 % (C) [w/w] trehalose.  
 
While DSC is capable to give information about the existence of an amorphous fraction, 
X-ray diffraction can be used to determine potential crystalline fractions in the spray-
dried product. The X-ray diffraction pattern of all spray-dried samples displays a broad 
halo in the range from 17 to 27° 2-Theta with two maxima at about 10° 2-Theta. The 
broad halo and thereby the packaging of trehalose was influenced by the trehalose 
concentration (Fig 15, (A-C)). The lack of resolved reflections in the diffraction patterns 
clearly indicated that no crystalline material could be detected by powder X-ray 
diffraction [24]. 
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Figure 15: Wide angle X-ray diffraction pattern for spray-dried particles for different trehalose concentrations 
5 % (A), 10.5 % (B) and 15 % (C) [w/w] trehalose.  
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The data from DSC and XRD suggested that the fundamental structure of the trehalose 
matrix in the spray-dried particles was amorphous. The glass transition temperature 
increased with inlet drying temperature and a reduction of residual moisture, which was 
evident by vacuum-dried particles with reduced residual moisture and higher Tg.  
 
3.1.8 Lipid recovery  
The initial lipid concentration of the liquid formulation before spray-drying was set as 
100 %. A slight increase and decrease in lipid concentration between 0.5 and 3 % for 
DOPC and DOTAP-Cl could be determined when spray-drying was performed at higher 
temperatures (Fig 16, left). When varying the atomizing air flow only a slight lipid loss of 
approximately 1.0 % was observed for the mass ratio of atomizing air to liquid feed 
(maa/lf) 1.83 and an increase of 3 % for 5.54 (maa/lf) (Fig 16, right).  
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Figure 16: Lipid concentration of DOTAP-Cl and DOPC after spray-drying with an atomizing air flow of 473 l/h 
performed at different temperatures (left), spray-drying at Toutlet of 100°C with a variation of atomizing air flows 
(right). 
 
However, at the low trehalose concentration of 5 % [w/v] the lipid degradation product 
oleic acid was determined for all studied conditions by RP-HPLC (data not shown). It can 
be concluded that more than 5 % [w/v] trehalose is required to prevent lipid 
degradation. 
 
3.2 SPRAY-DRYING OF PACLITAXEL FORMULATIONS  
Handling of cytostatic drugs always requires safety arrangements like working benches 
and protective clothing. Paclitaxel is a high potent anti-cancer drug candidate [31], which 
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makes working in a fully sealed off equipment mandatory like in the Mobile Minor system 
(Niro, Copenhagen, Denmark) installed in an isolator.  
 
3.2.1 Particle properties 
The scale-up equipment revealed an improved drying capacity. With such improved 
equipment the drying air volume behavior changed with respect to evaporation and heat 
transfer capacity. The process and nozzle gas rate and the maximum values of water 
evaporation were doubled compared to the Büchi equipment.  
In detail the drying capacity with a higher constant drying air volumetric flow rate (vda) of 
30 kg/h and the heat capacity (kinetic energy) were more efficient. This resulted in 
substantial higher mass ratios of atomizing air to liquid feed (maa/lf) values (Fig 17, left). 
The residual moisture could be reduced down to 0.6 % at 111°C Toutlet due to the larger 
scale of the spray-dryer and the very low liquid feed rate. A direct comparison with a 
maa/lf value of 3.58 to the experimental set-up used for the feasibility study with the 
placebo liposomes revealed comparable residual moisture levels. A linear behavior 
between Tinlet and Toutlet was found and the drying performance could be adjusted at an 
elevated mass ratio of atomizing air to liquid feed (Fig 17, right). With decreased residual 
moisture the glass transition temperature raised (Tab 1). 
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Figure 17: Residual moisture at increased outlet temperatures (left) and the relation of temperature and mass 
ratio of atomizing air to liquid feed (maa/lf) (right). 
 
The powder yield ranged between 69 and 106 % at high mass ratios of atomizing air to 
liquid feed (maa/lf) (Tab 1). At settings comparable to those used at the Büchi spray-dryer 
for the placebo studies the yield decreased by about 50 %. The loss of material could be 
assigned to lack of drying ability and the selected ratio drying gas to liquid feed. 
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Table 1: Product yield at different mass ratios of atomizing air to liquid feed (maa/lf) and temperatures.  
maa/lf 14.9 14.2 12.9 16.1 17.5 17.5 18.8 3.5 
Tinlet [°C] 64 77 89 102 113 127 142 140 
Toutlet [°C] 50 60 70 80 90 100 110 76 
Tg [°C] 56 69 76 82 >90 >90 >90 50 
yield [%] 73 83 69 76 84 84 106 36 
 
3.2.2 Liposome recovery 
Liposome size and polydispersity were affected by the drug loading with Paclitaxel and by 
the spraying pattern. For some process conditions liposomal integrity and drug loading 
was preserved comparable to the freeze-dried sample (Fig 18, left). Especially the low 
mass ratio of atomizing air to liquid feed (maa/lf) at a Tinlet temperature of 140°C resulted 
in liposomes with optimum polydispersity indices below 0.2. The lipid recovery of DOTAP-
Cl and DOPC was assured for the studied conditions (Fig 18, right).  
0.0
0.1
0.2
0.3
0.4
0.5
before 50°C 60°C 70°C 80°C 90°C 100°C 111°C 76°C FD
120
140
160
180
200
220
 
z-
av
er
ag
e 
[n
m
]
T
outlet
 [°C]
 z-average  polydispersity
p
o
ly
d
is
p
er
si
ty
 i
n
d
ex
0
5
10
15
20
25
50°C 60°C 70°C 80°C 90°C 100°C 111°C 76°C FD
0.0
0.5
1.0
1.5
2.0
2.5
3.0
3.5
4.0
4.5
m
aa
/l
f
 DOTAP-Cl   DOPC
 
lip
id
 r
ec
o
ve
ry
 [
m
g
/m
l]
T
outlet
 [°C]
 m
aa/lf
 
Figure 18: Liposome size and polydispersity index for spray-dried Paclitaxel formulations at increased outlet 
temperatures (left) lipid recovery of DOTAP-Cl and DOPC after spray-dried at increased outlet temperatures and 
feed rates (right) compared to the freeze-dried sample. 
 
3.2.3 Paclitaxel recovery 
As Paclitaxel stability and its loading ability in a lipid membrane are rather low in liquid 
formulations [32], it was of great importance for the studies to preserve the drug loading 
during the process. A partial crystallization of Paclitaxel was determined by light 
microscopy already prior the experiments. This could be attributed to the rather low 
storage stability and the shipping to the test station, resulting in an overall slight 
decrease in Paclitaxel content as compared to the freeze-drying sample. The impact of 
temperature exposure during the drying process on Paclitaxel was obvious by a 
decreased drug content (Fig 19, left). The heat sensitive anticancer drug formed 
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degradation products during spray-drying. Such impurities like 7-Epi-paclitaxel were 
determined after reconstitution of the spray-dried product (Fig 19, right). In general, the 
content of Paclitaxel impurities increased with higher drying temperature and ranged 
between 2 and 15 %. Insufficient drying capacities and the resulting high residual 
moisture content were the reason for the higher impurity rates of about 15 %, at the 
high vlf of 977 [g/h]. 
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Figure 19: Paclitaxel content after spray-drying at increased outlet temperatures and feed rates (left) and the 
impurities at the conditions (right).  
 
3.2.4 Particle contamination 
Due to the crystallization of Paclitaxel prior to the experiments the sub-visible particle 
fraction was already increased before the spray-drying process. A tremendous increase in 
the number of small particles was found after the spray-drying (Fig 20). However, the 
interpretation was difficult because of the quality of starting material with respect to the 
Paclitaxel crystallization.  
before 50°C 60°C 70°C 80°C 90°C 100°C 76°C FD
1
10
100
1000
10000
100000
 
 
p
ar
ti
cl
e 
[n
u
m
b
er
/m
l]
T
outlet
 [°C]
 [>= 1 µm/ml] 
 [>= 2 µm/ml] 
 [>= 5 µm/ml] 
 [>= 10 µm/ml] 
 [>= 25 µm/ml]
shipping
 
Figure 20: Sub-visible particles after spray-drying at increased outlet temperatures and feed rates 
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Further experiments are necessary to clarify the impact of spray-drying on the formation 
of sub visible and visible particles e.g. by repeating the spray-drying experiments directly 
after the production of the EndoTAG®-1 formulation.  
 
4. CONCLUSIONS 
Dry, free-flowable bulk material was obtained when spray-drying liposomal placebo 
formulations with the lab scale spray-drier from Büchi (B-290). The particle size ranged 
between 2 and 100 µm and was lowest at high atomizing airflows and low trehalose 
contents. At an atomizing air flow of 473 l/h and a drying temperature (outlet 
temperature) between 90 and 110°C yields over 80 % and residual moisture values of 
about 2.5 % were obtained. An additional vacuum-drying step was successfully tested to 
further reduce the residual moisture of the particles. The mean liposome size and 
polydispersity index of the starting material were remarkably well retained after spray-
drying, better as with freeze-drying. The protective role of trehalose on liposomal 
integrity became obvious when increasing the drying inlet temperatures to 200°C. Only 
at the higher trehalose concentration of 10.5 % [w/v], the liposomes were sufficiently 
preserved and lipid degradation was impeded. Optimum process conditions for the Büchi 
set-up with a sufficient preservation of the liposomal integrity were found at a drying 
temperature of 150°C with 10.5 or 15 % [w/v] trehalose. 
The Paclitaxel formulation was dried with the scale-up equipment SD Micro (Niro), 
operating with a higher mass ratio of atomizing air to liquid feed (maa/lf) and a larger 
drying capacity. Due to the different process conditions a direct comparison with the lab-
scale placebo experiments is not possible. An optimized particle collection system with a 
back pressure filter after the cyclone improved the product yield up to 70 - 100 % also 
due to the high mass ratios of atomizing air to liquid feed. Even at a low Tinlet of 50°C the 
residual moisture could be decreased to about 4 % and below 1 % at a Tinlet above 90°C. 
For many conditions liposome size and polydispersity were well preserved compared to 
the formulation before processing and in some cases better than in the freeze-dried 
formulation. A polydispersity index below 0.2 was obtained at low mass ratios of 
atomizing air to liquid feed. The lipid recovery after spray-drying was comparable to the 
freeze-dried formulation. The main drawback of spray-drying the liposomal Paclitaxel 
formulation was the formation of the degradation product 7-Epi-paclitaxel. Paclitaxel 
degradation appeared to be triggered by elevated temperatures during the spray-drying 
process, especially at the highest vlf of 977 [g/h]. Therefore, the focus of further 
investigation should be set on the optimization of the drying conditions at low inlet 
temperatures between 50 and 60°C.  
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CHAPTER 6 
 
New Liposome Preparation Technique by Single Pass Extrusion 
 
 
 
Abstract: 
The current preparation technique for the liposomal Paclitaxel formulation consists of 
several time consuming extrusion process steps. High pressure liposome preparation 
could be a possible method for a large scale, cost and time effective manufacturing 
process, which could be performed continuously. Several process conditions, e.g. nozzle 
size and pressure, as well as formulation composition e.g. ethanol concentration were 
varied to optimize the characteristics of the produced liposomes. Two different set-ups 
using an orifice nozzle, respectively an orifice nozzle in combination with a porous 
device were evaluated. The introduction of the porous device was an approach to 
further improve the liposome size and reduce the polydispersity index below 0.15. 
Higher flow rates resulted in higher pressure values and higher shear forces in the 
system, which could reduce the size of multi-lamellar liposome formulations. Increasing 
ethanol concentrations also led to smaller liposomes, even using only a nozzle. Above 
30 % ethanol [w/v] a formation of liposomes was not possible, due to a dissolving of 
the lipids. 
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1. INTRODUCTION  
A variety of basic procedures have been developed for the initial dispersion of lipids in an 
aqueous system and the subsequent preparation of liposomal suspensions. Commonly 
used methods are the hydratization of a dry lipid film with an aqueous medium (film 
method, hand shaken method) or the dispersion of an organic solvent solution of lipids 
into an aqueous medium (ethanol/ether-injection). The resulting multi-lamellar vesicles 
(MLV) usually exhibit a broad size distribution and a heterogeneous lamellarity and 
require additional processing steps to adjust size and uniformity. Several mechanical 
methods like vortexing or hand shaking of phospholipid dispersions [1], high shear 
homogenization [2], micro-fluidizer technique [3] or bubbling inert gas through aqueous 
phospholipids dispersions [4] have been employed to reduce the size of MLVs. Methods 
based on replacement of organic solvents by aqueous media are ethanol injection [5,6], 
ether vaporization [7], reversed phase evaporation [8], double emulsion or freeze 
thawing [9] and controlled dilution of organic solvents [10] have been applied. Other 
methods are based on the detergent removal, like gel exclusion chromatography [11], 
dialysis [12] or dilution [13]. Technical modifications of established methods based on 
spray-drying [14,15,16], freeze-drying of monophases [17] and the use of supercritical 
fluids [18,19] are described as well to reduce the size of liposomes.  
In a discontinuous process, a liposomal suspension was extruded at high pressure (up to 
about 160 MPa) through a small orifice, for example using a so called french press-
apparatus [20,21]. This process was repeated until the desired size distribution was 
achieved. The high pressure homogenization was also described as suitable for the 
preparation of liposomes from lipid/water dispersions without the use of organic solvent 
[22]. Here, typically small unilamellar vesicles (SUV) with quite broad and variable 
distribution are obtained. For the production of large unilamellar vesicles (LUV) with a 
defined size between about 100 and 400 nm and a narrow size distribution, methods of 
size-processing based on the extrusion of liposomal suspension through a uniform with 
defined pore size membrane have been developed [23,24]. Polycarbonate membranes 
with a pore size between 100 and 200 nm were employed in this method, which allowed 
a predetermination of the desired liposome size. To obtain liposomes of high 
homogeneity, they were extruded through the membrane several times [25]. For the 
processing of larger batch sizes, liposomal preparations were extruded through the 
membrane in a continuous cycling mode by a pump until the desired size and 
polydispersity had been achieved [26]. In general, the polydispersity of the liposomes 
decreased with increasing numbers of extrusion cycles. 
 
CHAPTER 6   
 
 
 
  
 
94 
To obtain liposomes with a narrow, well defined size distribution and to reduce the 
number of required extrusion steps, several variations of the extrusion membrane are 
known from established methods. By applying a polymer membrane with a web-like 
structure for the extrusion process good polydispersity indices of 0.2 were achieved for 
egg phosphatidylcholine (EPC) liposomes [27]. Other approaches are the use of an 
asymmetric membrane [28] or of a frit instead of a membrane for liposomal extrusion 
[29]. Different approaches to optimize the liposome formation method employed high 
pressure for the extrusion process with a series of staggered membranes [30]. However, 
no liposomal preparation procedure consisting of only one single step is available in 
literature up to the present. Summarizing, for the large scale production of liposomes 
with a suitable size and a narrow size distribution repeated processing steps either by 
high pressure homogenization or by membrane extrusion method are still required.  
The liposome preparation technique used so far in our project consists of an ethanol 
injection followed by several extrusion steps through a defined polycarbonate filter. The 
production procedure is susceptible to interference, whereby most difficulties are related 
to the blocking of the extrusion membranes. There exists the need for a large scale, cost 
and time effective manufacturing process to produce liposomal formulations, which can 
meet the growing market demands. Furthermore, a process and equipment capable of 
continuous processing and of recycling of the non entrapped drugs, the lipids and 
solvents is required. A possible method to fulfill these needs is high pressure preparation 
of liposomes. The idea arose when using a conventional two-fluid nozzle, which was 
capable to reduce the size of MLVs by the shear forces at the nozzle tip. By adjusting the 
atomizing air flow rate, the liposome size could be reduced and the polydispersity 
improved (data not shown). To achieve higher shear forces a reduction of the bore 
diameter of the nozzle was necessary. Therefore, the preparation with high pressure 
using an orifice nozzle was investigated. The use of high pressure pumps has enabled a 
cycling through an orifice at high pressure, rendering the processing of larger batch sizes 
possible. Homogenization chambers or homogenization nozzles have been especially 
designed for the use with high pressure pumps [31,32]. 
Within this study a new technical approach was developed, which allows both liposome 
formation and the dehydration of lipid formulation in a one step process. Here, large 
multi-lamellar liposomes were reduced in size and homogenized by a high pressure 
approach.  
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2. MATERIAL AND METHODS 
2.1 DEVELOPMENT OF THE HIGH PRESSURE LIPOSOME PREPARATION METHOD 
Multi-lamellar vesicles with a total lipid content of 10 mM were prepared by ethanol 
injection. For the lipid stock solutions 5 mM DOTAP-Cl (1,2-dioleoyl-3-
trimethylammonium-propane-chloride) and 5 mM DOPC (1,2-dioleoyl-sn-glycero-3-
phosphocholine) (both from Avanti Polar Lipids, Alabaster) were dissolved in increasing 
ethanol concentrations between 10 and 60 % [w/v]. Multi-lamellar liposomes formed 
spontaneously upon the injection of the lipid stock solution into a 10.5 % [w/v] aqueous 
trehalose solution (Ferro Pfanstiehl, IL, USA). The suspension of multi-lamellar liposomes 
was sprayed using an ISCO E100X syringe plunger pump (Teledyne ISCO, Lincoln, NE, 
USA) in a pressure range between 1 and 420 bar (Fig 1).  
porous 
device
high pressure 
 pumps
nozzle
(B)
Pic
Fi
(A)
liposome 
suspension
 
Figure 1: Experimental set-up for the spraying variations for the preparation of liposomes by direct spraying 
using an orifice nozzle (A) and in situ extrusion by the porous device (B) followed by nozzle atomization.  
 
Orifice nozzles of the model 121 V G ¼ (Schlick Atomization Technologies, Untersiemau, 
Germany) with a diameter of 0.1, 0.2 and 0.5 mm were used. A conventional stainless 
steel capillary with an inner diameter of 1 mm connected the pumps, the porous device 
and the nozzle. Two different experimental set-ups were developed. In set-up A the 
suspension was pumped directly through the orifice nozzle (Fig 2, left). For set-up B an 
additional porous device unit was placed between the pump and the nozzle, leading to an 
online extrusion of the liposomes (Fig 2, right). For this purpose polycarbonate filter 
membranes (Osmonics Inc., MN, USA) with a pore size of 0.1 and 0.2 µm supported by 
two drain discs (Osmonics Inc., MN, USA) were used. A stainless steel semi prep frit 
(Upchurch Scientific, WA, USA) with a filtration porosity of 10 µm supported the 
combination of drain discs and membrane. Liposome preparation was performed at flow 
rates between 5 and 100 ml/min. 
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Figure 2: Experimental set-up for the spraying direct spraying using an orifice nozzle (left) and in situ extrusion 
by the porous device (right) followed by nozzle atomization.  
 
2.2 DETERMINATION OF DENSITY 
The density of the different solvents was determined using a 25 cm3 DIN ISO 3507 
borosilicate glass pycnometer with stopper NS 10/19 (Brand GmbH & Co, Wertheim, 
Germany).  
 
2.3 DETERMINATION OF SURFACE TENSION 
The surface tension of the liquids was measured with a Processor Tensiometer K 100 
(Krüss GmbH, Hamburg, Germany) using an abraded platinum-iridium plate (height 
10 mm, width 19.9 mm and depth 0.2 mm). For the measurements a sample volume of 
15 ml was employed.  
 
All further methods used in this chapter are already described before.  
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3. RESULTS AND DISCUSSION 
3.1 LIPOSOME FORMATION USING THE CONVENTIONAL EXTRUSION PROCESS 
The conventional liposome formation process, consisting of the ethanol injection 
technique to provide multi-lamellar liposomes followed by the consecutive cycles of an 
extrusion process resulted in a continuous decrease of the liposome size. However, the 
polydispersity was not further improved after six extrusion cycles (Fig 3, left). The 
mechanism of vesicle (liposome) formation by extrusion followed the pattern of the 
cylindrical straight-through pores of a filter membrane. The multi-lamellar vesicles were 
forced through such long narrow tubes with different flow velocities depending on the 
size of liposomes (Fig 3, right).  
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Figure 3: Liposome size and polydispersity index after several extrusion cycles using a 200 nm polycarbonate 
membrane at an extrusion pressure of 2.5 bar (left) and the average calculated velocity of the aqueous 
trehalose/lipid suspension through one pore (right). 
 
The average linear velocity of the liposomal formulation through one pore was calculated 
by Equation 1 [33]. V is the total volume of the suspension, ρ the number of pores per 
unit area of the membrane, R the radius of the filter membrane, r the radius of the pore 
and t the time required to extrude the volume of liposomal suspension.  
Equation 1: Average linear flow velocity [cm/s] for the liposomal suspension through one pore. 
trRρπ
Vu
222
=
 
Water has an average linear flow velocity of about 3 cm/s through one pore, which was 
calculated for a 0.1 µm membrane pore at a pressure of 3 bar. Due to the increased 
viscosity of the aqueous trehalose/lipid suspension the velocity through the pores was 
reduced. The solvent flow inside the pore can be described as a laminar flow, with a 
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parabolic profile. The liquid feed break-up at the nozzle results in smaller droplets and 
reduces the vesicle size via shear stress, whereby the size can not sufficiently be reduced 
within a single step [34]. The relatively low forces obtained by a laminar flow were not 
large enough to result in a homogenous size distribution within one passage. Therefore, 
several extrusion cycles were necessary and a maximum size reduction was obtained 
after six cycles (Fig 3, left). Once vesicles with dimensions smaller than the pore 
diameter were formed, further extrusion did not significantly affect their size. To further 
improve the homogeneity the pressure and therefore the velocity through the pores 
should be enhanced or the pore size radius should be decreased.  
 
3.2 HIGH PRESSURE LIPOSOME FORMATION 
3.2.1 Liposome preparation using an orifice nozzle 
As starting material for high pressure liposome formation, a multi-lamellar liposome 
suspension produced by the standard ethanol injection with a z-average of 650 nm and a 
polydispersity index of 0.65 was employed. The used vaporizing nozzle type consists of 
three parts, the screw fitting, the centrifugal insert and the nozzle head (Fig 4, (A)). The 
forces inside the swirl chamber in the nozzle head are increased by the tangential slits 
and this energy is converted into a rotational energy. The centrifugal film of rotating 
liquids forms a hollow cone of fine droplets after leaving the nozzle (Fig 4, (B)). 
 
Figure 4: Liposome formation using a hollow cone nozzle and detailed description of the centrifugal insert (A) 
with a schematic droplet formation process (B) [35].  
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Gas entrainment results in destruction of the liquid film into liquid ligaments and cross 
triage into the final droplets. The droplet size is affected by the diameter of the orifice 
and pressure, as well as by density, viscosity and surface tension of the solution. Within 
this study the nozzle diameter and the viscosity of the solutions were varied in addition 
to pressure.  
The liposome size distribution was affected by the bore diameter of the orifice nozzle and 
the induced interfacial forces between the jet and the surrounding air. When the liquid jet 
is discharged into air, the disturbance on the jet surface is enlarged because of the 
aerodynamic interaction between the jet and the surrounding ambient. Growth of these 
disturbances causes the liquid column to disintegrate into droplets soon after the 
discharge [36]. As a commonly used classification of jet disintegration the Ohnesorge 
number (Oh), which combines the Weber number (We) and the Reynolds number (Re) 
can be considered [37]. It was suggested that four different break-up regimes for 
waterjets depending on the Ohnesorge number are existent. The first regime is called the 
Rayleigh break-up regime, followed by the 1st wind-induced, the 2nd wind-induced and 
finally the atomization break-up regime. 
The Reynolds number is the ratio between inertial forces and viscous forces and identifies 
the different flow regimes as laminar or turbulent flow. A turbulent stream is 
characterized by a random move, where the velocity of the particles has random 
direction compared to laminar flow. The Reynolds number is calculated by Equation 2 
where ρ is the density, v the liquid velocity, D the diameter of the nozzle and η the 
dynamic viscosity. 
Equation 2: Dimensionless Reynolds number for determination of laminar and turbulent flow.  
η
ρ DvRe ××=
 
The dimensionless Weber number indicates whether the kinetic energy or the surface 
tension energy is dominant for droplet formation. The number is calculated by Equation 3 
where ρ is the density, v the liquid velocity, D the diameter and σ the surface tension.  
Equation 3: Dimensionless Weber number for the ratio of disruptive hydrodynamic forces to the stabilizing 
surface tension force.  
σ
ρ 2vDWe ××=
 
Although the viscosity of the fluid is not considered in the We number it has a 
considerable effect on the droplet formation process [38]. At a higher liquid viscosity the 
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droplet break-up is delayed. Therefore, the Ohnesorge number was calculated by 
Equation 4, combining the Reynolds and Weber number. 
Equation 4: Dimensionless Ohnesorge number for the ratio of internal viscosity to surface tension energy. 
Re
Oh We
D
=
××
=
σρ
η
 
Depending on nozzle bore diameter and liquid flow rate the working pressure raised up to 
420 bar with high flow rates (Fig 5, left). At higher liquid flow rates the Reynolds number 
increased and with it the shear forces inside the nozzle. This resulted in different break-
up regimes and forces at the nozzle during droplet formation (Fig 5, right). In the 
Rayleigh break-up mode, the droplets pinch off the nozzle with diameters greater than 
the jet it self. In the 1st wind-induced regime the droplets are pinched off from the end of 
the jet. These droplets have a diameter close to the jet diameter with droplet formation 
at distances far downstream of the nozzle. Water jets with higher Re numbers and a 
turbulent flow break-up closer to the nozzle exit and tend to produce smaller droplets 
[39]. In the 2nd wind-induced break-up region an unsteady break-up with droplets much 
smaller than the jet can be observed. The last regime is called atomization region, where 
the liquid jet is dispersed directly into a spray at the nozzle outlet. The so formed 
droplets can be dried directly using for example, the spray-drying process. Droplet size 
will affect also the later drying procedure and the resulting particle (compare chapter 5). 
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Figure 5: Liquid flow rate and the resulting pressure with the calculated Reynolds number for the used nozzles 
(left) and the calculated Ohnesorge number for the experiments inside the classification modes of disintegration 
with the different break-up regimes at flow rates 5 (1), 20 (2), 40 (3), 60 (4) and 100 (5) ml/min (right). 
 
For the 0.1 mm nozzle pressures between 25 and 420 bar were obtained at flow rates 
between 5 and 100 ml/min when spraying the MLV liposomal formulations (Fig 6, left). 
The higher pressures at the 0.1 mm nozzle compared to the 0.2 mm nozzle led to 
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smaller liposome sizes and lower polydispersity indices (Fig 6, right). In the preferred 
working range between 60 and 100 ml/min with corresponding pressures between 260 
and 420 bar liposomes with a size of about 120 nm and polydispersities of 0.28 were 
formed. The droplet formation and the resulting shear forces in the atomization region 
are responsible for the improvement in homogeneity. The droplet break-up classification 
with the corresponding forces can be used to describe the effect of liposome formation. 
With high disintegration forces in the 2nd wind-induced and atomization region the 
liposome size can be reduced.  
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Figure 6: Size and polydispersity index of liposomes prepared by high pressure spraying with 0.1 mm nozzle 
(left) compared to the 0.2 mm nozzle (right)  
 
When using the 0.2 mm nozzle at a flow rate of 5 ml/min liposome size decreased from 
650 nm to 400 nm, with a polydispersity index of 0.5 (Fig 6, right). The wide standard 
deviation and the high polydispersity indicated an inhomogeneous size distribution of the 
prepared liposomes. By increasing the flow rate from 5 to 60 ml/min and with it the 
corresponding pressure from 2 to 62 bar, smaller liposomes with lower polydispersity 
indices were obtained. The obtained Re numbers for the 0.2 mm nozzle were relatively 
small compared to the 0.1 mm nozzle and all experiments were done in the 1st and 2nd 
wind-induced region. The droplet break-up changed into smaller droplets and a turbulent 
flow at the highest feasible liquid feed rate of 100 ml/min. However, the still high 
standard deviations for the polydispersity index were noticeable.  
When using the 0.5 mm nozzle it was only possible to work in the Rayleigh and the 1st 
wind-induced region and Reynolds numbers ranged between 160 and 3302. Only above 
80 ml/min turbulent flow rates (> 2500 Re number) were achieved. However, it was not 
feasible to obtain homogenous vesicles (data not shown).  
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3.2.2 Liposome Preparation using a porous device and the orifice nozzle 
3.2.2.1 Liposome preparation using a porous device  
Adjustment of the liposome size between 120 and 180 nm and with a polydispersity 
below 0.28 was not feasible using the orifice nozzle alone. To further improve the 
liposomal properties high pressure nozzles with bore diameters smaller than 0.1 mm and 
controlled parameters would be necessary. However, those nozzle qualities are not 
available on the market yet. Therefore, we developed a high pressure extrusion 
approach, the so-called porous device based on the well known extrusion concept. We 
combined this porous device with the orifice nozzle to further reduce the vesicle size.  
 
Figure 7: Liposome formation using the porous device (left) with a detailed construction (right). 
 
The porous device unit consists of a standard polycarbonate membrane with pore sizes of 
0.1 or 0.2 µm. To avoid rupture and deformation of the membrane at higher pressures, 
drain discs and a porous frit were necessary to stabilize the membrane (Fig 7). 
Furthermore, the porous device ended within the capillary pipe preventing a direct 
pressure drop within or after the porous device. Preformed multi-lamellar vesicle 
suspensions were pumped through the porous device equipped with a 0.1 and 0.2 µm 
membrane at a flow rate of 20 ml/min.  
Table 1: Liposome formation using only the porous device and polycarbonate membranes with 0.1 and 0.2 µm 
pore size.  
 
 
 
 
membrane 
[µm] 
pressure 
[bar] 
z-average 
[nm] 
polydispersity 
index 
velocity through one 
pore [cm/s] 
0.1  5.5 ± 3.3 157 ± 2.1 0.24 ± 0.01 2.16 
0.2  4.5 ± 6.4 166 ± 1.4 0.24 ± 0.01 0.72 
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At the corresponding pressures of 5.5 bar for the 0.1 µm membrane, respectively 4.5 bar 
for the 0.2 µm membrane liposome sizes of 157 nm, respectively 166 nm were obtained 
and the polydispersity index could be reduced to 0.24 for both membrane sizes (Tab 1). 
Different velocities through one pore were calculated for the used membranes with a 
three times faster velocity for the 0.1 µm membrane compared to the 0.2 µm 
membrane.  
 
3.2.2.2 Considerations on liposome preparation using a porous device  
The approach presented above allowed the formation of liposomes with a narrow size 
distribution by only one extrusion passage through the porous device. Still it is not yet 
clear, which mechanism leads to a break-up of large and polydisperse multi-lamellar 
vesicles into smaller, unilamellar and homogenously dispersed vesicles during membrane 
extrusion (Fig 8, (A)). Several mechanisms are described in literature, for example a 
break-up of cylindrical vesicles while passing the pore described by Clerc et al. (1994) 
[33]. The shear forces inside the membrane result in a deformation and at the end of the 
pore in a rupture of the liposomal membrane. 
 
 
Figure 8: The models of conventional extrusion (A) and the porous device extrusion (B) with the mobility of 
vesicles in pores and additionally the pores frit as function of driving field. 
 
The commonly occurring pressure drop across a moving vesicle through the membrane in 
the classical used extrusion equipment was found to increase linearly with the velocity of 
the solution [40]. This pressure drop to ambient conditions favors a coalescence of 
vesicles [41]. Furthermore, theoretical studies revealed vesicle formation within pores 
under shear stress [42]. Other studies focused on the flow of vesicles inside cylindrical 
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pores and the shape deformation occurring inside the pore [43]. The large size of 
polydisperse vesicles after ethanol injection requires energy to press the liposome into 
the smaller pore of the membrane. The formation of liposomes by conventional extrusion 
processes is limited since a further increase in shear force by an increase in pressure 
above 4 bar would rupture the membrane.  
We adopted a model for the porous device extrusion and liposome formation in 
figure 8 (B). The pressure drop directly after the membrane is inhibited by the porous 
device and the pressure in the down stream line, which additionally improved the vesicle 
formation and preserved the membrane. With our porous device the possibility was given 
to increase the flow rate into turbulent flow and achieve higher shear forces leading to 
smaller liposomes. The linear velocity of such viscous suspensions through a uniform 
pore is described with a parabolic profile [44]. The velocity gradient for the investigated 
liposome suspension using the porous device passage could be described as very steep. 
The vesicles move through the pores with a determined velocity and are separated from 
the pore wall by a lubrication layer of a certain thickness. This thickness is a function of 
the velocity of the vesicle in the pore and the surface tension in the lipid bilayer as 
described by Bruinsma (1996) [43]. As the lubrication layer increases, the radius of the 
vesicles in the pore will decrease. This results in a size reduction of the vesicles already 
in the filter membrane induced by the shear forces as well as the amount of lipids and 
viscous solution within the pore.  
 
3.2.2.3 Liposome preparation using a porous device and the orifice nozzle 
In the next step the nozzle was introduced in line after the porous device, equipped with 
a polycarbonate membrane. At a pressure of 4.6 bar (flow rate of 5 ml/min) liposomes 
with a size of 250 nm and a polydispersity index of 0.5 were obtained using only the 
nozzle, while a size of 144 nm and a polydispersity index of 0.26 was obtained when 
combining a 0.1 µm membrane and a 0.1 mm nozzle within the system. With further 
increased pressure at higher flow rates the liposome size decreased (Fig 9, (A)). When 
using the 0.2 µm membrane the homogeneity of the formed liposomes was comparable 
(Fig 9, (C)). After the introduction of the porous device, lower working pressures were 
found in comparison to using only the nozzle, which depended on membrane pore 
diameter and liquid feed. For the 0.1 µm membrane high liquid velocities between 1 to 
11 cm/s with a distinct gradient through the pores could be calculated (Fig 9, (B)).  
The membrane reduced the working pressure up to a flow rate of 40 ml/min. This 
suggested different vesicle formation processes depending on the flow rate and the 
maximum pressure resistance of the membrane to deform the vesicles based on the 
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lubrication layer thickness. The maximum in the plot indicated the changed permeability 
of the filter at a pressure of 20 bar. Within theses experiments much higher forces and 
flow rates were obtained leading to turbulent behavior. The different pressure drop 
induced by the porous device depending on the pore size could be explained by the 
reduced pore density of 3.0 x 108 cm-2 at the 0.2 µm membrane compared to 4.0 x 
108 cm-2 at the 0.1 µm membrane. However, the speed and the resulting shear forces 
within the pores of the membrane were reduced in a 0.2 µm membrane and resulted in 
three times slower velocities (Fig 9, (D)). The lubrication layer in the larger pores was 
more pronounced at the 0.2 µm membrane and the ratio of lipids to viscous solution was 
optimized.  
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Figure 9: Liposomes prepared by high pressure preparation using a porous device at flow rates of 5, 10, 20, 40, 
60, 80 and 100 ml/min with 0.1 µm polycarbonate membrane (A) and a 0.2 µm membrane (C) both adjusted 
with a nozzle size diameter of 0.1 mm and the related liquid velocity with the reduced pressure after the 
introduction of the porous device for the 0.1 µm (B) and 0.2 µm (D) membrane.  
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With an increased nozzle diameter the pressure generation in the system was diminished 
(Fig 10, (B and D)). However, the liposome size decreased slightly with increasing 
pressure and the polydispersity was lower for both membranes (Fig 10, (A and C)). The 
changed liposome size was affected by the reduced turbulences due to the lower 
Reynolds number at that flow rate.  
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Figure 10: Liposomes prepared by high pressure preparation using a porous device at flow rates of 5, 10, 20, 
40, 60, 80 and 100 ml/min with 0.1 µm polycarbonate membrane (A) and a 0.2 µm membrane (C) both 
adjusted with a nozzle size diameter of 0.2 mm and the related liquid velocity with the reduced pressure after 
introduction of the porous device for the 0.1 µm (B) and 0.2 µm (D) membrane. 
 
In summary, it can be pointed out that the combination of a porous device and the orifice 
nozzle resulted in a single size adjusting step to achieve homogenous liposomes smaller 
than 200 nm with polydispersity indices below 0.2 for many process parameters.  
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3.3 HIGH PRESSURE LIPOSOME FORMATION AT HIGH ETHANOL CONCENTRATIONS 
3.3.1 Liposome preparation by ethanol injection  
Ethanol is one of the few organic solvents acceptable in the manufacturing process of 
pharmaceutical products. Due to its good miscibility with water it can be removed easily 
from liposomal preparations by gel filtration, dialysis or tangential flow. Within our 
evaluations, the removal of the aqueous-ethanol phase was investigated by a novel inert 
spray-drying process, which is described in chapter 8. For this purpose, evaluation 
studies to prepare homogenous liposomes with increasing ethanol concentrations were 
performed. Our goal was to investigate up to which ethanol concentrations liposomes 
form spontaneously. At ethanol concentrations between 2.5 and 30 % [w/v] multi-
lamellar vesicles (MLV) formed spontaneously when the ethanolic lipid stock solution was 
injected into an aqueous trehalose solution. The size of the multi-lamellar vesicles 
decreased with increasing ethanol contents in the aqueous phase. At a final ethanol 
concentration of 30 % [w/v] a size of 338 nm and a promising polydispersity index of 
0.38 were achieved (Fig 11)  
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Figure 11: Liposome size after ethanol injection with varied ethanol concentrations in the final formulation. 
 
The results could not be improved by higher stirring or injection rate. Upon the injection 
of lipid solution into the water/trehalose mixture smaller lipid containing droplets are 
formed at higher ethanol concentrations, which yield in smaller vesicles after 
reorientation of the lipid monomers [45]. The liposomes were solubilized at ethanol 
concentrations above 30 % [w/v] resulting in clear solutions (data not shown). This 
result indicates that the liposomes were dissolved at concentrations above 30 % [w/v] 
ethanol to a molecular disperse solution. 
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3.3.2 Liposome preparation using an orifice nozzle 
In the following experiments multi-lamellar vesicles prepared by ethanol injection 
containing between 10 and 30 % ethanol [w/v] in the formulations were fed into the high 
pressure preparation process to achieve monodisperse vesicles. The shear forces inside 
the nozzle are affected by the diameter of the orifice, the pressure, spray-angle, as well 
as the density and the viscosity of the solutions (Fig 12, left). At increased ethanol 
concentrations the viscosity was raised, which resulted in higher shear forces at the 
nozzle determined by the Reynolds number. The viscosity has a considerable effect on 
the droplet formation process and the distribution within a droplet [38]. The different 
ethanol concentrations at various pressures and flow rates resulted in varied droplet 
break-up regions (Fig 12, right). The lower the Ohnesorge number, the weaker are the 
friction losses due to the viscous forces. For this reason most of the energy at the nozzle 
is converted into the surface tension energy 
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Figure 12: Pressure at the liquid flow rates 5, 15, 30 and 60 ml/min for the 0.1 and 0.2 mm nozzle at 10, 20 
and 30 % [w/v] ethanol concentration (left) and the calculated Ohnesorge number vs. the Reynolds number for 
the same conditions (right).  
 
Higher ethanol concentrations resulted in a higher Weber numbers (smaller Ohnesorge 
numbers) and a dominant kinetic energy. For this reason liposome size and 
polydispersity are reduced. Depending on the orifice diameter, pressure and the Re 
number the forces of droplet break-up changed. Small uniform vesicles were achieved at 
a flow rate of 60 ml/min for all ethanol concentrations using the 0.1 mm nozzle (Fig 13, 
(A)). At this flow rate the experiments were performed inside the atomization region. The 
polydispersity only decreased for the ethanol concentration of 30 % [w/v] to values 
below 0.1 (Fig 13, (C)), because most of the inserted energy is converted into kinetic 
energy. This effect was less pronounced for the larger nozzle (Fig 13, (B and D)). 
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Figure 13: Liposome size and polydispersity index at ethanol concentrations between 10 and 30 % [w/v] 
ethanol after pressurization through the orifice diameter of 0.1 mm (A and C) and of 0.2 mm (B and D). 
 
With the addition of ethanol the viscosity increased as well as the shear forces increased 
with lower Ohnesorge numbers and improved kinetic energy by higher Weber numbers. 
This resulted in very small liposomes with an optimized polydispersity. With the porous 
device very high flow rates and pressures are technically feasible and together with 
increasing viscosities this can be used to adjust the liposome size.  
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3.3.3 Liposome preparation using a porous device and the orifice nozzle 
Upon the introduction of the porous device with 0.1 and 0.2 µm membranes into the 
system, a decrease in liposome size was observed even at lower flow rates (Fig 14). 
Depending on the increased viscosity of the multi-lamellar suspension at higher ethanol 
concentrations the liposome size decreased significantly. The 0.2 µm membrane resulted 
in smaller and more homogeneous liposome sizes. With increased flow rates the size 
decreased as described before (compare 3.3.1).  
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Figure 14: Liposome size using membranes with a pore size of 0.1 and 0.2 µm and nozzles of 0.1 and 0.2 mm 
orifice bore diameter.  
 
The polydispersity of the liposome size distribution was dependent on the extrusion 
pressure and the viscosity of the suspension. Compared to the experiments without 
membrane, particularly the polydispersity index was positively affected by the 
combination of membrane and nozzle (Fig 15). For example at 30 ml/min and 
10 % [w/v] ethanol the polydispersity index was 0.34 without and 0.18 with a 0.1 µm 
membrane for the 0.1 mm nozzle. The effect of shear stress on the structure of liposomal 
membranes can be assumed as a perturbation or a change in its spatial organization. 
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With such higher energy levels and hydrodynamic stress the short range order of the 
liposomes can be modified [46]. Above a certain pressure and flow velocity the vesicle 
structure with their binding energy was overcome and reorientation was possible 
resulting in very homogenous vesicles.  
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Figure 15: Polydispersity index using membranes with a pore size of 0.1 and 0.2 µm and nozzle of 0.1 and 
0.2 mm orifice bore diameter.  
 
Although the liquid feed rate and the velocity through the membrane pores were 
constant, the pressure in the system rose compared to the conditions used without the 
additional ethanol content. This effect was a result of the higher viscosity of the liposomal 
suspensions (Fig 16). For all membrane and nozzle combinations and liquid feed rates up 
to 30 ml/min a linear pressure increase was determined. The extrusion process of the 
ethanol containing formulations required more power of the system to maintain the feed 
rate and this resulted in smaller liposomes.  
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Figure 16: Additional pressure increase of ethanol containing formulations after introduction of the porous 
device using membrane with a pore size of 0.1 and 0.2 µm to the nozzle of 0.1 and 0.2 mm orifice bore 
diameter.  
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4. CONCLUSIONS 
The newly developed porous device allowed the use of conventional polycarbonate 
membranes to extrude liposomes and adjust size and polydispersity in a single step. A 
0.2 µm membrane together with a 0.1 mm nozzle was found as optimum combination. 
The advantage of the high pressure preparation is that the shear forces at the nozzle 
described by the Ohnesorge number and at the membrane are sufficient to generate 
liposomes within narrow specifications in a one-step process. The reproducibility of the so 
prepared liposomes was extremely good, low standard deviations for size and 
polydispersity. The high pressure liposome formation performed continuously and is not 
limited in batch size, since it can be easily up-scaled by using larger pumps, filter units 
and nozzle installations. Even with the used continuous working lab-scale equipment, 
flow rates of 100 ml/min were reached corresponding to 6 l/h or 48 l/day.  
The homogeneity of the resulting liposomes was improved by varying membrane and 
nozzle size and thereby increasing the shear forces. The second approach to improve the 
homogeneity was a change of the composition of the formulation by increasing the 
ethanol concentrations and thereby changing kinetic energy values inside membrane and 
nozzle. Very small liposomes with extremely narrow size distributions were obtained at 
high ethanol concentrations. Such a high pressure liposome formation technique could be 
implemented into a spray-drying process, whereby the higher ethanol concentrations 
could positively influence the drying behavior and reduce the drying temperature.  
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CHAPTER 7 
 
Preparation and Spray-Drying of Liposomes using a Single-Step Process 
 
 
Abstract: 
High pressure liposome formation out of a multi-lamellar vesicle suspension followed by 
subsequent spray-drying is a smart one-step process resulting in a dry free flowable 
powder. Hollow spherical particles were obtained, whereby the size of the used nozzle 
influenced the particle size distribution. By using an orifice nozzle to rupture the multi-
lamellar vesicles, liposome size decreased depending on the used flow rate and pressure. 
The introduction of a porous device to achieve an in-situ extrusion was essential to 
improve the polydispersity index. Finally, liposome size and polydispersity were 
dependent on spray-drying conditions and pressure in the system. Within a wide 
temperature range the drying-step did not affect liposome integrity and lipid content of 
the formulations. The combination of high pressure liposome formation with spray-drying 
offered a promising new combination, which is capable for large-scale production of 
homogeneous liposomes. 
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1. INTRODUCTION  
In the spray-drying process the drug containing feed solution is atomized into droplets 
that dry rapidly in a drying gas [1]. The drying time depends on the process conditions 
e.g. liquid feed rate, drying air temperature and aspirator capacity. The heat exposure of 
the droplets is considerably lower than the temperature of the drying air because of the 
evaporative cooling effect. The relatively fast drying process within the drying chamber 
reduces stress for the material. Finally, the product is removed from the air stream by 
the cyclone. A promising study using the spray-drying technique for liposomal 
formulations was already discussed in chapter 5. For large scale production of liposomes 
with a suitable and narrow size distribution usually several repeated sizing steps of the 
liposomal material either by high pressure homogenization [2] or by the membrane 
extrusion are required [3].  
A single step extrusion method for the continuous preparation of appropriately sized 
liposomes was investigated [4] and described in chapter 6. Here, a single extrusion 
process through a porous device is followed by an atomization over the orifice nozzle. In 
the study presented in this chapter the high pressure liposome formation was combined 
with spray-drying to form and dry liposomes in a single step. A multi-lamellar vesicle 
(MLV) liposome suspension was pressurized by an orifice nozzle or by a combination of 
porous device and orifice nozzle followed by a subsequent spray-drying step. Parameters 
like nozzle size, flow rate and corresponding pressure, as well as drying air temperature 
were varied. Both, the spray-dried particles and the liposomes were characterized.  
 
2. MATERIAL AND METHODS 
2.1 LIPOSOME PREPARATION AND DRYING PROCESS 
Multi-lamellar vesicles (MLV) with a total lipid content of 10 mM were prepared by 
ethanol injection. A lipid stock solution with 5 mM DOTAP-Cl (1,2-dioleoyl-3-
trimethylammonium-propane-chloride) and 5 mM DOPC (1,2-dioleoyl-sn-glycero-3-
phosphocholine) (both from Avanti Polar Lipids, Alabaster) dissolved in ethanol was used 
as lipid component for liposome preparation. Multi-lamellar liposomes formed 
spontaneously upon the injection of the lipid stock solution into 10.5 % [w/v] aqueous 
trehalose solution (Ferro Pfanstiehl, IL, USA). The suspension of multi-lamellar liposomes 
was sprayed using an ISCO E100X syringe plunger pump (Teledyne ISCO, Lincoln, NE, 
USA). Orifice nozzles of the model 121 V G ¼ (Schlick Atomization Technologies, 
Untersiemau, Germany) with a diameter of 0.1, 0.2 and 0.5 mm were used. Two 
different experimental set-ups were evaluated (Fig 1). In the first set-up the suspension 
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was pumped directly through the nozzle into the pilot-plant drying chamber with a height 
of 135 cm and a diameter of 80 cm (Mobile Minor, Niro, Copenhagen, Denmark) (Fig 1, 
(pathway A)). Such a pilot plant apparatus with a wide drying chamber and an enlarged 
drying capacity is necessary because of the liquid flow rate of 20 ml/min up to 100 
ml/min and the resulting spray-angle of the orifice nozzle. This drying equipment avoided 
the droplets colliding with the walls and the loss of material during the spraying process. 
For set-up B the porous device was incorporated between the pump and the nozzle, 
leading to an online extrusion of the liposomes (Fig 1, (pathway B)) followed by drying 
process. For the extrusion polycarbonate filter membranes (Osmonics Inc., MN, USA) 
with a size of 0.1 and 0.2 µm supported by two drain discs (Osmonics Inc., MN, USA) 
were employed. Liposome preparation was performed at flow rates of 5 to 100 ml/min 
resulting in a pressure of 1 to 780 bar. The spray-drying process consists of atomization 
of the liquid feed over the nozzle into a spray, spray air contact, moisture evaporation of 
the spray inside the drying chamber and the separation of the dried particles from the 
air. Within the hot dehumidified drying air produced by the dehumidifier and air in-take-
heater, particles dry very rapidly less than 1 second for spray droplets smaller than 100 
µm in the main drying chamber. Powder collection occurs by a cyclone separator into the 
final product container. After separation of the dried product the air passes through the 
aspirator.  
 
Figure 1: Schematic construction of the experimental set-up with high pressure pump and the used Mobile 
Minor pilot plant production spray-dying unit with the diagram of the product and air flow. 
 
The following process conditions were employed for the high pressure liposome 
formation: orifice nozzle diameters were 0.1, 0.2 and 0.5 mm, membrane pore size was 
0.2 µm and the liquid feed volumetric flow rate (vlf) was between 20 and 100 ml/min 
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resulting in a corresponding pressure between 20 and 780 bar. The process conditions for 
the spray-drier were: drying air inlet temperature (Tinlet) between 100 and 240°C, drying 
air outlet temperature (Toutet) in the range of 60 and 150°C and the drying air volumetric 
flow rate (vda) was constant at 80 kg/h.  
 
All further methods used in this chapter are already described before. 
 
 
3. RESULTS AND DISCUSSION 
3.1 PARTICLE FORMATION PROCESS 
The used vaporizing nozzle consisted of three parts: a nozzle head, a centrifugal insert 
and a screw fitting (Fig 2, (A)). When increasing the liquid feed rate and consequently 
the pressure, the spray-angle changed from 76° at 20 ml/min to 127° at 100 ml/min 
using a 0.1 mm (Fig 2, (B)) and from 53° at 20 ml/min to 90° at 60 ml/min using a 
0.2 mm (Fig 2, (C)) orifice diameter nozzle.  
 
76°
91°
127°
105°
53°
61°
90°
nozzle bore diameter 0.1 mm nozzle bore diameter 0.2 mm
outlet outlet
hollow cone nozzle
spray pattern
nozzle head
centrifugal insert
screw fitting
(A) (B) (C)
drying 
chamber
spray 
angle
° > 60, 40, 20 
[ml/min]
° > 100, 60, 40, 20 
[ml/min]
 
Figure 2: Schematic drawing of the hollow cone nozzle with the spray pattern (A), and spray angle related to 
the diameter of the orifice 0.1 mm (B) and 0.2 mm (C) in respect of the liquid feed.  
 
First experiments within a Büchi spray-dryer with an inner diameter of the drying 
chamber of 16 cm were not satisfying because of the too small drying chamber size and 
volume. Particle preparation was not feasible with the Büchi spray-dryer because a 
minimum liquid feed rate of 20 ml/min was necessary to obtain a homogenous droplet 
pattern within the orifice nozzle of 0.1 mm diameter. The drying of the droplets and 
particles did not proceed sufficiently before they impacted with the wall. The still wet 
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droplets and particles attached to the wall, moreover the liquid rinsed from the wall 
already after starting the process. The technical approach to overcome this problem was 
to raise the drying capacity of the equipment. With a reduced flow rate the atomization of 
the liquid feed within the nozzle was not sufficient, which resulted in too large droplets 
impossible to be dried. Therefore, a pilot plant spray-dryer with a wider drying chamber 
of 80 cm was used to avoid the droplets colliding to the wall. With such a larger 
production scale unit and the higher liquid throughput the outlet temperature decreases 
resulting in higher residual moisture values. Therefore, to achieve the same drying levels 
assigned by the outlet temperature a higher air inlet temperature was inevitable.  
The combination of high pressure vesicle formation with a subsequent spray-drying step 
was feasible in the described mobile minor system. A high pressure nozzle with wider 
spraying angles was successfully implemented into the spray-drying process. Free 
flowable powder could be collected and even high liquid feeds up to 100 ml/min were 
dried without any droplet deposition at the vertical wall of the drying chamber. As 
already described in chapter 6 the formation of liposomes was feasible using only the 
orifice nozzle without the drying step. The liposomes were formed out of a multi-lamellar 
suspension induced by the shear forces at the nozzle (pathway A) or by the second 
approach (pathway B) using a single extrusion step through the porous device followed 
by the atomization according.  
 
3.2 PARTICLE MORPHOLOGY 
Particle size and shape were influenced by the properties of the droplets formed by the 
orifice nozzle, as well as by the drying conditions like temperature and aspirator flow. 
The particles exhibited a smooth spherical surface in the SEM micrographs for the 
0.1 mm and the 0.2 mm nozzle (Fig 3). 
   
Figure 3: Scanning electron micrographs of spray-dried particles containing liposomes using a 0.1 mm nozzle 
(left) and 0.2 mm nozzle (right). 
 
Tinlet 200°C, vlf 20 ml/min Tinlet 200°C, vlf 20 ml/min 
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Particles dried at an inlet temperature of 200°C and a vlf of 40 ml/min were composed of 
an outer shell with a thickness of about 2.5 µm and a hollow core, which is obvious in 
figure 4. However, a fraction of broken particles suggested a too high drying rate 
compared to the rate of water diffusion to the particle surface, which resulted in a raised 
internal vapor pressure [5].  
 
          
Figure 4: Scanning electron micrographs with at a magnification of 2700x (left) and 8500x (right) of spray-
dried fractured particles using a 0.2 mm nozzle.  
 
Droplet break-up within a two fluid nozzle is influenced by differences in the relative 
velocity of the flowing liquid and the atomizing air [6]. The dimensionless Reynolds 
number describes the inertial force to friction force ratio of the used orifice nozzle. The 
Reynolds number only depends on the nozzle size and the viscosity, and therefore 
different droplet break-up conditions were found for the used nozzles (compare chapter 
6). When using a hollow cone nozzle the liquid feed is pressurized through the tangential 
slits and this energy is converted into rotational energy. The angular momentum is 
maintained and the peripheral velocity increases towards the orifice bore. This results in 
a reduced static pressure in the nozzle tip itself leading to a liquid film inside the spray 
orifice and a droplet break-up into radial and axial direction building a hollow cone spray 
pattern. Water jets with higher Reynolds number (> 2500 Re) and turbulent flow break-
up closer to the nozzle exit and tend to produce smaller droplets [7]. With increased 
nozzle diameters and reduced Reynolds number larger droplets were formed with lower 
spraying angles. Exemplarily shown for a flow rate of 40 ml/min the mean particle 
fractions were found at 32, 124 and 180 µm for the 0.1 mm, 0.2 mm and 0.5 mm 
nozzles (Fig 5, left). A second, larger particle fraction was obtained for the 0.2 and 0.5 
mm nozzle. The lower pressure of 20 bar for the 0.2 mm nozzle compared to 83 bar for 
the 0.1 mm nozzle led to this bimodal distribution. The span average, which describes 
the width of the volume size distribution, varied significantly with maximally 2.0 for the 
0.1 mm nozzle diameter compared to values above 5 for the 0.2 mm nozzle and above 
10 for the largest 0.5 mm nozzle (Fig 5, right). To sufficiently improve the particle size 
Tinlet 200°C, vlf 40 ml/min Tinlet 200°C, vlf 40 ml/min 
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distributions, a higher liquid flow rate resulting in raised pressure and a higher rotational 
energy would be required. The so formed smaller droplets should be more homogenous.  
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Figure 5: Particle size distribution using 0.1, 0.2 and 0.5 mm nozzle at a flow rate of 40 ml/min (left) and the 
average particle sizes with resulting span (right). 
 
In respect of a more homogenous particle size distribution the 0.1 mm nozzle should be 
used for these experiments. The droplet break-up in the between the 2nd wind-induced 
and the atomization region resulted more homogeneous droplets at the selected 
conditions, which resulted in a span value below 2. For the 0.2 mm nozzle in between the 
1st and 2nd wind-induced the droplets are more heterogeneous.  
 
3.3 PROCESS TEMPERATURES  
The relation between the inlet air temperature (Tinlet) and the outlet temperature (Toutlet) 
depended on the bore diameter of the applied nozzle and the so formed droplet size. For 
the 0.1 mm nozzle a linear relationship between the Tinlet and Toutlet was found (Fig 6, 
left). This is in agreement with the observations made during the spray-drying process 
using a two-fluid nozzle (compare chapter 5). Additionally, the spray-angle within the 
drying chamber impacts the Toutlet. With reduced liquid feed rates and the larger orifice 
diameter the spray-angle is smaller and therefore the drying efficiency is reduced. This 
influence was already evident for the 0.2 mm nozzle where the outlet temperature 
remained constant independent of the inlet temperature in the range of 120 to 210°C 
and a pressure below 100 bar (60 ml/min liquid feed rate) (Fig 6, right). This can be 
explained by the larger droplets formed at the 0.2 mm nozzle with a more heterogeneous 
size distribution due the reduced atomization forces and the low Re numbers of the 
0.2 mm nozzle. The larger droplets and the small spray angles at the selected conditions 
affected the mass transfer and water vapor evaporation.  
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Figure 6: Outlet temperature (Toutlet) versus inlet temperature in respect of the pressure for the 0.1 mm (left) 
and 0.2 mm (right) nozzle.  
 
To achieve optimum drying efficiencies the droplet size distribution should be as 
homogenous as possible and use of the 0.1 mm nozzle is more favorable compared to 
the 0.2 or 0.5 mm nozzles.  
 
3.4 PARTICLE YIELD AND RESIDUAL MOISTURE 
The yield at the different process conditions strongly depended on the nozzle size and the 
spray-drying conditions (Tab 1). Although the drying capacity of the pilot plant with a 
drying volumetric flow rate of 80 kg/h and a water evaporation capacity up to 6 kg/h was 
sufficient for all tested conditions the product yield remained low. Generally, material loss 
occurs mostly due to the attachment of sprayed droplets and dry powder at the wall of 
the drying chamber and the poor cyclone efficiency in collecting fine particles [8]. In our 
case a sufficient drying of the formed droplets was observed, because less than 1 % of 
the droplets, respectively of the dried particles were attached to the drying chamber after 
all drying processes. For the 0.2 mm nozzle higher yields were achieved compared to the 
0.1 mm nozzle. A relatively good yield of 52.1 ± 14.9 % was obtained at a flow rate of 
40 ml/min with a pressure of 26 bar and an outlet temperature of 85°C with the 0.2 mm 
nozzle. The larger droplets and finally larger particles were necessary to increase the 
yield with outlet temperatures below 85°C. The relatively low yield could be assigned to 
the very fine droplet sizes generated by the orifice nozzle. Therefore, the reduced particle 
separation might be induced due to an insufficient cyclone resistance, which was not able 
to collect such small powder particles. A larger pressure drop when using a cyclone with 
a smaller radius could improve product recovery [9].  
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Table 1: Yield and residual moisture achieved for the used process conditions and experimental set-ups. 
flow rate 
[ml/min] 
pressure 
[bar] 
Toutlet  
[°C] 
residual moisture 
[%] 
yield 
[%] 
0.1 mm nozzle 
30 23 105 2.1 44 
40 75 75 2.9 44 
50 162 85 2.8 65 
60 500 110 3.1 10 
80 690 130 4.0 18 
100 800 95 4.5 38 
0.1 mm nozzle and 0.2 µm membrane 
10 20 96 2.7 ± 0.6 20.0 ± 9.9 
40 180 89 2.8 ± 1.2 14.5 ± 13.4 
50 280 130 3.3 ± 0.2 42.0 ± 5.6 
60 525 86 3.2 ± 0.3 41.0 ± 5.6 
0.2 mm nozzle and 0.2 µm membrane 
40 21 90  3.2 ± 0.5 52.1 ± 14.9 
60 94 110 3.5 ± 0.8 49.0 ± 10.4 
0.5 mm nozzle and 0.2 µm membrane 
40 11 110 3.3 1.1 
 
An increase in residual moisture was observed independent of the experimental set-up 
when higher flow rates were applied (Tab 1). With the 0.1 mm nozzle 2.1 % residual 
moisture was determined for a flow rate of 30 ml/min and 4.5 % for a flow rate of 
100 ml/min. The drying-temperature only had a minor impact on the residual moisture of 
the products compared to droplet size. Residual ethanol could not be detected for any 
process conditions, even for relatively low inlet temperatures by HS-GC chromatography. 
The evaporation temperature during the drying process revealed sufficient extraction 
forces for ethanol.  
Thus, the droplet break-up of the liquid feed in respect of the drying temperature is 
responsible for the drying efficiency. Optimum condition with favorable residual moisture 
and product yield were not yet achieved. Although the moisture content could be reduced 
to 2.1 % and for some conditions a product yield increased above 50 % further 
investigations are necessary to find appropriate working parameters.  
 
 
 
CHAPTER 7   
 
 
 
  
 
126 
3.5 LIPOSOME CHARACTERIZATION 
3.5.1 Using the orifice nozzle 
Without the porous device only the 0.1 mm nozzle resulted in relatively small and 
homogenous liposomes. Similar results were described for the liposome formation 
process in chapter 6 without the drying step. After rehydration of the spray-dried powder 
liposome size properties comparable to that before drying were obtained. Above a 
pressure of 500 bar (vlf of 50 ml/min) the size decreased to 125 nm and the 
polydispersity was significantly lowered to values of 0.29 (Fig 7). As already shown within 
the spray-drying process using a two-fluid nozzle (compare chapter 5) the drying 
conditions in respect of outlet temperature did not affect the liposome properties.  
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Figure 7: Size and polydispersity index of the liposomes produced by the 0.1 mm nozzle without a porous 
device in relation to pressure and outlet temperature.  
 
3.5.2 Using the porous device and the orifice nozzle 
During the spray-drying process the porous device equipped with a 0.2 µm membrane 
combined with the 0.1, 0.2 or 0.5 mm nozzle diameter was added. The optimum 
conditions for the 0.1 mm nozzle with a membrane were found around 270 bar with an 
outlet temperature of about 90°C (Fig 8, left). The 0.2 mm nozzle on the other hand 
resulted in pressures between 5 and 100 bar for the flow rates of 20 to 100 ml/min liquid 
feed rates. By the use of the larger 0.2 mm nozzle in combination with the porous device 
liposome size and polydispersity decreased as well with increasing the pressure in the 
system (Fig 8, right). At 40 ml/min flow rate at 20 bar and an outlet temperature of 83°C 
an optimum size of 135 nm and a polydispersity index of 0.15 was achieved. Finally, with 
the 0.5 mm nozzle and a 0.2 µm membrane it was possible to produce liposomes, with a 
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size of 152 nm and a polydispersity index of 0.23 at a pressure of 11 bar (data not 
shown). 
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Figure 8: Size and polydispersity index of the liposomes produced by the 0.1 mm nozzle (left) and 0.2 mm 
nozzle (right) with a 0.2 µm membrane in relation to pressure and outlet temperature.  
 
When calculating the Ohnesorge number and the Reynolds number for the employed set-
ups differences in the jet disintegration and break-up regimes were obvious. During 
spray-drying the liposomal properties were not affected when working in the 1st and 2nd 
wind-induced droplet break-up region. For the 0.1 mm nozzle the atomization region was 
reached (compare chapter 6), which was reflected in a higher PI of the reconstituted 
liposomes. The 0.2 mm nozzle resulted in larger droplets and a favorable drying 
behavior, which preserved the liposomes during the drying process. 
 
3.6 LIPID RECOVERY  
RP-HPLC revealed that the stability of the lipids was assured after the drying process. A 
slight increase in the lipid concentration could be determined when spray-drying was 
performed with the 0.1 and 0.2 mm nozzle at temperatures around 100°C (Tab 2). When 
using the 0.5 mm nozzle a slight decrease in lipid recovery was observed. However, more 
important no oxidized or hydrolyzed lipids were present, indicating chemical stability of 
the lipids at the heat exposure during the drying process (data not shown).  
Table 2: Lipid recovery after reconstitution of the spray-dried powder for the different nozzle sizes and outlet 
temperatures.  
nozzle diameter 
[mm] 
Toutlet  
[°C] 
DOPC recovery 
[%] 
DOTAP-Cl recovery 
[%] 
0.1 110 104.9 104.7 
0.2 100 100.6 101.3 
0.5 110 97.3 96.1 
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Only when working with the 0.1 mm nozzle, the lipid recovery declined with increasing 
outlet temperatures (Fig 9, left). Above an outlet temperature of 150°C degradated and 
oxidated lipids were detectable, which was reflected in a decreased lipid recovery by 
about 13 %. The flow rate and the pressure on the other hand did not influence the lipid 
recovery. In the temperature range from 85 to 100 °C the recovery was constant for the 
0.1 mm and 0.2 mm nozzle (Fig 9, right). 
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Figure 9: Lipid recovery of the spray-dried powder produced by the 0.1 mm nozzle (left) and by 0.1 mm and 
0.2 mm in comparison for the different outlet temperatures and pressure ranges. 
 
Finally, it can be stated that the lipid recovery was reduced at higher drying 
temperatures due to a degradation of the lipids. The applied pressure, nozzle type and 
the resulting droplet break-up regime had no obvious impact on the degradation of the 
lipids. 
 
3.7 DRUG LOADING STUDIES 
To simulate drug loading of the liposomes the fluorescent dye Nile Red was used as 
model compound in this study. The maximum solubility of Nile Red in water ranges below 
1 µg/ml [10], which makes it a suitable model substance for poorly soluble compounds. 
Furthermore, the fluorescence properties of Nile Red are strongly depending on the 
polarity of its environment. In polar media Nile Red fluorescence exhibits a very low 
fluorescence intensity and the emission maximum is red shifted compared to less 
nonpolar solvents. The maximum is located at 657 nm in water compared to 595 nm in 
chloroform [10]. Furthermore, a significant increase in fluorescence intensity is measured 
in non-polar solvents and hydrophobic environment. This solvatochromic effect can be 
explained by the concept of the twisted intramolecular charge transfer (TICT) type 
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excited state. The TICT state, which forms upon the excitation of Nile Red is 
characterized by a higher polarity as compared to the ground state. Therefore, its 
formation is favored in more polar environments. As the TICT state is the major 
radiationless relaxation process of Nile Red the fluorescence intensity is declining when 
the TICT is favored in more polar solvents [11,12]. The very low fluorescence in water 
combined with the solvatochromic effect makes Nile Red a valuable marker in biological 
membrane reasearch. For example the fluorescence anisotropy of Nile Red was used to 
gain information concerning the polarity and hydration levels [13].  
An aliquot of the ethanolic Nile Red stock solution was added to the lipid stock solution 
followed by the subsequent ethanol injection. The resulting liposomal solution contained 
0.26 µg/ml Nile Red. The emission maximum of Nile Red in the liposomal formulation 
after the ethanol injection was located at 633 nm. When using the 0.1 mm nozzle for 
spray-drying at different temperatures a decline in fluorescence intensity was measured 
after the reconstitution of the spray-dried powder (Fig 10, (A)).  
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Figure 10: Fluorescence emission spectra after excitation at 550 nm of Nile Red containing liposomal 
formulations dried with the 0.1 mm nozzle at a liquid flow-rate of 40 ml/min (A), the 0.5 mm nozzle at a liquid 
flow-rate of 40 ml/min (B) and the 0.2 mm nozzle at a liquid flow-rate of 20 ml/min (C) and 40 ml/min (D). 
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The decline in intensity was more pronounced at Toutlet of 76°C compared to Toutlet 65°C. 
Furthermore a slight shift of the emission maximum to 629 nm at Toutlet of 76°C was 
observed. The decrease in intensity after rehydration could be explained by a slight 
change of the environment of Nile Red to a less polar environment. More pronounced 
changes were observed when spray drying was performed with the larger 0.2 and 0.5 
mm nozzles (Fig 10, (B-D)). Besides the decline in intensity at 633 nm a clear shift of the 
emission maximum to about 600 nm occurred. This shift of the emission maximum 
indicates a reduction of the polarity of the Nile Red environment and a lower hydration 
level, compared to the process solution feed [14]. 
It can be concluded that the process using the 0.1 mm nozzle appears to be more 
feasible in preserving the integrity of Nile Red within the liposomes. Using the 0.1 mm 
nozzle smallest droplets are formed. These smaller droplets require shorter drying times. 
Consequently, viscosity within the droplets increases, leading to a change of the 
liposomal structure.  
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4. CONCLUSIONS 
The work in this chapter demonstrated that the preparation of liposomes by combining 
the high pressure preparation process either with the nozzle alone or in combination with 
the porous device with a subsequent spray-drying is feasible. The selection of an 
appropriate spray-dryer with sufficient drying capacity was a prerequisite to obtain a dry 
product. The droplet formation and the consecutive drying process were optimized for 
both the 0.1 and 0.2 mm orifice nozzle. Nozzle size and liquid feed rate affected the 
particle properties significantly. Smaller, more homogeneous particles could be achieved 
by the 0.1 mm nozzle and a higher liquid feed rate and resulting higher atomization 
pressure. The residual moisture content was below 2 % for a flow rate of 20 ml/min, 
while it ranged above 4 % at a flow rate of 100 ml/min. Although the obtained yield 
between 1 and 65 % was low, the technical feasibility was proven. With an optimized 
collection of particles, e.g. by using improved cyclones or vacuum filter units it should be 
possible to increase the yield [9,15]. When using the 0.1 mm nozzle, the size of the 
spray-dried and reconstituted liposomes decreased below 150 nm due to the elevated 
shear forces at the smaller bore diameter. This was in good correlation with the results of 
the high pressure liposome preparation (compare chapter 6). The introduction of the 
porous device was important to further reduce the polydispersity index. However, the 
droplet break-up for the 0.1 mm nozzle, which was in the atomization region, negatively 
affected the liposomes size to a larger polydispersity although the porous device was 
used. The larger droplets obtained by the 0.2 mm nozzle in combination with the porous 
device led to more favorable liposome properties, regarding size and PI at all process 
conditions.  
The combination of liposome formation and drying offered a promising new combination 
to produce and dry liposomal formulations in a one-step process. Furthermore, the up-
scale of this one-step process to a larger pilot production unit, which showed already 
comparable drying behavior to a large scale production unit, was possible.  
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CHAPTER 8 
 
Inert Spray-Drying using High Organic Solvent Concentrations for the 
Preparation and Drying of Liposomes  
 
 
 
Abstract : 
Inert spray-drying enables the processing of formulations with high organic solvent 
content. It was investigated if the process temperature during spray-drying can be 
reduced by the addition of the organic solvents ethanol, methanol or acetone to 
liposomal formulations. A further goal was to analyze to which extend the liposome size 
distribution can be optimized by a new method using a porous device and an orifice 
nozzle for a size adjustment of the liposomes followed by the inert spray-drying step. 
Nitrogen was used as inert-drying gas and the process was performed at different 
temperatures and nozzle bore diameters. We demonstrated that stable, free flowable and 
dry powders of liposome preparations were obtained under inlet temperatures between 
80 to 200°C resulting in corresponding outlet temperature between 30 and 120°C. The 
feed was adjusted to 20 ml/min resulting in nozzle pressures between 18 and 25 bar. 
Optimum conditions were found when using a 0.1 mm nozzle connected to a 200 nm 
membrane with 20 % [w/v] ethanol or 40 % [w/v] acetone added to the formulation. 
The resulting liposomes were 120 nm in size with polydispersity indices of 0.13 for both 
solvents. In comparison to the conventional two-fluid nozzle spray-drying, the process 
temperature could be reduced by at least 20°C down to about 40°C. Major advantages of 
this technique are the online preparation of liposomes from crude multi-lamellar 
suspensions, the very low drying temperatures and the high flow-rates of the liquid feed.  
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1. INTRODUCTION  
It was shown that spray-drying is a feasible technique to dry liposomal formulations 
(compare chapter 3 and 7). The orifice nozzle used during spray-drying generated a 
cloud of very fine droplets with a tremendous air-liquid interfacial area. The liquids can 
evaporate rapidly from the droplets with the consequence that the drying process is 
completed within milliseconds up to a few seconds [1]. However, in most cases high 
temperatures are required to obtain a dry product with improved particle properties. With 
the addition of organic co-solvent like ethanol, methanol or acetone this specific drying 
behavior can be further enhanced. Several publications described the influence of organic 
solvents during spray-drying, for example of ethanol [2], acetone [3] or halothane [4].  
A dehydration process was so far not often described for formulations with high organic 
solvent contents above 10 %. Under atmospheric spray-drying conditions only a 
maximum ethanol concentration of 10 to 12 % can be brought into a regular set-up, due 
to the risk of explosion at high temperatures [5]. To dry formulations with higher organic 
solvent concentrations a closed drying system must be used. Under such inert conditions 
the system is maintained with over-pressure using gaseous nitrogen and under exclusion 
of oxygen. The idea behind using higher organic solvent concentrations is the different 
heat capacities of solvents compared to water and their higher evaporation speed. It was 
assumed that the evaporation rate of e.g. ethanol could be increased in a way that phase 
separation or an increased concentration of lipids in water takes place, so that 
spontaneous liposome formation could occur during the inert spray-drying. 
We tested if the size distribution of liposomes can be retained with this inert spray-drying 
process. Because inert spray-drying is performed using an orifice nozzle at high pressure 
and at a much higher flux as compared to two-nozzle spray-drying, very high shear-
forces are involved. It was shown in chapter 6 that liposomes with a defined size 
distribution can be formed directly by making use of the shear-forces of an orifice nozzle 
and an extrusion membrane in the high-pressure set-up. However, due to the 
introduction of additional organic solvents to the formulation the drying behavior differed. 
The ratio water-organic solvent raised the drying capacity and the inert spray-drying 
process made this adjustment feasible. Formulations with different organic solvent 
concentrations were employed. The major aspects during this process were the product 
qualities, which were investigated with respect to yield, residual moisture, particle and 
liposome size distribution, as well as integrity of the lipids.  
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2. MATERIAL AND METHODS 
2.1 LIPOSOME PREPARATION 
The ethanol injection technique was used for preparing the liposomes. Briefly, a solution 
of 200 mM DOTAP-Cl (1,2-dioleoyl-3-trimethylammonium-propane-chloride) and 200 mM 
DOPC (1,2-dioleoyl-sn-glycero-3-phosphocholine) was injected under stirring into a 
10.5 % [w/v] trehalose solution. The fluorescent probes Nile Red and Coumarin were 
directly dissolved within the lipid stock solution. 25 ml of the ethanolic lipid stock solution 
were injected into 975 ml of the aqueous phase to obtain a final lipid concentration of 
10 mM in total, and a final concentration of 15.4 µM Coumarin and 0.26 µg/ml Nile Red. 
Afterwards, ethanol was step-wise added to the multi-lamellar liposome suspension to 
achieve final ethanol concentrations between 10 and 30 % [w/v]. Above 30 % [w/v] 
ethanol a clear solution was obtained. The homogenization of liposomes was carried out 
by an online extrusion through a 0.2 µm polycarbonate membrane (Osmonics, Inc., MN, 
USA) and a 0.1 and 0.2 mm orifice nozzle 121 VG ¼ (Schlick Atomization Technologies, 
Untersiemau, Germany).  
In a second process approach the same concentrations of lipids were used and directly 
dissolved in 40 to 60 % [w/v] ethanol, methanol or acetone at 40 % [w/v]. Dissolving all 
components without any pre-formulation step like ethanol injection to prepare multi-
lamellar vesicles would simplify the whole process. The lipids dissolved in organic solvent 
contents and water mixtures were added into the aqueous trehalose solutions to achieve 
a total lipid concentration of 10 mM. This approach inhibited the formation of liposomes 
and led to clear solutions after adding the lipid stock solution to the aqueous trehalose. 
The solutions were sprayed through the porous device with a 0.2 µm polycarbonate 
membrane (Osmonics, Inc., MN, USA) and the 0.1 and 0.2 mm orifice nozzle 121 VG ¼ 
(Schlick Atomization Technologies, Untersiemau, Germany) and subsequently dried.  
 
2.2 INERT SPRAY-DRYING METHOD 
The different formulations were spray-dried under inert conditions using nitrogen with a 
B-290 mini spray-dryer (Büchi, Switzerland) combined with a dehumidifier LT mini 
(Much, Germany) and an inert-loop system B-295 (Büchi, Switzerland). The high 
pressure pump ISCO E100x syringe plunger pump (Teledyne ISCO, Lincoln, NE, USA) 
was equipped with an orifice fluid nozzle, respectively a combination of orifice nozzle and 
porous device (compare chapter 6). The employed orifice nozzles of the model 121 VG ¼ 
(Schlick Atomization Technologies, Untersiemau, Germany) had diameters of 0.1 and 0.2 
mm. Two different experimental set-ups, which are shown in Figure 1, were evaluated. 
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Due to the absence of an atomizing gas in the orifice nozzle a relatively high liquid flow 
rate of 20 ml/min flow rate was necessary. Further studies with slower or even higher 
flow rates were not feasible, because of the minimum atomization power and the limited 
drying capacity of the equipment to obtain dry particles. In set-up A the liquid was 
pumped directly through the nozzle (Fig 1, pathway A). For set-up B an additional 
filtration unit, the already described porous device, was placed between the pump and 
the nozzle, leading to an online extrusion of the liposomes (Fig 1, pathway B). For this 
purpose polycarbonate filter membranes (Osmonics Inc., MN USA) with a pore size of 
0.2 µm supported by two drain discs (Osmonics Inc., MN USA) were used. Liposome 
preparation was performed at a flow rate of 20 ml/min resulting in a pressure between 1 
and 110 bar depending on nozzle size and solution viscosity. 
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Figure 1: Schematic construction of a Büchi mini spray-dryer B-290 equipped with a dehumidifier LT Mini and 
an inert loop B-295 coupled with a nitrogen supply.  
 
The inert spray-drying process consists of the atomization of the aqueous-organic feed 
over the nozzle into a spray, spray nitrogen contact, aqueous-organic evaporation out of 
the spray inside the drying chamber and the separation of the dried particles from the 
gaseous nitrogen. Within the hot dehumidified drying nitrogen gas produced by the 
dehumidifier and the gaseous in-take-heater, particles dry very rapidly for spray droplets 
smaller than 100 µm. Powder collection was conducted by the improved cyclone into the 
final product container. After separation of the dried product the nitrogen passes a filter 
unit through the dehumidifier into the inert-loop, where the organic phase is separated 
before the aspirator circulates the nitrogen back into the pressurized system at about 
50 mbar. Thereby, the employed ethanol is recycled by the inert loop in the spray-drying 
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set-up. The following process conditions were used for the inert spray-drying process: 
drying nitrogen inlet temperature (Tinlet) between 80 and 200°C, drying nitrogen outlet 
temperature (Toutlet) in the range of 30 to 110°C, the drying air volumetric flow rate (vda) 
was constant at 100 %, which is given as percentage of total aspirator rate.  
 
All further methods used in this chapter are already described before. 
 
3. RESULTS AND DISCUSSION 
3.1 INERT SPRAY-DRYING OF MULTILAMELLAR SUSPENSIONS 
3.1.1 Influence of ethanol concentration on powder yield  
With the addition of ethanol to the formulation and the relatively dry nitrogen used as 
drying gas, it was again feasible to work with the lab scale equipment in combination 
with the orifice nozzle. Contrary to the observations made in chapter 7, no material loss 
was observed on the chamber wall of the lab scale equipment during the atomization of 
the ethanol containing suspensions, although the orifice nozzle resulted in a wider spray-
angle at the liquid feed rate of 20 ml/min. As working range the 2nd wind-induced region 
was achieved for both nozzles (Fig 2, left). The product yield was mainly affected by the 
nozzle diameter and the resulting droplet size distribution. High Reynolds numbers at 
lower ethanol concentrations resulted in turbulent flows and agglomeration of the 
droplets. For the 0.2 mm nozzle the obtained droplets were even too large to be dried 
sufficiently. The high flow rate and the limited drying capacity of the spray-dryer resulted 
in high material loss (Fig 2, right).  
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Figure 2: Calculated Ohnesorge numbers for formulations with 10 to 30 % [w/v] ethanol using the 0.1 and 
0.2 mm nozzle equipped with 0.2 µm membrane (left) and product yield (right) after inert spray-drying of 
formulations with 10 mM lipid and 10.5% trehalose at Tinlet of 150°C and a 0.2 mm nozzle with a 0.2 µm 
membrane at Tinlet of 200°C. 
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The yield after inert spray-drying could be improved by increasing the ethanol 
concentrations in the formulation and the drying temperatures (Fig 3, left). Limited by 
the drying capacity of the spray-drier, a maximum yield of about 85 % was obtained for 
formulations with 30 % [w/v] ethanol dried at an inlet temperature of 200°C. Optimized 
droplet size distribution and evaporation favored the result. An almost linear relationship 
between inlet and outlet temperature could be observed. Changes can be explained by 
the relatively high liquid feed rate of 1.2 l/h, which exceeded the maximum drying 
capacity of 1.0 l/h of the used spray-dryer (Fig 3, right). Using ethanol concentration in 
the formulations it has to be considered that water has a much higher heat capacity than 
ethanol and the flow rates of drying air and liquid feed should aligned [6].  
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Figure 3: Yield after inert spray-drying of multi-lamellar liposome suspensions with 10 mM lipid and 10.5% 
trehalose with 10 to 30 % [w/v] ethanol using a 0.1 mm nozzle (left), the corresponding outlet temperatures 
(right) at liquid feed rate of 20 ml/min. 
 
3.1.2 Influence of ethanol concentration on particle morphology and size 
The particle morphology of the inert spray-dried powders for multi-lamellar liposomes 
(pathway B with porous device) and ethanol concentrations between 10 and 30 % [w/v] 
are shown in the scanning electron microscopy (SEM) pictures (Fig 4). For formulations 
with 10 and 20 % [w/v] ethanol agglomerated spherical particles were obtained. At 
higher ethanol concentrations the agglomeration tendency was reduced due the faster 
drying process and the reduced turbulences of the droplets. However, a rupture of the 
particles occurred, which was evident by broken, hollow particles. The addition of ethanol 
resulted in a higher vapor pressure that led finally to a rupture of large particles.  
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Figure 4: SEM micrographs of the dried particles for the formulations of 10.5 % trehalose, 10 mM lipid content 
with 10 to 30 % [w/v] ethanol using a 0.1 mm nozzle and a 0.2 µm membrane. 
 
At increasing ethanol concentrations within the multi-lamellar suspensions using the 
process with the porous device (Fig 1, (pathway B)) the mean particle diameter was 
shifted to smaller sizes from 320 µm for 10 % [w/v] ethanol to 120 µm for 30 % [w/v] 
ethanol (Fig 5, left). Furthermore, the size distributions changed from bimodal to 
monomodal. This was also indicated by the span, which was reduced from 3.88 at 10 % 
[w/v] ethanol to 1.94 at 30 % [w/v] ethanol (Fig 5, right). As described before, the 
limited size of the drying tower further enhanced the turbulences and assisted the 
collision of wet particles especially at lower ethanol concentrations.  
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Figure 5: Particle size distribution with ethanol concentrations between 10 and 30 % [w/v] (left) and average 
particle size including span (right) after inert spray-drying of multi-lamellar-liposome suspensions with 10.5 % 
trehalose and 10 mM lipid with using a 0.1 mm nozzle and a 0.2 µm membrane with 10 to 30 % [w/v]. 
 
3.1.3 Effect of ethanol on residual moisture and residual solvent content  
With increasing ethanol content the goal to reduce the drying outlet temperature was 
achieved. For 30 % [w/v] ethanol concentration the inlet air temperature could be 
reduced to 100°C, which resulted in an outlet temperature of 38°C (Fig 6, left). 
Tinlet 200°C, 10 % [w/v] ethanol  Tinlet 200°C, 20 % [w/v] ethanol  Tinlet 200°C, 30 % [w/v] ethanol  
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Compared to the conventional spray-drying using a two-fluid nozzle the drying 
temperature can be reduced by at least 10°C (compare chapter 5). The residual moisture 
of the particles was also affected by increasing ethanol contents and drying temperature. 
Residual moisture varied for 10 % [w/v] ethanol between 6.5 % at a Tinlet of 130°C and 
4.5 % at a Tinlet of 200°C (Fig 6, right). 
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Figure 6: Outlet temperatures of multi-lamellar suspensions (left) and the residual moisture content (right) in 
relation to inlet temperature with 10, 20 and 30 % [w/v] ethanol in the formulation using a flow rate of 
20 ml/min and a 0.1 mm nozzle.  
 
With the addition of organic solvents to the formulation a reduction in drying temperature 
was achieved. Due to the relatively short drying process with high solvent concentrations 
the remaining residual solvent traces need to be quantified and considered with respect 
of their concentration limits [7,8]. After the conventional spray-drying processes 
(compare chapter 5 and 7) no residual ethanol content could be determined by static 
headspace chromatography for reconstituted powders. After inert spray-drying, the 
residual ethanol concentration depended on the initial ethanol content of the formulation 
and the drying temperature. Only about 700 ppm ethanol could be determined in the 
reconstituted dried product at 10 % [w/v] ethanol at a drying temperature of 120°C 
(Fig 7). A maximum residual ethanol content of 4500 ppm was observed for formulations 
with 30 % [w/v] ethanol dried at 120°C, which is similar to the concentration obtained 
after freeze-drying (compare chapter 2). At the highest drying temperature of 200°C the 
residual ethanol concentrations could be decreased below 1600 ppm for all used ethanol 
concentrations. An additional vacuum-drying step applied to the inert spray-dried 
powders (described in chapter 5) resulted in residual ethanol concentration below the 
detection limit for all formulations (data not shown). 
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Figure 7: Residual ethanol concentration of multi-lamellar inert spray-dried liposomes with 10, 20 and 
30 % [w/v] ethanol after reconstitution using a flow rate of 20 ml/min 0.1 mm nozzle.  
 
3.1.4 Morphological characterization of the inert spray-dried products 
DSC and X-ray powder diffraction were used to characterize the morphology of the inert 
spray-dried products. The morphology of the dried particles was analyzed, as it can affect 
the storage stability of the formulations regarding the liposomal integrity. The glass 
transition temperature, which is characteristic for amorphous systems, was determined 
by DSC. For the studied formulations, the glass transition temperature of inert spray-
dried trehalose containing liposomal formulations increased when the drying temperature 
rose from 150 to 200°C (Fig 8, left).  
10 20 30
0
10
20
30
40
50
60
70
 
 
g
la
ss
 t
ra
n
si
ti
on
 t
em
p
er
at
u
re
 [
°C
]
ethanol concentration [%]
 150 °C T
inlet
   200 °C T
inlet
 
10 20 30
0
20
40
60
80
100
120
140
160
180
200
 
 
 30 % ethanol
 20 % ethanol
 10 % ethanol
in
te
n
si
ty
 [
cp
s]
diffraction angle [° 2-theta]  
Figure 8: The glass transition temperature (left) and wide-angle X-ray diffraction pattern (right) after inert 
spray-drying of multi-lamellar liposome suspensions with 10.5 % trehalose and 10 mM lipid with 10 to 
30 % [w/v] ethanol using a 0.1 mm nozzle and the porous device with a 0.2 µm membrane at a inlet 
temperature of 150°C and 200°C (DSC), respectively 200°C (XRD). 
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This effect was most pronounced for 20 % [w/v] ethanol were the Tg raised from 47.2°C 
at Tinlet 150°C to 61°C at Tinlet 200°C. The Tg of the formulations needs to be considered 
when selecting appropriate storage conditions for the formulations. Above Tg a higher 
molecular mobility would foster the fusion and leakage of the liposomes and an increased 
vesicle size in the rehydrated dispersion [9]. The amorphous state of the product was 
also assured by the X-ray powder diffraction pattern (Fig 8, right).  
 
3.1.5 Liposome Properties  
3.1.5.1 Effect of ethanol on liposome size using the orifice nozzle 
In set-up (A) multi-lamellar suspensions were directly sprayed through the orifice nozzle. 
Size adjustment of liposomes by this set-up was successful as described in chapter 6. 
Ethanol concentration and nozzle size affected liposome size and polydispersity index 
after reconstitution of the inert spray-dried products. With the 0.1 mm nozzle liposomes 
of about 100 nm and a polydispersity index of 0.26 were obtained from a multi-lamellar 
liposome suspension with 10 and 20 % [w/v] ethanol (Fig 9, left). With 30 % [w/v] 
ethanol, the polydispersity index of the liposomes increased significantly to 0.35 with a 
larger standard deviation. For the 0.2 mm nozzle larger liposomes of 150 nm were 
formed while the polydispersity index remained at a constant level of 0.27 (Fig 9, right). 
For both nozzles, the liposome size and polydispersity were lower after the drying step as 
compared the data without the drying step. 
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Figure 9: Liposome size and polydispersity index with increasing ethanol concentrations after inert spray-drying 
of multi-lamellar liposome suspension with 10 mM lipid and 10.5 % trehalose at 200°C (Tinlet) using a 
0.1 mm (left) and 0.2 mm (right) nozzle. 
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3.1.5.2 Effect of ethanol on liposome size using the porous device / orifice 
nozzle 
The ethanol concentration has a considerable effect on the droplet formation process. 
However, the main size adjustment of the liposomes takes place during the extrusion 
through the porous device (compare chapter 6). It can be assumed that the extraction of 
the solvents during the dehydration step influences the liposome size. High concentration 
of ethanol evaporated much faster, which resulted in larger polydispersity of 0.37 at 
30 % [w/v] ethanol due to the partial rupture of the liposomes (Fig 10, left). Without the 
drying step very small and homogenous liposomes were obtained under these conditions. 
Only the 10 % [w/v] ethanol concentration revealed adequate liposomal properties 
(Fig 10, right). Although the data from chapter 6 suggested an improved polydispersity 
index for all formulations when using the porous device the drying step affected the 
liposomal properties. Too rapid drying and droplet size with higher ethanol concentrations 
reduced the liposomal quality after the drying process. 
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Figure 10: Liposome size and polydispersity index with increasing ethanol concentrations after inert spray-
drying of multi-lamellar liposome suspension with 10 mM lipid and 10.5 % trehalose at 200°C (Tinlet) using a 
0.1 mm (left) and 0.2 mm (right) nozzle both in combination with a 0.2 µm membrane. 
 
3.1.5.3 Effect of drying temperature on liposome size using the orifice nozzle 
The liposome size and polydispersity were not only affected by the droplet size and 
ethanol concentration, but also by the drying temperature (Tinlet). Smaller liposomes 
(Fig 11, left) with improved polydispersity indices (Fig 11, right) were obtained using the 
0.1 mm nozzle at higher inlet temperatures above 120°C for all evaluated ethanol 
concentrations. An optimum was found with 20 % [w/v] ethanol for inlet temperatures 
between 120 and 200°C. 
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Figure 11: Liposome size (left) and polydispersity index (right) with increasing Tinlet and ethanol concentrations 
of 10, 20 and 30 % [w/v] after inert spray-drying using a 0.1 mm nozzle. 
 
3.1.6 Lipid recovery after inert spray-drying 
The lipid composition of the particles after the inert spray-drying process was analyzed 
by RP-HPLC. The major aspects affecting the lipid recovery are the heat exposure and a 
possible phase separation of the lipids within the particles at high ethanol contents. In all 
experiments no degradation products were determined after inert spray-drying between 
10 and 30 % [w/v] ethanol up to an inlet temperature of 200°C. The homogeneity of the 
lipids was preserved for all conditions without any decomposition. Lipid recovery varied 
between 65 and 105 % depending ethanol concentration and drying conditions, when 
using the orifice nozzle (Tab 1). Compared to the combination of porous device and 
nozzle the lipids recovery varied between 120 and 148 %. Such an effect was observed 
neither with the two-fluid nozzle in chapter 5 nor the orifice nozzle in chapter 7.  
Table 1: Lipid recovery after inert spray-drying at inlet temperatures of 120°C, 150°C and 200°C using a 
0.1 mm nozzle at 10, 20 and 30 % [w/v] ethanol. 
10 % ethanol [w/v] 20 % ethanol [w/v] 30 % ethanol [w/v] 
Tinlet 
[°C] 
DOTAP-
CL  
[%] 
DOPC 
[%] 
Toutlet 
[°C] 
DOTAP-
CL  
[%] 
DOPC 
[%] 
Toutlet 
[°C] 
DOTAP-
CL  
[%] 
DOPC 
[%] 
Toutlet 
[°C] 
120 - - - 95.2 94.7 47 96.8 95.7 48 
150 65.4 66.8 57 97.1 97.3 60 99.9 98.9 61 
200 86.9 87.2 87 99.9 99.2 87 104.1 102.4 79 
200* 120.9 119.4 77 125.5 123.7 74 142.5 140.4 72 
 * data obtained using the porous device and the nozzle. 
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Varied ethanol concentrations within the formulation and the resulting higher Reynolds 
numbers induced the shear forces. The droplet formation and break-up probably resulted 
in a phase separation of the lipids and the solvents within a single droplet due to the 
mixture of ethanol and water. It is known that higher viscosity delays the onset of the 
droplet formation [10]. And with the different surface tension and density of ethanol and 
water these droplet formation process could be responsible for the reduced lipid content. 
Very fine droplets containing more water or ethanol with varied or even no lipid could 
occur. On the other hand, the porous device used in the system increased the lipid 
recovery. This can be explained by the homogeneity of the lipid distribution within the 
liquid feed. Higher residual ethanol content and lower residual moisture content with 
increasing the ethanol fraction indicated such a phenomenon.  
The lipid recovery in the dry particles depended on the ethanol concentration and the 
drying behavior of the formulation. Droplet formation and distribution of the lipids were 
mainly affected by the nozzle bore diameter and the droplet break-up. Optimum 
conditions with 10 mM lipids and 10.5 % [w/v] trehalose were found at 20 % [w/v] 
ethanol. 
 
3.1.7 Drug loading studies 
3.1.7.1 Using Nile Red as model compound 
The model compound Nile Red was dissolved together with the lipids and subsequently 
ethanol injection into aqueous trehalose solution was performed to produce liposomes. 
After ethanol injection the emission maximum Nile Red was located at 640 nm (excitation 
with 550 nm) for 30 % [w/v] ethanol and was slightly blue shifted to 636 nm for 10 and 
20 % [w/v] ethanol with a slight increase in intensity at the same time (Fig 12, (A)). The 
blue shift indicated that Nile Red is present in a slightly more hydrophobic environment 
at lower ethanol concentrations. For a comprehensive interpretation of these findings 
control experiments were performed, to clarify the impact of ethanol and liposomes on 
the fluorescence properties of Nile Red. In a control experiment Nile Red was added to 
liposomes after the ethanol injection (Fig. 12, (B)). A comparable blue shift of the 
emission depending on the ethanol concentration occurred. Furthermore, the 
fluorescence intensity was significantly higher for the lower ethanol concentrations of 10 
and 20% [w/v]. When measuring Nile Red in the presence of 10, 20 and 30% [w/v] 
ethanol the emission maximum was not affected, while the intensity was slightly higher 
for the less polar solutions with 30% [w/v] ethanol (Fig. 12, (C)).  
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Figure 12: Fluorescence intensity when Nile Red was added to the lipid stock solution and subjected to ethanol 
injection (A), Nile Red added to preformed liposomes in 10, 20 and 30 % [w/v] ethanol (B) and of Nile Red in 
10, 20 and 30 % [w/v] ethanol (C). 
 
The data indicated that Nile Red is incorporated into the liposomes in a similar way for all 
ethanol concentrations when the compound was already present during the ethanol 
injection process. The tremendous increase in Nile Red fluorescence at lower ethanol 
concentrations when the probe was added to liposomes after the ethanol injection is 
indicative for changed interactions with the hydrophobic lipids. It can be assumed that 
the interactions between Nile Red and the lipids are more favored at lower ethanol 
concentrations, due to the low solubility of Nile Red in the aqueous phase. 
After rehydration of the inert spray-dried particles, the fluorescence intensity of Nile Red 
increased for all studied conditions (Fig 13). The increased Nile Red fluorescence intensity 
of the reconstituted inert spray-dried products can be indicative for a stronger interacting 
of Nile Red with the hydrophobic liposomes. It was evident that the Nile Red fluorescence 
intensity after inert spray-drying depended on the ethanol content of the stock solutions, 
with a more pronounced intensity increase for 30 % [w/v] ethanol (Fig 13, (C)). This is in 
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agreement with the results from DLS, which revealed that the liposome size and PI were 
most affected at 30 % [w/v] ethanol. The second parameter influencing Nile Red 
fluorescence was the drying temperature. For 10 % and 20 % [w/v] ethanol the intensity 
increase of the Nile Red fluorescence was more pronounced at 200°C compared to 150°C 
(Fig 13, (A and B)). For 30 % [w/v] ethanol on the other hand the intensity was slightly 
higher after the drying process with 150°C as compared to 200°C. 
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Figure 13: Fluorescence intensity of Nile Red loaded liposomes for Tinlet of 150 and 200°C for ethanol contents of 
10 % (A), 20 % (B) and 30 % [w/v] (C). 
 
It can be concluded that Nile Red is present in a more hydrophobic environment after 
drying when the initial solutions contained higher ethanol content, which could be related 
to the greater change in liposome size and polydispersity index of these formulations. 
More precisely the more hydrophobic environment could be equal to a stronger binding of 
Nile Red to the liposomes. 
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3.1.7.2 Drug loading using Coumarin 
The liposomes were furthermore loaded with Coumarin. The Coumarin content after inert 
spray-drying was slightly reduced for 10 and 20 % [w/v] ethanol (Fig 14) at Tinlet 200°C. 
At Tinlet 150°C the concentration was not affected for all ethanol concentrations. With a 
higher ethanol content of 30 % [w/v] a stronger influence of drying temperature was 
determined resulting in raised Coumarin content. For the used lipids no leakage induced 
by inert spray-drying and rehydration occurred.  
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Figure 14: Coumarin concentration in relation to drying temperature Tinlet of 150 and 200°C and ethanol content 
between 10 and 30 % [w/v].  
 
3.2 INERT SPRAY-DRYING OF CLEAR LIPID-TREHALOSE SOLUTIONS  
3.2.1 Influence of initial ethanol concentration on powder yield 
With higher Ohnesorge numbers the internal viscous dissipation is more dominant and 
most of the inserted energy is converted, which makes droplet formation difficult (Fig 15, 
left). In general, an increased amount of ethanol in the formulation prior to spray-drying 
and with it a higher Ohnesorge number increased the yield after inert spray-drying 
(Fig 15, right). Furthermore, the liquid feed break-up at the orifice nozzle significantly 
influenced the droplet size and with it the drying performance. With a 0.1 mm nozzle the 
yield ranged between 70 and 85 %. Lower yields of maximum 35 % at 4.5 mPas were 
reached with the larger 0.2 mm nozzle even at the higher inlet temperature of 200°C. 
Compared to the product yield obtained at ethanol contents between 10 and 30 % [w/v] 
the yield was doubled because of the changed droplet formation and the faster drying at 
higher ethanol contents. 
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Figure 15: Calculated Ohnesorge numbers for 0.1 and 0.2 mm nozzle and increasing ethanol concentrations 
between 40 and 60 % (left) and product yield (right) after inert spray-drying of formulations with 10 mM lipid 
and 10.5% trehalose using a 0.1 mm nozzle 0.2 µm membrane at Tinlet of 150°C and a 0.2 mm nozzle with a 
0.2 µm membrane at Tinlet of 200°C.  
 
3.2.2 Influence of ethanol concentration on particle morphology and size 
The particle rupture was more pronounced at higher ethanol concentrations between 40 
and 60 % [w/v] ethanol (Fig 16) when spraying the clear solutions of lipids and trehalose 
containing as compared to solutions with 10 to 30 % [w/v] ethanol. Due to this effect the 
bulk density was significantly lowered for particles dried from higher ethanol 
concentrations [11]. The results indicated that an increased ethanol concentration in the 
formulation led to a decrease in particle diameter by optimized droplets formation and 
drying behavior [12,13]. However, formulation characteristics such as surface tension 
and the saturated vapor pressure of the inert spray-drying solutions influenced the size 
of the droplets generated by the orifice nozzle, and hence affected the size and the 
morphology of the produced particles [14]. High vapor pressure occurred during the 
drying process resulting in a rupture of particles.  
 
   
Figure 16: SEM micrographs of the dried particles for the formulations of 10.5 % trehalose, 10 mM lipid content 
with 40 to 60 % [w/v] ethanol using a 0.1 mm nozzle and a 0.2 µm membrane. 
Tinlet 200°C, 40 % [w/v] ethanol  Tinlet 200°C, 50 % [w/v] ethanol  Tinlet 200°C, 60 % [w/v] ethanol  
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Spraying of the clear solution of lipids and trehalose with ethanol concentrations between 
40 and 60 % [w/v] led to more homogenous size distributions compared to lower ethanol 
concentration (Fig 17, left). Droplet formation due to the reduced Reynolds numbers 
were optimized and the evaporation resulted in smaller particles between 20 and 
110 µm, which decreased slightly with raising ethanol content (Fig 17, right).  
It can be concluded that the particle formation was mainly influenced by the ethanol 
concentration of the initial formulation. With the addition of ethanol the Ohnesorge 
number increased and the Reynolds number decreased, which affected the droplet 
formation process. The droplets consistence finally impacted the drying behavior in 
respect of a reduced heat capacity with raised ethanol contents.  
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Figure 17: Particle size distribution with ethanol concentrations between and 40 to 60 % [w/v] (left) and 
average particle size including span (right) after inert spray-drying of multi-lamellar liposome suspensions with 
10.5 % trehalose and 10 mM lipid with using a 0.1 mm nozzle and a 0.2 µm membrane. 
 
3.2.3 Particle formation model 
Based on the data a simple mechanism to illustrate the evaporation of solvents out of the 
droplets and finally the particle formation during the inert spray-drying of water-ethanol 
containing formulations was developed (Fig 18). The driving force during drying is the 
difference in vapor pressure between the drying gas and the droplet surface, which 
furthermore is affected by the varied vapor pressure of the organic solvent and water 
[15,16]. This driving force is responsible for the three different particle types, which were 
determined: spherical and smooth particles (< 30 % [w/v] ethanol), small spherical and 
disintegrated particles (< 50 % [w/v] ethanol) and fully disintegrated particle fragments 
(> 50 % [w/v] ethanol). At higher water-ethanol ratios, e.g. in the range between 30 and 
50 % [w/v] ethanol, the evaporation rate was accelerated compared to the diffusion rate 
resulting in a hollow core. When the pressure inside the droplet reached a certain limit a 
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disintegration of the particle occurred. This effect was even more pronounced when using 
ethanol concentrations above 50 % [w/v]. Only disintegrated particles and fragments of 
particles were observed. The evaporation and drying rates were so high that the vapor 
pressure increased dramatically, resulting in cracked particles with a hollow interior. This 
evaporation of the solvents happens early at the top of the drying chamber [17], with a 
maximum droplet temperature (wet-bulb temperature) of approximately 30 to 70°C at 
the process conditions used here.  
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Figure 18: Schematic model of the inert spray-drying process of droplets containing vesicles or which are clear 
solutions with different water-ethanol ratios.  
 
3.2.4 Effect of ethanol on residual moisture and residual solvent content 
With increasing ethanol content the drying outlet temperature was reduced down to 38°C 
at 30 % [w/v] ethanol for multi-lamellar suspensions. For clear solutions the outlet 
temperature was further reduced down to 30°C at 50 and 60 % [w/v] ethanol (Fig 19, 
left). Compared to the conventional spray-drying process the temperature could be 
reduced by about 20°C for concentrations above 40 % [w/v] ethanol. For the clear 
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solution lower residual moisture levels between 4 % at Tinlet of 80°C and 3 % at Tinlet of 
200°C (Fig 19, right) were determined.  
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Figure 19: Outlet temperatures of multi-lamellar suspensions (left) and the residual moisture content (right) in 
relation to inlet temperature and ethanol content using a flow rate of 20 ml/min, a 0.1 mm nozzle with 40, 50 
and 60 % [w/v] ethanol in the formulation.  
 
When spray-drying the clear solutions with higher ethanol concentrations the residual 
solvent depended once more on the inlet temperature (Fig 20). High residual ethanol 
concentrations of about 5500 ppm were observed at 50 to 60 % [w/v] ethanol at an inlet 
temperature of 80°C. For the ethanol content of 40 % [w/v] the residual solvent content 
remained below 1200 ppm. The relation between trehalose and residual ethanol content 
was already discussed in chapter 2, were a linear trend was found in freeze-dried placebo 
formulations for different trehalose-ethanol concentrations. By increasing the inlet 
temperature to 200°C the residual ethanol content could be significantly decreased.  
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Figure 20: Residual ethanol concentration of multi-lamellar inert spray-dried clear solutions inert spray-dried 
with 40, 50 and 60 % [w/v] ethanol after reconstitution in respect of inlet temperature using a flow rate of 
20 ml/min 0.1 mm nozzle.  
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3.2.5 Effect of drying temperature on liposome size using the orifice nozzle 
Inert spray-drying of clear solutions using a 0.1 mm nozzle resulted in liposomes size 
between 100 nm at 40 % and 170 nm at 60 % [w/v] ethanol (Fig 21, left). Although the 
size of the liposomes varied and the polydispersity was not improved below values of 0.2, 
such a method offers some advantages as it can simplify the process and should 
therefore be further investigated (Fig 21, right). Ideally, the liposomes are formed in the 
water fraction when the organic-aqueous phase is removed or during rehydration. This 
would lead to a spontaneous formation of vesicles in the water phase.  
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Figure 21: Liposome size (left) and polydispersity index (right) using clear solutions between 40 and 60 % 
[w/v] ethanol after inert spray-drying using a 0.1 mm nozzle at different Tinlet.  
 
3.3 INERT SPRAY-DRYING USING OTHER CO-SOLVENTS 
The influence of other co-solvents was tested on the liposome properties. Results like 
product yield, particle morphology and size distribution were comparable to the 
formulations with 40 % [w/v] ethanol content. Therefore, only the effect of residual 
moisture, residual methanol and acetone concentration were described, as well as the 
most important parameter the liposome properties.  
 
3.3.1 Effect of solvents on residual moisture and residual solvent content 
Methanol and acetone as new co-solvents were added in a concentration of 40 % [w/v] 
compared to ethanol. The residual solvent content of methanol and acetone decreased to 
lower levels, as compared to residual ethanol concentrations (Fig 22, left). Both, 
methanol and acetone have lower boiling points of 65 and 56.2°C compared to ethanol 
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with 78.5°C. With the higher vapor pressure the evaporation of the solvents during the 
drying process was enhanced. Especially acetone with a vapor pressure of 160 mmHg 
(at 20°C) compare to methanol with 87.9 mmHg and ethanol with 41.0 mmHg showed 
this effect most pronounced and reached the lowest level residual solvent content [18]. 
The residual moisture for acetone was 2.1 % and methanol about 2.9 % after inert 
spray-drying. Due to their higher vapor pressure and lower boiling point the drying rate 
could be improved. This resulted in lower residual moisture contents compared to ethanol 
as a co-solvent with 3.2 % at the same conditions (Fig 22, right).  
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Figure 22: Residual solvent content for different co-solvents (left) and the residual moisture content (right) 
using a 10 mM lipid content after inert spray-drying of liposomal formulations at 200°C with a porous device 
equipped with a 0.2 µm membrane and a 0.1 mm nozzle.  
 
3.3.2 Effect of other solvents on the liposome size 
As already shown before (compare 3.2.5), ethanol resulted in a high polydispersity index 
of the liposomes as well as methanol. Only acetone preserved the liposomes size and 
polydispersity (Fig 23). With acetone as co-solvent liposome size remained at 125 nm 
and more important the polydispersity index reached a remarkable value of 0.13. A very 
low drying temperature of 45°C could be achieved when using acetone. The reduced 
solubility of the lipids in acetone with the low vapor pressure may be the reason for this 
positive result [19]. Further studies are necessary to clarify the effect of acetone on the 
preservation of liposomes at such high co-solvent concentrations.  
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Figure 23: Liposome size and polydispersity index with 40 % [w/v] organic solvent after inert spray-drying at 
120°C (Tinlet) using a 0.1 mm nozzle both in combination with a 0.2 µm membrane. 
 
 
4. CONCLUSIONS 
An approach to reduce the heat exposure during spray-drying is the addition of organic 
solvents to the aqueous formulation. With the addition of such organic solvents the heat 
capacity and the gaseous inlet temperature can be significantly reduced. However, to 
prevent explosive conditions the use of inert spray-drying equipment is necessary. The 
presented inert spray-drying approach combined liposome formation with a porous 
device and an orifice nozzle as well as inert spray-drying in a single step. Organic 
solvents like ethanol, methanol and acetone were employed in concentrations up to 60 % 
[w/v].  
Inert spray-drying of mulitlamellar liposome suspensions with ethanol concentrations up 
to 30 % [w/v] was feasible. Depending on ethanol content and drying temperature a 
product yield of up to 80 % was reached. With the addition of ethanol the outlet 
temperature was reduced below 40°C at a gas inlet temperature of 100°C. Comparable 
to the yield, the residual moisture depended on the ethanol concentration and the drying 
temperature, as well. With increasing inlet gas temperature the residual moisture can be 
reduced below 3 %. Liposomes with an optimized size of 100 nm and a polydispersity 
below 0.15 were obtained for ethanol concentrations up to 20 % [w/v] using the porous 
device in combination with the small orifice bore diameter of 0.1 mm. With higher 
ethanol concentrations and larger nozzle bore diameters liposome size and polydispersity 
were elevated. Lipid recovery and drug loading studies revealed a significant influence of 
the ethanol concentration on these parameters. While the lipid recovery increased with 
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higher ethanol contents, e.g. to 100 at 30 % [w/v], the liposomal quality decreased. The 
drying behavior and the droplet formations with a possible phase separation should be 
considered and further investigated. For a successful liposome formation and drying 
process optimized conditions were found, which made this technique an alternative to the 
conventional spray-drying approach.  
At higher ethanol concentrations above 30 % [w/v] the multilamellar structure of the 
liposomes is destroyed resulting in a clear solution of lipids, trehalose and solvents. A 
study with process conditions comparable to the multilamellar liposome approach 
revealed higher yields and lower drying temperatures down to 30°C. The particle size 
was reduced to 50 µm with a homogeneous distribution compared to several 100 µm for 
multi lamellar solutions. Residual moisture decreased due to the reduction of water in the 
formulation and the lower heat capacity necessary to dry these formulations. However, 
homogeneous distributions could not be achieved. The resulting liposome size were 
between 100 and 170 nm with a polydispersity above 0.45. Only the use of 40 % [w/v] 
acetone resulted in small liposomes of 125 nm with excellent polydispersity of 0.13. A 
further reduction of the drying temperature during inert spray-drying was achieved for all 
studied conditions. Too high ethanol contents negatively affected the quality of the 
liposomal formulations, as the liposome structure was not fully formed or preserved. 
Overall, the main goal of preparing liposomes and thereby reducing the drying 
temperature was achieved. Due to the addition of ethanol, the drying temperature could 
be reduced to 40°C. Drug loading studies with model compounds were done, but 
experiments with Paclitaxel loaded formulations are still required. Furthermore, droplet 
formation and break-up processes have a considerable effect on the lipid recovery. To 
clarify this, further studies are necessary to predict phase separation and fluctuation of 
lipids in the droplets.  
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CHAPTER 9 
 
Liposome Drying using Subcritical- and Supercritical Fluids  
 
 
Abstract: 
There are numerous advantages of subcritical- and supercritical fluids. The selective 
solvating power of supercritical fluids (SCF) makes it possible to separate a particular 
component from a multi-component mixture at a relatively low temperature range. 
Secondly, the favorable mass transfer properties and the solubility of solvents in 
supercritical fluids make the drying of liposomes rapid and efficient in a one-step process, 
using non-toxic and environmentally friendly supercritical carbon dioxide (CO2). The 
particle formation and drying studies with different nozzles and process conditions were 
necessary to understand the thermodynamic behavior and evaluate a working area. With 
and without the addition of co-solvents the mutual solubility of the compounds was 
studied on the liposome properties. Subcritical conditions were chosen to fully avoid lipid 
solubility in carbon dioxide. The droplet size distribution and the mass transfer are the 
key parameters in the perseveration of the liposomal structure. Using acetone as a co-
solvent the solubility of water was enhanced without the extraction of lipids. While using 
the other solvents a significant solubility of lipids was determined. Without any co-solvent 
and at subcritical conditions no irritation was observed, the liposome structure stay 
intact.  
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1. INTRODUCTION  
Supercritical fluid (SCF) technology has been commercially used for the past 30 years as 
an environmentally benign, energy- and cost-saving tool in various industries. It is 
applied for dry cleaning, metal cleaning, as well as for preparing foods and fragrances. 
Also for several pharmaceutical operations in industrial scale supercritical fluids are 
employed, e.g. for crystallization, particle size reduction, solvent extraction, coating and 
product sterilization [1]. SCF technology is furthermore a feasible option to stabilize 
particulate drug delivery systems, such as microparticles, nanoparticles, liposomes and 
inclusion complexes [2]. Supercritical fluids have many attractive properties such as 
providing mild conditions for pharmaceutical processing, which is advantageous for labile 
drugs. Besides this, the use of organic solvent can be minimized and the production of 
particles with controllable morphology, narrow size distribution, and low static charge can 
be achieved [3]. A substance whose temperature and pressure are above the critical 
temperature (Tc) and the critical pressure (Pc) is referred to as a supercritical fluid [4]. 
Above this critical point the liquid and vapor phase of the substance is indistinguishable 
(Fig 1).  
 
Figure 1: Pressure-temperature phase diagram of a pure substance, with different region and the supercritical 
fluid region. 
 
Supercritical fluids have unique thermophysical properties [5], which are between those 
of the pure liquid and the pure gas. The properties of supercritical fluids, such as polarity, 
viscosity and diffusivity can be altered several-fold by varying the operating temperature 
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and/or pressure during the process. Supercritical fluids offer liquid-like densities, gas-like 
viscosities, gas-like compressibility properties and ten times higher diffusivities than 
liquids, which gives them good mixing properties. For particle formation, however, the 
combination of liquid-like density and the large compressibility is of interest.  
Carbon dioxide (CO2) is the most commonly used supercritical fluid in pharmaceutical 
processing due to its unique properties, such as an oxygen-free environment and 
working conditions at relatively low temperature and pressure. Furthermore, it is non-
toxic, non-flammable, relatively inexpensive, recyclable and removable from the system. 
It has a critical temperature (Tc) of 31.1 °C and a critical pressure (Pc) of 78.3 bar. 
Other solvents used in supercritical fluid technology are for example ethylene, nitrous 
oxide, propylene, ethanol and water (Tab 1).  
Table 1: Critical temperature Tc in [°C], pressure Pc in [bar] and density at critical condition Dc in [g/ml] of 
commonly used supercritical fluids [6,7]. 
solvent Tc [°C] Pc [bar] Dc [g/ml] 
ethylene (C2H4) 9.0 49.7 0.220 
carbon dioxide (CO2) 31.3 73.8 0.468 
nitrous oxide (N2O) 36.0 71.5 0.450 
propylene (C3H7) 91.8 46.0 0.232 
ethanol (C2H5OH) 240.8 61.4 0.276 
water (H2O) 374.1 221.2 0.315 
 
Around the critical point, density and hence solvating power of supercritical fluids can be 
varied widely when applying small temperature and/or pressure changes to the system. 
This enables the operator to use supercritical fluids as solvents or anti-solvents during 
particle formation [1].  
Rapid expansion of supercritical solutions (RESS) and gas anti-solvent precipitation 
(GAS) are the two basic processes employed for the precipitation of particles (Fig 2). 
During RESS, the solute is first solubilized in the supercritical fluid and the mixture is 
then expanded across a capillary at supersonic velocities, leading to a super-saturation of 
the solution and a subsequent precipitation. Co-solvents, such as methanol or acetone, 
can be mixed with supercritical fluids to increase the solvating power of supercritical 
fluids during RESS. The use of RESS as a comminution alternative to for the production 
of ultra-fine pharmaceutical powders is very promising. The chief limitation of RESS is 
the very low solvent power of the commonly used supercritical solvents for potentially 
useful solutes, such as proteins. The GAS method overcomes this limitation by using the 
supercritical fluid as an anti-solvent. For GAS precipitation one or more solutes, which 
are immiscible with the supercritical fluid, are dissolved in a conventional pharmaceutical 
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solvent, which is miscible with the supercritical fluid. Within supercritical fluids, the 
solution is subsequently expanded, which results in the decrease of the liquids cohesive 
energy causing the solute to precipitate [8,9]. The solute must be insoluble in the 
supercritical fluid, which will then immediately be an anti-solvent. The solvent on the 
other hand has to be at least partially miscible with the supercritical fluid. The GAS 
method is typically use in a way that a supercritical fluid is introduced into a volume of 
solution in a pressure chamber or by spraying solution through a nozzle into a 
supercritical fluid-filled chamber. This technique has many acronyms, with further 
variation in the process: such as aerosol extraction system (ASES), precipitation with 
compressed anti-solvent technique (PCA), solution enhanced dispersion by supercritical 
fluids (SEDS) and supercritical anti-solvent method (SAS) [10,11].  
 
Figure 2: Schematics of the rapid expansion of supercritical solution (RESS) (A), the gas anti-solvent 
precipitation (GAS) (B) and the supercritical anti-solvent (SAS) process (C). 
 
The supercritical anti-solvent method (SAS) utilized the low solvent power of supercritical 
fluids with moderate critical temperatures e.g., CO2 for polymers, proteins and many 
biological molecules for drying [12]. The solutes of interest are dissolved either in a 
suitable organic or aqueous phase (Fig 2, (C)). This technique has been applied for the 
drying of polymeric systems [13,14]. It offers diverse advantages with respect to particle 
morphology, size range and reduction of heat induced stress. 
 
1.1 THERMODYNAMIC BEHAVIOR OF SUPERCRITICAL FLUIDS (SCF) 
Explanations for the infinite compressibility and other unique properties are given in a 
schematic diagram showing the variation of density with pressure (Fig 3). Small changes 
in pressure and temperature around the critical point have a deep impact on the 
thermodynamic behavior of the system. This diagram includes the coexistence of vapor 
and liquid phase, the critical point (CP) and the supercritical region. The critical isotherm 
(TR=T/TC=1; used by correlation of carbon dioxide viscosity [15]) has a vertical slope at 
the critical point, which means that the rate of density change with respect to pressure is 
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infinite. In contrast, the parts of the isotherms corresponding to liquid states have almost 
horizontal slopes, because liquids have a very small compressibility. In the vicinity of the 
supercritical point fluids are almost freely compressible: the fluid density changes 
drastically with the pressure. Above the critical temperature the density of the vapor 
increases more gradually with pressure. Therefore, supercritical fluids are typically 
hundreds of times denser than gases at ambient conditions, but they are much more 
compressible than liquids. So the physical properties are intermediate between that of 
liquids and that of a gas. 
 
Figure 3: Schematic density-pressure phase diagram of a pure fluid in the relative vicinity of the critical point 
(adopted from McHugh et al. [16]). TR = reduced temperature, T = temperature and TC = critical temperature; 
ρR = reduced density, ρ = density and ρC = critical density; PR = reduced pressure, P = pressure and PC = 
critical pressure. 
 
Based on this, the physical properties of supercritical fluids such as high density, low 
viscosity and high diffusivity can be adjusted to obtain optimal product characteristics by 
changing pressure and temperature. For particle formation, the combination of liquid-like 
density and large compressibility is relevant. Large density means that supercritical fluids 
have a solvent power that is comparable with the one of the same substance in the liquid 
state [17]. High compressibility implies that this solvent power is continuously adjustable 
between gas- and liquid-like extremes, with small changes in pressure.  
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1.2 TERNARY SYSTEM CARBON DIOXIDE / ETHANOL / WATER 
The solubility of water in supercritical carbon dioxide is low. It is expressed as weight 
fraction very similar to that of water in typical natural oil [18]. Two methods can be used 
for drying of aqueous systems under supercritical conditions: the evaporation and the 
anti-solvent technique, which was described before. With the addition of co-solvents like 
ethanol, methanol, isopropanol or acetone to the supercritical carbon dioxide the polarity 
of the extraction medium is increased and the solubility of water in carbon dioxide 
becomes higher [19,20]. Thereby, they increase the solubility of compounds to be 
extracted in the supercritical carbon dioxide / organic mixture. Thus, they are used as 
co-solvents for extractions [21]. When using the anti-solvent process, the addition of co-
solvents results in improved extraction forces for water out of the obtained particles. For 
particle formation processes the mass transfer and the saturation levels of the 
compounds are important. The solubility of the compounds in supercritical fluid affect the 
extent of saturation and thereby the particle properties [22].  
By the introduction of an organic solvent to the supercritical phase the number and the 
size of co-existing phases above the critical point can be changed. At a pressure above 
the critical point of a binary mixture of organic solvent and supercritical CO2 one phase 
exists. However, it is still possible that additional phases occur in the region of the critical 
point for CO2-ethanol which is described by Durling et al. (2007) [23]. The phase 
equilibrium data for the CO2-C2H5OH-H2O system at 40°C and at 100 and 200 bar are 
shown in Figure 4. As the pressure increases at a constant temperature, the size of the 
single phase region in the ternary diagram is increased.  
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Figure 4: Ternary diagram for the CO2, C2H5OH and H2O system at 40°C at 100 bar (left) and 200 bar (right) 
using the light squares as SCF and the dark circles as liquid molar fraction [23,24].  
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The main advantage of CO2 in particle formation by precipitation is that the solubility of 
solids in the supercritical phase is very low compared to that of the solids in commonly 
used solvents. Thus, CO2 can function as an anti-solvent and the solid can precipitate out 
of the supercritical solution. At the end of the process, the pressure is reduced to 
atmospheric pressure and carbon dioxide becomes a gas and evaporates easily from the 
dry particles. Density values enable appreciable solvating power, optimized mass transfer 
properties and high compressibility and solvating power [25]. To optimize the 
precipitation process and to obtain a product with specific properties, it is necessary to 
study the behavior in the ternary system and the type of phase separation that occurs. A 
system composed of water-ethanol-carbon dioxide is not fully miscible resulting in 
several phases (Fig 4). Consequently, the experiments can be performed either in the 
one-fluid region (SFC) or in the two-fluid phase, where liquid and SFC are coexisting. The 
solvent power towards a particular compound can be changed significantly by the 
addition of a small amount of volatile co-solvent, e.g. methanol, ethanol, isopropanol and 
acetone, which can facilitate the extraction of water into the supercritical fluid [26,27] 
Particle formation and drying are then governed by two fundamental processes, at first 
due the evaporation of the organic solvent and partially the diffusion of carbon dioxide 
into the aqueous droplet and secondly because of the evaporation of the water into the 
anti-solvent phase. During the evaporation the droplets start swelling due to the 
condensation of the organic solvent into the droplet. This is followed by a decrease in 
droplet radius after saturation of the droplet with the organic solvent and carbon dioxide 
by the extraction of the fluids [28,29].  
The drying time is reduced by the addition of ethanol and the mass transfer follows with 
water evaporating out of the droplets and solvent and carbon dioxide diffusing into the 
droplet [30]. The initial solvent concentrations, the atomization and other process 
parameters like pressure and types of solvents can influence the particle formation 
process. With the expansion of the organic solvent, the solubility of the precipitate 
decreases causing a better nucleation of the solute [31]. Residues of the organic solvent 
can be partially removed from the precipitate by flushing with the pure supercritical fluid. 
This is possible, because of the low surface tension of supercritical fluids, which can 
penetrate even in the smallest pores of the prepared particles. The formation of 
liposomes using supercritical fluids was already described but an aqueous based drying 
process was not yet tested [32,33]. 
The aim of this work was to identify optimum set-ups and working conditions for the 
drying of aqueous liposomal formulations. Therefore, numerous process development 
experiments were necessary to gain knowledge of such a new drying approach. Technical 
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requirements like atomization with varied nozzles and mass transport by carbon dioxide 
flow rates were tested to obtain dry powders. The limited solubility of water in 
supercritical carbon dioxide and the complicated phase behavior were the major 
concerns. The mass transfer should be selected in a way that the co-solvents evaporate 
first into the droplets and that carbon dioxide can diffuse into the droplets before the 
extraction forces induces an inverse flux and destroy the liposomes. The properties of 
carbon dioxide changed after the addition of co-solvents and therefore, an adapted 
working set-up and conditions had to be found. 
 
1.3 PARTICLE FORMATION AND DRYING PROCESS UNDER SUBCRITICAL CONDITIONS 
Using a carbon dioxide at subcritical conditions for drying of aqueous formulations is a 
rather new approach and was investigated especially in the field of silica aerogel 
formation and drying [34,35]. Only few data on solubility of carbon dioxide in water and 
its phase behavior are available below the supercritical point [36]. The following model 
approach derived from literature and from the basics of the drying experiments should 
help to understand the drying capability of subcritical carbon dioxide (Fig 5). The high 
solubility of water in CO2 at low pressure decreased above 20 bar. The discontinuity in 
water solubility at subcritical conditions coincides with the phase change from a gaseous 
to a liquid CO2-rich phase. The pressure interval in which three phases are coexisting 
(H2O-rich liquid, CO2-rich gas and CO2-rich liquid) is very small. Above this saturation 
pressure or more precisely, above this three-phase coexisting line the water solubility in 
the CO2-rich phase increases with slight changes in pressure. 
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Figure 5: Mutual solubility of water and carbon dioxide at 40°C and pressures up to 600 bar based on lit. [39].  
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1.4 EXPERIMENTAL OUTLINE  
We studied the use of sub- or supercritical fluids for the preparation of dry and free 
flowable powders containing liposomes in a one step process. Comparable to spray-
drying (compare chapter 5) the unique feature of such a method lies in the ability to 
combine both particle formation and drying in one continuous process. However, the 
main advantage of such a technique is the very fast production and drying of liposomes 
at gentle temperature conditions of about 40°C. Compared to other drying techniques 
where the driving force are heat exposure or vacuum applied for a longer time, which 
lacks efficacy the mass transfer is important force [37]. 
Parameters like set-up configuration, nozzle type, pressure, solvent type and 
concentration as well as trehalose concentrations were varied. The liposome formation 
using the porous device described in chapter 6 was used for some experiments. Another 
drying approach was tested using subcritical drying conditions, which could be described 
as drying at ambient pressure with CO2 as drying gas [38]. The main difference between 
subcritical and supercritical drying is the phase behavior of carbon dioxide. The solvent 
anti-solvent mixture is situated within the two-phase region with an interface between 
the droplet and the anti-solvent phase passing the two-phase region. The droplet 
diameter increases due to condensation of carbon dioxide followed by the evaporation of 
water once the saturation is reached, which results in dry particles [29]. The evaporation 
strength and solubility are changed by pressure reduction below the critical point. 
However, recently published phase diagrams indicate a miscibility of water within the 
fluidized carbon dioxide [39]. The major advantage compared to the supercritical phases 
could be assigned to the significantly low solubility of compounds within the subcritical 
phase [40]. 
 
 
2. MATERIAL AND METHODS 
2.1 MATERIAL 
The lipids DOTAP-Cl (1,2-dioleoyl-3-trimethylammonium-propane-chloride), DOPC (1,2-
dioleoyl-sn-glycero-3-phosphocholine) from Avanti Polar Lipids (Alabaster, AL, USA) were 
used. Trehalose dihydrate from Ferro Pfanstiehl (IL, USA) was used as the stabilizing 
agent. 99 % ethanol (Merck, Darmstadt, Germany) was used for dissolving the lipids. 
Water for injection was used for dissolving trehalose. The 99.9 % solvents acetone, 
methanol, ethanol and isopropanol (Sigma-Aldrich, Zwijndrecht, The Netherlands) were 
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used as co-solvents within the carbon dioxide. The carbon dioxide (grade 3.5) was 
purchased from Hoek Loos (Schiedam, The Netherlands).  
 
2.2 METHODS 
2.2.1 Liposome preparation 
Three different approaches for liposome preparation were evaluated. First the 
supercritical drying of preformed liposomes, secondly the preparation and drying of 
liposomes out of multi-lamellar suspensions and finally the preparation of liposomes 
using a solvent-lipid-trehalose mixture in the anti-solvent approach.  
The ethanol injection technique was used for preparing multi-lamellar liposomes. A 
solution of 5 mM DOTAP-Cl (1,2-dioleoyl-3-trimethylammonium-propane-chloride) and 
5 mM DOPC (1,2-dioleoyl-sn-glycero-3-phosphocholine) was injected under stirring into a 
10.5 % [w/v] trehalose solution. To achieve preformed liposomes the ethanol injection 
was followed by five extrusion cycles through a 0.2 µm polycarbonate membrane and a 
sterile filtration. The fluorescent probes Coumarin and Nile Red were used as model 
drugs. They were dissolved within the lipid stock solution at a concentration of 31 µM.  
Multi-lamellar vesicles (MLV) with a total lipid content of 10 mM were prepared by the 
already described ethanol injection and extruded through the porous device. Both 
suspensions of preformed- and multi-lamellar liposomes were sprayed into the 
supercritical fluid using the syringe plunger pump. 
 
2.2.2 Particle formation methods  
2.2.2.1 Supercritical spray-drying methods 
By using the experimental set-ups shown in figure 6, the solution was supplied to the 
particular particle formation set-ups, which differed mainly in nozzle configurations. The 
first experimental set-up was constructed using a long residence-tube to increase the 
degree of supersaturation while the formed droplets are flowing through the tube (Fig 6, 
(A)). As a nozzle, a capillary tip with an inner diameter of 0.1 mm was centered in the 
residence-tube prior to the connection of the tube with the particle drying cylinder. An 
orifice nozzle (Fig 6, (B)) with an inner diameter of 0.08 mm was used in the second set 
up. Furthermore, a gravity fed spray nozzle (SS 1650 fluid cap and a 64 air cap) with 
external mixing was employed (Fig 6, (C)) (Spraying systems, IL, USA). For round sprays 
an angle of about 18° was maintained, beyond that point the spray becomes turbulent. 
The fourth nozzle (Fig 6, (D)) was a concentric coaxial two-fluid nozzle (HSS 600 
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Sonimist, Misonix, NY, USA) with inner and outer diameter 0.15 mm and 1.1 mm. A sonic 
field was created at the throat of the nozzle as the compressed gas accelerates and 
reaches the velocity of sound. High frequency waves created by the resonator cavity 
produce a chopping effect that breaks the liquid stream into a fine, evenly dispersed 
cloud of extremely small droplets.  
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Figure 6: Scheme of the used nozzle set-ups. The residence tube (A), the orifice nozzle (B), the gravity coaxial 
two-fluid nozzles (C) and the concentric coaxial sonic field nozzle (D) were used in the supercritical fluid set-up. 
 
Figure 7 shows the experimental set-up for the spraying procedure with supercritical 
anti-solvent. With all nozzles the ISCO DM 260 syringes pump (Teledyne ISCO, Lincoln, 
NE, USA) (1) was applied for spraying at a required constant volumetric flow rate 
between 0.11 and 1.0 ml/min for the preformed and multi-lamellar liposomal suspension. 
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Prior to the spraying the systems were adjusted to equilibrium with the selected pressure 
and temperature. The carbon dioxide was taken from the carbon dioxide tank with a dip-
pipe and cooled to -5°C in a heat exchanger (6) before it entered a positive displacement 
pump (7). The capacity of the pump could be varied between 20 and 600 g/min. A buffer 
vessel (9), which was heated to 66°C, was installed after the pump. The mass flow of 
carbon dioxide was measured with a corrolis type mass flow meter (11). 
 
Figure 7: Schematic experimental set-up used for the spray procedure with supercritical anti-solvent. 
 
The pressure in the buffer vessel between 18 and 170 bar was limited by a control loop 
(8), by which the pump also could be turned off. From the buffer vessel the carbon 
dioxide was supplied to the drying vessel at a constant flow rate of between 250 and 
650 g/min, by opening a valve (10). Before it entered the reaction vessel the CO2 was 
thermostated in a heat exchanger (12). For experiments with co-solvents, this was 
reheated (3) and added to the carbon dioxide flow by a syringe pump (4) before entering 
the drying vessel. The drying vessel had an inner diameter of 10 cm and a volume of 
4 liters. A mesh size filter (13) was fitted at the bottom to retain the particles. The drying 
vessel was heated by a water jacket to a temperature between 37 to 41°C. To prevent 
condensation of the vapor at the top of the vessel the lid was isolated with expanded 
material. The solvent was discharged through the bottom of the vessel to a separation 
vessel to collect the residual solvents dissolved in CO2 (16). Before depressurization, the 
solvent was heated to approximately 76°C by a heat exchanger (14) to prevent plugging 
of the flash valve (15) that controlled the pressure by an electronic system. 
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After the spraying procedure the co-solvent flow was stopped and the vessel was flushed 
with an additional amount of carbon dioxide (6 kg) to remove residual moisture and 
solvent traces. The pressure was slowly released from the system to avoid liquefaction of 
eventually remaining solvents. The particles were collected from the filter and the wall of 
the drying vessel and separately stored. 
 
2.2.2.2 Subcritical spray-drying method 
Subcritical spray-drying was performed with the described experimental set-up in 
Figure 7 as well. The gravity fed spray nozzle (SS 1650 fluid cap and a 64 air cap) and 
the concentric coaxial two-fluid nozzle (HSS 600 Sonimist, Misonix, NY, USA) described in 
figure 6 (C) and (D) were used. For the subcritical mode the pressure of carbon dioxide 
was between 17 and 24 bar with relatively high flow rates between 500 and 620 g/min. 
The temperature was adjusted to 40°C and the solution flow rate was set to 0.11 ml/min. 
After the spraying procedure, the vessel was flushed with an additional amount of carbon 
dioxide (10 kg) to remove residual solvent traces.  
 
All further methods used in this chapter are already described before. 
 
 
3. RESULTS AND DISCUSSION 
The first studies were conducted to gain knowledge about the set-ups and parameters 
required for a feasible drying and particle formation process using supercritical carbon 
dioxide. Several technical changes of the set-up and the nozzle were necessary to find 
appropriate working conditions, which allow the preparation of dry particles and the 
preservation of the liposomal structure.  
 
3.1 PARTICLE FORMATION AND DRYING STUDIES  
A modified precipitation with compressed anti-solvent (PCA) process in the residence 
tube (see Fig 6, (A)) with the addition of ethanol as a co-solvent was used to study the 
particle formation out of preformed aqueous liposomal formulation. So far, this process 
was only used for the precipitation of organic compounds containing less than 5 % [w/v] 
water [41,42,43]. The drying of aqueous systems was not feasible, because the 
miscibility of carbon dioxide with water, as well as its solubility in water was too low 
[44,45]. Therefore, we investigated the addition of ethanol to the anti-solvent flow to 
enhance the solubility of water in supercritical CO2. This addition furthermore reduced the 
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interfacial tension within the system (CO2-water) and increased the evaporation capacity 
and eventually the degree of saturation, finally resulting in particle formation. To further 
illustrate the correlation, which was prevalent in this experimental set-up the water 
uptake capacity was plotted against the fraction ethanol in the extractant (Fig 8). The 
operating pressure, temperature, droplet size and mass transfer rates between the 
droplet and the carbon dioxide / co-solvent controlled the particle size and morphology 
as described by Baldyga et al. (2004) [4]. 
 
0.0 0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9 1.0
0.0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
0.0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
liquid & SCF 
m
ole fraction of C
2 H
5 O
H
m
ol
e 
fr
ac
tio
n 
of
 H
2
O
mole fraction of CO
2
SCF 
         
0.00 0.05 0.10 0.15 0.20 0.25 0.30
0.02
0.04
0.06
0.08
0.10
1 phase region 
       (SFC)
 1.0 ml/min feed rate
 0.5 ml/min feed rate
 vapor-liquid equlibrium
 
 
m
o
l 
H
2
O
 /
 m
o
l 
C
O
2
 +
 m
o
l 
E
tO
H
mol EtOH / mol CO
2
 + mol EtOH
2 phase region 
 (liquid & SCF)
 
Figure 8: Phase equilibrium ternary diagram for CO2-C2H5OH-H2O including the experimental conditions (left), 
and converted into a drying capacity diagram using the residence tube of the CO2-C2H5OH-H2O system (right).  
 
If the miscibility of a fluid in the supercritical phase, in our case water, is low mass 
transfer requires special attention and can be optimized with an improved atomization 
approach [46]. To improve the particle formation in the supercritical fluid process an 
orifice-spray-nozzle (Fig 6, (B)) was introduced to atomize the liquid feed into fine 
droplets directly in the drying vessel at 100 bar and 40°C. Such an enhanced particle 
formation process could further induce the drying behavior with optimized droplet break-
up, induced mass transfer and saturation levels. This optimized spraying approach and 
the selection of the set-up conditions shown in figure 9 (A) could help to overcome the 
limitation of using the residence tube. However, the improved atomization device using 
an orifice nozzle did not lead to sophisticated particle morphologies and process 
properties. Due to the very low miscibility of water with carbon dioxide a further 
improvement with respect to mass transfer between these components was desired using 
the solution enhanced dispersion by supercritical fluids (SEDS) configuration. The 
advantage of the SEDS was the incorporation of a coaxial nozzle (Fig 6, (C)), with a 
mixing chamber to increase the relative velocity of the dispersing supercritical fluid [47]. 
Higher velocities of the supercritical carbon dioxide assist the droplet formation by 
improved jet break-up and fine droplet formation. Furthermore, the mixing properties 
 
CHAPTER 9   
 
 
 
  
 
172 
within the drying vessel and the saturation levels of the actively combined anti-solvent / 
co-solvent and solution feed could be improved [31].  
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Figure 9: Drying capacity diagram using of the CO2-C2H5OH-H2O system including the experimental conditions 
using the orifice nozzle (A), the gravity coaxial two-fluid nozzles (B) and the concentric coaxial sonic field nozzle 
(C).  
 
The liquid was dispersed through a coaxial gravity feed nozzle and the droplet formation 
was induced by the anti-solvent/co-solvent stream. The carbon dioxide / ethanol ratio 
and the relative velocity between aqueous solution and CO2-ethanol was increased using 
higher carbon dioxide flow rate and varied ethanol feed rates between 7 and 30 ml/min 
(Fig 9, (B)). To further improve the droplet formation process a concentric coaxial nozzle 
(Fig 6, (D)) was used in which the supercritical fluid flow induces ultrasounds and causing 
a turbulent flow mixing of the phases resulting in an improved mass transfer. The 
reduced liquid feed rates of 0.5 ml/min and carbon dioxide flow rates of 250, 350 and 
416 g/min were investigated (Fig 9, (C)).  
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3.1.1 Particle morphology 
3.1.1.1 Residence tube  
The first studies to evaluate the experimental set-up and spraying parameters were 
performed at constant pressure conditions. The solution and the amount of carbon 
dioxide/ethanol mixture was pumped through the annular gap surrounding the capillary 
tip (Fig 6, (A)). Higher mass transfer of the supercritical phase into the particles directly 
affected the saturation levels and the morphology of dry particles (Fig 10), obvious by 
rough particle surface structures.  
 
   
Figure 10: Scanning electron micrographs of particles obtained by supercritical-drying using the residence tube 
described in figure 2 (A) with 170, 190 and 210 g/min CO2 with a solution flow rate of 1.0 ml/min.  
 
3.1.1.2 Orifice atomization nozzle 
The morphology of the particles prepared by the atomization nozzle indicated no 
homogenous droplet formation, as only fragments without a distinct shape were obtained 
(Fig 11). The mixture’s critical pressure, which is required to create spherical particles, 
was not achieved for the main droplet fraction. This was obvious by a thin viscous film of 
lipids and trehalose on the inner surface of the drying vessel.  
 
  
Figure 11: Scanning electron micrographs of particles obtained by supercritical-drying using the improved anti-
solvent precipitation with atomization described in Figure 2 (B) with 210 g/min CO2 and a solution flow rate of 
0.63 and 1.0 ml/min.  
 
100 bar, 170 g/min CO2, 20ml/min ethanol 
1.0 ml/min sol. 
100 bar, 190 g/min CO2, 20ml/min ethanol
1.0 ml/min sol.
100 bar, 210 g/min CO2, 20ml/min ethanol
1.0 ml/min sol. 
100 bar, 210g/min CO2, 20 ml/min ethanol, 
0.63 ml/min sol. 
100 bar, 210g/min CO2, 20 ml/min ethanol,  
1.0 ml/min sol.
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Only fine droplets could be dried, whereby most of the liquid feed was retained and 
spread at the wall of the vessel. Neither a variation of the liquid feed rate and 
corresponding mass transfer and evaporation, nor of the droplet size itself resulted in a 
sufficient and homogenous particle formation process. 
 
3.1.1.3 Gravity feed nozzle  
In the coaxial two-fluid nozzle the diffusion of the CO2/ethanol solvent stream into the 
liquid solvent depended on anti-solvent feed rate, pressure and co-solvent addition. This 
nozzle was included in the study to elucidate the influence and quality improvement of 
micronized jet break-up, reduction of particle agglomeration, as well as controlling the 
extent of mixing and solute-solvent interaction on the resulting particles. Pressure and 
ethanol concentration were responsible for particle shape and morphology. When 
produced at 100 and 120 bar the particles had an irregular shape, which changed to 
more spherical shapes with raising pressure (Fig 12).  
 
    
    
Figure 12: SEM pictures of supercritically spray-dried powders at 100, 120, 145 and 170 bar with an ethanol 
flow rate of 7 and 15 ml/min using the coaxial nozzle. 
 
The low mole-fraction of ethanol within the carbon dioxide resulted in less agglomerated 
and spherical particles from above 145 bar (Fig 12). Thereby, the ethanol concentration 
was below the maximum mole fraction of ethanol (< 0.34 for 100 bar and 36.5°C), which 
could be loaded into a droplet [50]. Doubled ethanol mole fraction resulted in a high 
saturation of ethanol in the gas phase and therefore in enhanced evaporation. The 
droplet formation process and the jet length of the liquid feed can provide an explanation 
for the more spherical particles at 170 bar. At constant temperature the jet length 
decreases when the pressure is increased, which results in different droplet diameters 
and enhanced mass transfer [48]. The saturation concentration of ethanol and carbon 
100 bar, 350g/min CO2, 
7ml/min ethanol, 1ml/min sol. 
100 bar, 350g/min CO2, 
15ml/min ethanol, 1ml/min sol.
120 bar, 350g/min CO2, 
7ml/min ethanol, 1ml/min sol.
120 bar, 350g/min CO2, 
15ml/min ethanol, 1ml/min sol.
145 bar, 350g/min CO2, 
7ml/min ethanol, 1ml/min sol.
145 bar, 350g/min CO2, 
15ml/min ethanol, 1ml/min sol.
170 bar, 350g/min CO2, 
7ml/min ethanol, 1ml/min sol.
170 bar, 350g/min CO2, 
15ml/min ethanol, 1ml/min sol.
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dioxide in droplets and droplets radius were described to decrease with increased 
pressure [29]. This favored two particle formation processes, the evaporation of water 
and the precipitation considered by supersaturation. Particle morphology was affected by 
this phenomenon, which was described by the reduction of convective flow [29].  
Different trehalose concentrations of 5, 10.5 and 15 % [w/v] were dried at 170 bar and 
at a further increased ethanol rate of 30 ml/min. Two separate particle fractions were 
present within the drying vessel. One fraction was collected from the wall, while a larger 
fraction of about 60 % was retained at the filter plate. The particles adhering at the wall 
had no distinct shape. Needle like structures were observed for particles collected from 
the filter plate (Fig 13).  
 
   
Figure 13: SEM pictures of supercritically spray-dried powders collected from filter plate at 170 bar with an 
ethanol flow rate of 30 ml/min and a solution flow rate of 1.0 ml/min using the coaxial nozzle and different 
trehalose concentrations. 
 
3.1.1.4 Concentric coaxial nozzle  
The different velocities of the CO2-ethanol stream and the jet velocity were reduced to 
enhance the evaporation forces for the concentric coaxial nozzle (Fig 6, (D)). After 
mixing, the two streams leave the nozzle tip at a velocity equal to a two-phase flow and 
end up in a so called hydrodynamic relaxation zone. This zone is mainly influenced by the 
mass flow ratio and represents the key control parameter for mass transfer.  
 
   
Figure 14: SEM pictures of supercritically spray-dried powders at 100 bar with an ethanol flow rate of 20 
ml/min using the concentric coaxial nozzle and different carbon dioxide flow rate and solution flow rates. 
filter, 170 bar, 30ml/min ethanol, 5% tre. filter, 170 bar, 30ml/min ethanol, 10.5% tre. filter, 170 bar, 30ml/min ethanol, 15% tre. 
100 bar, 250 g/min CO2, 0.5 ml/min sol. 
20 ml/min ethanol 
100 bar, 350 g/min CO2, 0.5 ml/min sol. 
20 ml/min ethanol 
100 bar, 416 g/min CO2, 0.5 ml/min sol. 
20 ml/min ethanol 
 
CHAPTER 9   
 
 
 
  
 
176 
If this mass transfer factor and the equilibrium phase are optimized, the subsequent 
mass transfer zone leads into a uniform saturation and drying zone [49]. With a solution 
feed rate of 0.5 ml/min a phase change of the vapor-liquid equilibrium occurred. 
However, scanning electron microscope images indicated predominantly spherical and 
smooth particles. As water required a large amount of carbon dioxide to become fully 
evaporated the liquid feed rate should be reduced or the carbon dioxide flow increased.  
 
3.1.2 Particle size distribution 
3.1.2.1 Residence tube  
The mean particle size obtained with the residence tube ranged from 160 to 320 µm at a 
solution feed rate of 1.0 ml/min (Tab 2). At a carbon dioxide feed rate of 190 g/min, 
mixed with 20 ml/min ethanol the mean particle size was 141 µm. These large particles 
indicate an insufficient drying resulting in agglomeration of moist particles at the filter 
plate. Further increases in carbon dioxide flow and hence a lower molar fraction of 
ethanol in the mixture resulted in a decreased particle size, reaching a mean size of 
75 µm at 210 g/min CO2. However, the data pointed at a phase separation of carbon 
dioxide and ethanol occurring at low ethanol concentration due to the broad particle size 
distribution. The mass transfer rates were not sufficient to reach saturation of soilds in all 
formed droplets [50]. The particle size at 0.5 ml/min solution feed rate was reduced for 
both investigated experimental conditions (Tab 2). Decreasing the molar fraction of water 
by reducing the solution feed compared to the evaporation mixture resulted in smaller, 
but still agglomerated particles.  
Table 2: Particle size diameter, residual moisture and product yield using the residence tube at a pressure of 
100 bar with 170, 190 and 210 ml/min carbon dioxide flow and solution rates of 0.5 and 1.0 ml/min. 
nozzle 
type 
pressure 
[bar] 
CO2 
[g/min] 
ethanol 
[ml/min] 
solution 
[ml/min] 
d[10] 
[µm] 
d[50] 
[µm] 
d[90] 
[µm] 
d[4,3] 
[µm] 
span 
res. tube 100 170 20 1.0 42.1 141.0 320.6 165.4 1.9 
res. tube 100 190 20 1.0 35.1 102.6 299.6 150.3 2.5 
res. tube 100 210 20 1.0 30.5 75.9 165.8 94.1 1.7 
res. tube 100 190 20 0.5 15.6 47.5 116.3 54.8 2.1 
res. tube 100 210 20 0.5 12.9 37.1 76.0 42.7 1.7 
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3.1.2.2 Orifice atomization nozzle 
The additional atomization of the liquid feed directly into the compressed larger volume 
of carbon dioxide / ethanol resulted in smaller droplet sizes. The swelling process of the 
droplets due to the condensation of ethanol and CO2 was on the other hand favored. But 
for both, 1.0 and 0.63 ml/min liquid feed particle fractions with sizes around 15 µm were 
obtained (Tab 3). The molar fractions of the ethanol / carbon dioxide and the smaller 
droplets were sufficient to improve evaporation of water and to finally achieve the 
optimized particle morphology and size. Furthermore, the agglomeration tendency was 
reduced because of a more homogenous evaporation  
Table 3: Particle size diameter using the improved anti-solvent precipitation with atomization of 100 bar with 
210 g/min CO2 and a solution flow rate of 0.63 and 1.0 ml/min.  
nozzle 
type 
pressure 
[bar] 
CO2 
[g/min] 
ethanol 
[ml/min] 
solution 
[ml/min] 
d[10] 
[µm] 
d[50] 
[µm] 
d[90] 
[µm] 
d[4,3] 
[µm] 
span 
orifice 100 210 20 0.63 6.1 15.7 31.2 31.2 2.2 
orifice 100 210 20 1.0 7.5 17.4 34.0 34.0 2.4 
 
3.1.2.3 Gravity feed nozzle  
An effect of pressure and ethanol concentration on particle size was visible (Tab 4). 
Higher operating pressures and ethanol concentration resulted in a slight decrease of 
particle size. Small particles with a mean diameter of 27 µm were obtained at a pressure 
of 170 bar and the higher ethanol content. However, the width of the volume distribution 
indicated by the span value remained relatively large for all conditions. A certain amount 
of ethanol was expected to condense into the droplet and increase the solvent extraction 
[51]. This effect depended on pressure and density of the system [52].  
Table 4: Particle size diameter using the coaxial gravity feed nozzle at a pressure of 100, 120, 145 and 170 bar 
with 350 ml/min carbon dioxide flow, ethanol flow rates of 7 and 15 ml/min and a solution rate of 1.0 ml/min. 
nozzle 
type 
pressure 
[bar] 
CO2 
[g/min] 
ethanol 
[ml/min] 
solution 
[ml/min] 
d[10] 
[µm] 
d[50] 
[µm] 
d[90] 
[µm] 
d[4,3] 
[µm] 
span 
gravity 100 350 7 1.0 3.9 23.1 119.4 45.6 5.0 
gravity 100 350 15 1.0 4.1 16.3 72.1 30.1 4.1 
gravity 120 350 7 1.0 5.4 49.1 154.2 67.2 3.0 
gravity 120 350 15 1.0 4.2 20.8 128.0 46.7 5.9 
gravity 145 350 7 1.0 3.0 10.8 73.1 27.8 6.4 
gravity 145 350 15 1.0 4.8 17.4 121.7 42.8 6.7 
gravity 170 350 7 1.0 5.6 24.7 78.1 37.5 2.9 
gravity 170 350 15 1.0 3.7 12.0 65.9 26.9 5.1 
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Due to the improved mixing of aqueous solution with carbon dioxide and ethanol already 
in the air-cap (Fig 6, (C)) the saturation in smaller droplets became already earlier 
sufficiently large, with the result of faster water evaporation. The kinetic of the saturation 
onset depended on the time of ethanol expansion and the so-called diffusion time, which 
was influenced by the radius of the droplets and the diffusivity in the solvent carbon 
dioxide mixture [53]. At a high ethanol concentration of 15 ml/min an anti-solvent 
approach within the particles could become feasible. As already described, two particle 
fractions were obtained when using the coaxial gravity feed nozzle. The particles 
collected from the wall were generally larger than the particles from the filter plate 
(Tab 5). Moreover, the size distribution was more homogenous for the particles form the 
filter plate with span values around 2.0, which could be explained by the smaller droplets 
formed at the nozzle. 
Table 5: Particle size diameter using the coaxial gravity feed nozzle with different trehalose concentrations at a 
pressure of 170 bar with 350 ml/min carbon dioxide flow with an ethanol flow rate of 30 ml/min and a solution 
rate of 1.0 ml/min. 
trehalose 
% [w/v] 
particle 
collection 
pressure 
[bar] 
CO2 
[g/min] 
ethanol 
[ml/min] 
d[10] 
[µm] 
d[50] 
[µm] 
d[90] 
[µm] 
d[4,3] 
[µm] 
span 
5.0 wall 170 350 30 5.5 28.0 69.5 35.0 2.2 
5.0 filter 170 350 30 3.5 9.6 20.4 11.2 1.7 
10.5 wall 170 350 30 4.3 13.1 40.4 21.2 2.7 
10.5 filter 170 350 30 3.5 11.0 34.9 16.6 2.8 
15.0 wall 170 350 30 6.5 17.8 97.5 35.2 5.1 
15.0 filter 170 350 30 4.5 16.6 49.7 26.2 2.6 
 
 
3.1.2.4 Concentric coaxial nozzle  
The particle size measurement indicated a homogenous drying resulting in a product with 
a narrow particle distribution with a span of around 1.0 for the liquid feed rate of 
0.5 ml/min. The mixing rate between carbon dioxide / ethanol and the solution feed 
influenced the particle size. When using 250 g/min CO2 a mean size of 2.0 µm was 
reached. Increasing the carbon dioxide flow rate up to 350 and 416 g/min raised the 
particle size to 10 µm (Fig 15, left). The initial swelling stage induced by the supercritical 
phase influenced the particle size by the condensation of ethanol and carbon dioxide into 
the droplet. The different solubilities of CO2 and ethanol in water affected this swelling. 
Because of the higher ethanol concentration and at the same time lower carbon dioxide 
flow this evaporation level was improved. The opposite was achieved with 1.0 ml/min 
solution feed rate, which was characterized by the insufficient diffusion of both CO2 and 
ethanol into droplets in the hydrodynamic relaxation zone (Fig 15, right). If the ethanol 
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content and therefore the solubility of water in the supercritical phase were high enough, 
the drying procedure was independent from the atomization force. The mass transport 
process became the key control particle formation parameter.  
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Figure 15: Cumulative volume-based size distribution curves of supercritically spray-dried particles at a solution 
flow rate of 0.5 ml/min (left) and 1.0 ml/min (right) with a pressure of 100 bar and carbon dioxide flow rates of 
250, 350 and 416 g/min.  
 
 
3.1.3 Yield and residual moisture 
3.1.3.1 Residence tube  
The particle formation process resulted in very low yields below 40 % for this set-up 
(Tab 6). The most common sources of product loss were insufficient drying and leakage 
of powder between filter plate and the vessel wall. The fine particle fraction also vanished 
through the filter itself. The mixing energy was not high enough when using the 
residence tube due to the restricted nozzle geometry and the large droplets.  
Table 6: Residual moisture and powder yield of particles obtained within the residence tube.  
nozzle type 
pressure 
[bar] 
CO2 
[g/min] 
ethanol 
[ml/min] 
solution 
[ml/min] 
residual 
moisture [%] 
yield 
[%] 
res. tube 100 170 20 1.0 6.0 30 
res. tube 100 190 20 1.0 4.8 24 
res. tube 100 210 20 1.0 1.4 15 
res. tube 100 190 20 0.5 2.1 41 
res. tube 100 210 20 0.5 2.4 37 
 
Evaporation during the relatively short time inside the precipitation pipe followed by 
movement of the droplets through the drying vessel distance influenced the yield. They 
were floating through the drying vessel and adhered at wall or filter plate before they 
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reached sufficient drying levels. An additional amount of particles was retained inside the 
precipitation tube. The overall inhomogeneous drying procedure resulted in particles with 
residual moisture contents below 6.0 %.  
 
3.1.3.2 Gravity feed nozzle  
A similar residual moisture content of about 4.5 % and relatively low product yields of 
40 % were found for the atomization nozzle. Therefore, further investigations were 
necessary to identify optimum working conditions for drying of aqueous formulations in 
respect of jet break-up of the liquid feed at the nozzle tip, mass transfer and nucleation. 
When using the concentric co-axial nozzle the residual moisture content was mainly 
affected by the ethanol concentration in the CO2-ethanol mixture. The solubility of 
ethanol in carbon dioxide increased sharply with the pressure. High ethanol contents of 
15 ml/min in the anti-solvent led to relatively low moisture values between 4 and 5 % in 
comparison to the lower ethanol concentration with values between 6 and 7.5 % 
(Fig 16, left). Ethanol concentration in the gaseous phase has large impact on the mass 
transfer. The droplet drying time could be significantly reduced because of the higher 
solubility of water when the carbon dioxide was richer in ethanol as described by Martin 
et al. (2007) [30]. This working region above the mixture’s critical point was not fully 
achieved. However, the increased ethanol content at high pressure resulted in a phase 
behavior with increased miscibility of water resulting in higher product yield (Fig 16, 
right).  
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Figure 16: Residual moisture (left) and powder yield (right) after supercritical spray-drying of liposome 
suspensions with 10 mM lipid and 10.5 % trehalose using 7 and 15 ml/min ethanol flow rate within in the 
supercritical carbon dioxide flow of 350 g/min and a pressure between 100 and 170 bar using the gravity feed 
nozzle.  
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For all studied trehalose concentrations the particles from the wall had a residual 
moisture of about 3 % and the particles from the filter of about 4 % when using the 
gravity feed nozzle (Tab 7). The particle yield could be increased to almost 100 % (wall 
and filter combined) by these settings. High ethanol concentrations led to a favorable 
phase behavior. Most common sources of product loss were reduced and the filters 
stayed intact. However, the allocation of particle in a mass ratio of 1:3 at wall to filter 
pointed at two decisive factors important for aqueous formulation drying at high ethanol 
concentrations: the phase behavior and the choice of co-solvent concentration with the 
additional atomization properties. 
Table 7: Residual moisture and powder yield of particles obtained with 5, 10.5 and 15 % trehalose.  
trehalose 
% [w/v] 
nozzle 
type 
particle 
collection 
pressure 
[bar] 
CO2 
[g/min] 
ethanol 
[ml/min] 
solution 
[ml/min] 
residual 
moisture 
[%] 
yield 
[%] 
5.0 gravity wall 170 350 30 1.0 2.9 33 
5.0 gravity filter 170 350 30 1.0 4.2 64 
10.5 gravity wall 170 350 30 1.0 3.4 35 
10.5 gravity filter 170 350 30 1.0 4.3 62 
15.0 gravity wall 170 350 30 1.0 3.1 39 
15.0 gravity filter 170 350 30 1.0 4.0 59 
 
At high ethanol concentrations in the CO2 the formation of a second liquid phase can be 
suppressed and the working conditions were closer to the even critical point of the 
ternary mixture [50]. 
 
3.1.3.3 Concentric coaxial nozzle  
When using the concentric coaxial nozzle low residual moisture contents could be 
achieved by increasing the molar fraction of ethanol to the carbon dioxide while reducing 
the solution feed rate (Tab 8).  
Table 8: Residual moisture and powder yield of particles obtained at 100 bar with an ethanol flow rate of 
20 ml/min using different carbon dioxide flow rates and solution flow rates.  
nozzle 
type 
pressure 
[bar] 
CO2 
[g/min] 
solvent 
[ml/min] 
solution 
[ml/min] 
residual 
moisture [%] 
yield 
[%] 
concen. 100 250 20 0.5 1.9 95 
concen. 100 250 20 1.0 8.0 52 
concen. 100 350 20 0.5 1.9 95 
concen. 100 350 20 1.0 5.9 60 
concen. 100 416 20 0.5 1.6 90 
concen. 100 416 20 1.0 6.4 61 
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The rapid evaporation resulted in faster saturation and extraction levels of water. A water 
mole fraction of 0.07 within the carbon dioxide / ethanol phase should not be exceeded 
due to the limited solubility. The loading of ethanol into supercritical phases could not be 
further optimized. Leaving all other parameters constant an increased solution feed rate 
doubled the mole fraction of water in the system. However, this led to an insufficient 
drying of the formed droplets which resulted in residual moisture content above 6 % and 
a decline in yield to 50 to 60 %.  
 
3.1.4 Residual solvents 
For the application of the dried product as therapeutic agent it is a pre-requisite to keep 
the residual solvent level low [54]. No residual ethanol was detected in particles prepared 
with the residence tube and additional atomization using the static headspace gas 
chromatography (HS-GC).  
 
3.1.4.1 Gravity feed nozzle  
When using the gravity nozzle for the atomization of the liquid feed at pressures between 
100 and 170 bar, the remaining residual ethanol content increased with pressure and the 
amount of ethanol added as a co-solvent. At higher densities and a solvent flow rate of 
15 ml/min, ethanol diffusion into the particles was improved, which resulted in a residual 
ethanol concentration of 2500 ppm (Fig 17, left). After precipitation and particle 
formation the ethanol was bound via hydrogen bonds to the trehalose and could not be 
totally removed by the additional carbon dioxide washing step. With increasing trehalose 
concentrations the residual ethanol content increased, which is further indicative for the 
retaining effect of trehalose on ethanol (Fig 17, right).  
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Figure 17: Residual ethanol concentration of supercritically spray-dried particles at increasing pressure with 7 
and 15 ml/min co-solvent feed (left) at increasing trehalose concentration in the formulation from 5, 10.5 and 
15 % [w/v] with 30 ml/min co-solvent feed and 170 bar (right). 
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The particles from the wall contained less residual ethanol compared to the particles from 
the filter. Depending on trehalose concentration, the swelling and diffusion time of 
ethanol into the particles rose over the time of flight in the drying vessel. The higher 
residual ethanol content of the particles from the filter could directly be correlated with 
the particle formation and drying process, due to the initial swelling of carbon dioxide 
and ethanol into the droplet. After reaching saturation inside the droplets the evaporation 
of the solvents began, which result in a decreased particle size. 
 
3.1.4.2 Concentric coaxial nozzle  
The diffusion of ethanol into the droplets and the evaporation of water was more 
pronounced for the concentric coaxial nozzle, resulting in very homogenous particle 
formation. At reduced aqueous feed the residual moisture levels were significantly 
reduced below 2 %. Additionally, the particle size was lowered, which was achieved by 
the forced diffusion of ethanol into the atomized droplet and the resulting homogenous 
water evaporation due to the tremendous levels of saturation. The consequence was the 
extraction of both, water and ethanol into the supercritical phase. The inverse flux of 
carbon dioxide into the droplets led to the expansion of the organic phase creating local 
saturation and finally precipitation of the solute. The precipitation levels of solutes were 
much higher because of the smaller droplet size and the larger surface area resulting in 
the high remaining residual ethanol content between 5000 and 7000 ppm (Fig 18). The 
liquid feed rate of 1.0 ml/min resulted in residual ethanol contents below 2000 ppm. 
However, the broader particle size distribution, the lower yield of about 60 % and 
particularly the high residual moisture content up to 8 % recommend the lack of drying 
performance and mass transfer.  
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Figure 18: Residual ethanol concentration of supercritically spray-dried solution with a feed of 0.5 and 
1.0 ml/min and increasing carbon dioxide flow rates 250, 350 and 416 g/min using the concentric coaxial 
nozzle at 100 bar with a co-solvent flow of 20 ml/min.  
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3.1.5 X-ray powder diffraction  
When using the gravity feed nozzle at a pressure of 100 bar with additional ethanol flow 
of 7 ml/min the process resulted in crystalline powders, because of the longer drying 
time and the reduced water solubility in the supercritical phase (Fig 19, left). The XRD 
diffraction pattern indicated the presence of crystalline trehalose dihydrate by the peaks 
at 8.8 and 23.3° 2-Theta [55]. Particle morphology and size already had indicated 
insufficient evaporation of the carbon dioxide into the particle. Drying time increased due 
to the reduced water solubility in CO2, the liberated water was not removed quickly 
enough out of the particles and crystallization occurred. The residual water acts as a 
plasticizer reducing the Tg and favoring the crystallization of the trehalose either during 
process or storage. After drying at higher pressure and with a higher density of the 
carbon dioxide a broad halo pattern, typical for amorphous material was visible in the 
XRD patterns. The high pressure of 170 bar enhanced the mole fraction ethanol in the 
carbon dioxide and increased the water solubility with the consequence of having 
different particle fractions at the wall and the filter plate. The fractions from wall and 
filter exhibited different physical properties. Particles from the wall were amorphous, 
whereas the fraction collected from the filter showed crystalline structures (Fig 19, right). 
The high residual moisture content between 4 to 5 % and the very small size of the 
particles from the filter resulted in a crystalline morphology.  
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Figure 19: Wide angle X-ray diffraction pattern after supercritically spray-drying of liposomes at pressures 
between 100 and 170 bar with 3, 7 and 15 ml/min ethanol flow (left) and 30 ml/min (right) to the carbon 
dioxide flow of 350 g/min at a solution feed of 1.0 ml/min.  
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3.2 LIPOSOME SIZE AND LIPID SOLUBILITY 
3.2.1 Liposomes dried by the residence tube 
Liposome size was determined after the reconstitution of the supercritically dried 
powders. For the preformed liposomes dried within the residence tube the carbon dioxide 
flow of 210 g/min positively influenced the liposome size resulting in a size of 200 nm 
and a low polydispersity index (PI) of 0.21. Increasing the molar fraction CO2-water by 
decreasing the solution feed rate did not further improve the PI (Tab 9). The size 
distribution of liposomes prepared by the atomization nozzle was not further improved 
compared to the residence tube (data not shown). More efficient atomization and 
distribution of the liquid feed rate with the carbon dioxide flow rate is necessary to 
reduce the influence of lipid solubility in the supercritical fluid. This will be further 
described in section 3.4.5. 
Table 9: Liposome size and polydispersity index of supercritically dried particles obtained within the residence 
tube.  
nozzle 
type 
pressure 
[bar] 
CO2 
[g/min] 
ethanol 
[ml/min] 
solution 
[ml/min] 
z-average 
[nm] 
polydispersity 
index 
before     170 0.20 
res. tube 100 170 20 1.0 220 0.43 
res. tube 100 190 20 1.0 190 0.48 
res. tube 100 210 20 1.0 201 0.21 
res. tube 100 190 20 0.5 140 0.31 
res. tube 100 210 20 0.5 220 0.30 
 
3.2.2 Liposomes dried by the gravity feed nozzle 
3.2.2.1 Liposomes size at varied pressure 
Size and PI of liposomes dried by supercritical fluids and the co-axial nozzle were 
affected by pressure and ethanol concentrations. At pressures between 100 and 145 bar 
and high ethanol mole fraction of 0.257 mol/min liposomes with a z-average of 140 to 
120 nm, but an increased PI were obtained. This could be attributed to the swelling 
process induced by carbon dioxide and the co-solvent. The configuration pathway 2 B 
(Fig 7) to form liposomes in combination with a porous device from a multi-lamellar 
vesicles suspension was successfully tested at 170 bar. The size of the liposomes was 
reduced to 130 and 115 nm with polydispersity indices of 0.25 and 0.22, respectively 
(Tab 10). This approach allowed the direct formation of liposomes and drying within a 
single process step. 
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Table 10: Liposome size and polydispersity index using the coaxial gravity feed nozzle at a pressure of 100, 
120, 145 and 170 bar with 350 ml/min carbon dioxide flow with ethanol flow rates of 7 and 15 ml/min and a 
solution rate of 1.0 ml/min.  
nozzle type 
pressure 
[bar] 
CO2  
[g/min] 
ethanol 
[ml/min] 
solution 
[ml/min] 
z-average 
[nm] 
polydispersity 
index 
before     165 0.21 
gravity 100 350 7 1.0 225 0.51 
gravity 100 350 15 1.0 143 0.45 
gravity 120 350 7 1.0 200 0.48 
gravity 120 350 15 1.0 127 0.47 
gravity 145 350 7 1.0 181 0.44 
gravity 145 350 15 1.0 120 0.42 
gravity 170 350 7 1.0 130 *0.25 
gravity 170 350 15 1.0 115 *0.22 
* Liposomes prepared with the modification described in set-up (2B) the porous device. 
 
3.2.2.2 Lipid recovery at varied pressure  
The use of supercritical fluids is always based on the different solubility of compounds in 
CO2 and/or co-solvents. The extraction of the lipids and the ethanol content in the 
gaseous phase was determined as the key factor on lipid solubility [56]. The solvent 
selectivity of ethanol for the liquid and the gaseous phase can be obtained by the ratio of 
the partition coefficients of ethanol and water in CO2 [57] and calculated using the mole 
fraction of ethanol in the gaseous and liquid phases, respectively [35]. 
Figure 20 shows the solvent selectivity in comparison with the lipid recovery of DOTAP-Cl 
(left) and of DOPC (right). Data from literature at 100 bar and 200 bar showed that the 
solvent selectivity decreases with increasing pressure and ethanol concentrations in the 
liquid phase (symbols with dotted line). The used lipids DOTAL-Cl and DOPC revealed 
different solubility behavior in the experiments depending on the ethanol mole fraction in 
the liquid phase and the pressure in the system. For DOTAP-Cl (Fig 20, left) the high 
selectivity and the low ethanol mole fraction in the liquid phase resulted in lipid 
extraction of 30, 45, 50 and 60 % depending on pressure 170, 145, 120 and 100 bar. 
With reduced selectivity and a lower mole fraction ethanol in the liquid phase the 
extraction of lipids could be reduced to 12, 32, 45 and 47 % in the same pressure range. 
The solubility of DOPC at the conditions with higher selectivity differed from those of 
DOTAP-Cl (Fig 20, right). For DOPC almost 100 % recovery was measured at a drying 
pressure of 170 bar. Within the used systems the addition of the co-solvents at increased 
pressure reduced the solubility of the lipids due to the enhanced drying performance by 
the raised miscibility of water in the system.  
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Figure 20: Solvent selectivity for the CO2-C2H5OH-H2O ternary system for 100 and 200 bar at 40°C [23] 
compared to the lipid recovery at the pressure 100, 120, 145 and 170 bar and different lipids DOTAP-Cl (left) 
and DOPC (right). 
 
The viscosity of the fluid increases with its density due to the increased intramolecular 
forces, when the molecules in the fluid become more closely packed as described by 
Durling et al. (2007) [23]. The addition of the co-solvents to the supercritical carbon 
dioxide increases the viscosity and the selectivity resulting in reduced lipid solubility. 
However, the determined lipid recoveries were not in agreement with recent publications 
where the solubility raised for the studied triglycerides and pure lipids at increased 
pressure [58]. This effect was obtained by increased density and solubility of carbon 
dioxide in combination with the co-solvent addition. Further studies revealed that the 
lipid solubility depended on the molecular weight of the lipids and on the pressure 
increase up to maximum saturation [59]. This level of maximum saturation depended 
again the molecular weight of the substance [60].  
 
3.2.2.3 Liposomes size and lipid recovery at varied trehalose concentration 
Liposome properties at a high pressure of 170 bar and varied trehalose content with 
additional co-solvent concentration of 30 ml/min were affected by the high ethanol 
content in the supercritical phase. Although particle size and product recovery were 
optimized, the liposome size and especially the polydispersity index for 5 and 15 % [w/v] 
trehalose was too high in both, particles from the wall and the filter plate (Tab 11). The 
internal structure of the liposomes was disordered by the different solubility of the lipids 
in the gaseous phase. The solubility of DOTAP-Cl compared to DOPC in ethanol was 
enhanced. Within the mixture of the carbon dioxide-ethanol DOTAP-Cl was extracted to a 
greater extent.  
 
CHAPTER 9   
 
 
 
  
 
188 
Table 11: Liposome size, polydispersity index and lipid recovery of DOTAP-Cl and DOPC using the coaxial 
gravity feed nozzle with different trehalose concentrations 5, 10.5 and 15 % [w/v] at a pressure of 170 bar 
with 350 ml/min carbon dioxide flow with an ethanol flow rate of 30 ml/min and a solution rate of 1.0 ml/min. 
trehalose 
[w/v] 
nozzle 
type 
particle 
collection 
pressure 
[bar] 
z-average 
[nm] 
polydispersity 
index 
DOTAP-Cl 
[%] 
DOPC 
[%] 
5.0 gravity wall 170 135 0.54 38.7 55.0 
5.0 gravity filter 170 127 0.48 58.7 63.9 
10.5 gravity wall 170 129 0.37 33.2 43.7 
10.5 gravity filter 170 120 0.30 40.3 58.9 
15.0 gravity wall 170 141 0.60 39.3 51.6 
15.0 gravity filter 170 120 0.54 43.1 75.0 
 
3.2.2 Liposomes dried by the concentric coaxial nozzle 
3.2.3.1 Liposomes size at varied co-solvent flow rate 
Liposome size and the polydispersity index after supercritical drying using the concentric 
co-axial nozzle resulted in a broad size distribution. A reduced liquid feed resulted in a 
doubled carbon dioxide flow rate, which influenced the polydispersity index of the 
liposomes. However, the size distribution and the high polydispersity are still insufficient 
compared to the liposome properties before processing.  
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Figure 21: Liposome size and polydispersity index after supercritical spray-drying of liposomes suspensions at 
100 bar, 20 ml/min ethanol flow rate using 0.5 and 1.0 ml/min solution flow rate and different carbon dioxide 
flow rates (250, 350, and 416 g/min). 
 
3.2.3.2 Lipid recovery at varied co-solvent flow rate 
The effect of an increased carbon dioxide flow rate on lipid recovery is also reflected in 
the solubility and selectivity of the lipid in the supercritical phase. With a high mole 
fraction of water, the lipid recovery was in relation to the carbon dioxide flow rate, as 
high CO2 flow rates resulted in a reduced ethanol mole fraction and therefore in a higher 
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lipid recovery. The lipid recovery determined at low mole fraction of water was low. 
Moreover, the lipid recovery for DOTAP-Cl was enhanced under these conditions as well 
(Fig 22, left). DOPC solubility on the other hand was less affected by the variation of the 
mole fraction water and ethanol within the CO2. At a CO2 flow of 250 g/min the lipid 
recovery was 100 % and decreased slightly with increased CO2 flow (Fig 22, right). 
Important for the selection of process parameters are the initial ratio of water and the 
mixture of carbon dioxide/co-solvent in respect to their solubility in the liquid phase.  
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Figure 22: Solvent selectivity for the CO2-C2H5OH-H2O ternary system for 100 bar at 40°C [23] compared to the 
lipid recovery at different carbon dioxide flow rates of 250, 350 and 416 g/min and different lipids DOTAP-Cl 
(left) and DOPC (right). 
 
3.3 PHASE DIAGRAMS FOR METHANOL, ETHANOL, ISOPROPANOL AND ACETONE 
The choice of co-solvent for the supercritical fluid drying of an aqueous solution was a 
key parameter controlling solute solubility, particle morphology and size. The used 
systems were not fully miscible with water and selected process conditions were used to 
modify the working regions (Fig 23). The expanded solvents have potential to further 
increase the solubility of water, as well as that of the components in the supercritical 
phase and thereby enhance the mass transfer [61]. Extended ternary phase equilibrium 
data of the carbon dioxide / water mixtures and the used solvents ethanol and acetone 
are shown in Figure 23 (A) and (C). For methanol only limited data are available (Fig 23, 
(B)). For isopropanol only the phase equilibrium data were plotted because of the 
complicated unclear phase behavior (Fig 23, (D)) [62]. However, it can be assumed that 
the experiments were done under supercritical conditions in a one phase region. The 
different phase behaviors resulted in varied solubilities of co-solvent/carbon-dioxide 
within the aqueous droplets and therefore influenced the particle size distribution. The 
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working region was selected with respect to the critical point of the mixture, so that the 
experiments were done under ideal drying properties.  
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Figure 23: Ternary diagram at 40°C at 100 bar for the CO2, ethanol (A) [50], methanol (B) [63], acetone (C) 
[64] and H2O system using the light square as SCF and the dark circle as liquid molar fraction, respectively. 
Vapor-liquid equilibria of CO2-isopropanol at 40°C (D) [65].  
 
3.3.1 Particle morphology 
The different co-solvent carbon dioxide mixtures were examined using the concentric 
coaxial nozzle (Tab 12). The impact on solvent polarity, dielectric constant and vapor 
pressure on the particle properties was studied.  
Table 12: Summarizing the drying capacity diagram of the CO2-solvent-water system at 100 bar using 
methanol, acetone or isopropanol at a 0.5 ml/min solution feed rate and CO2 mass flow rates of 250 g/min. 
nozzle 
type 
solvent 
type 
mol solvent 
mol solvent + mol CO2 
mol H2O 
mol solvent + mol CO2 
dielectric 
constant (ε) 
dipole 
moment 
concen methanol 0.12100 0.00595 33.0 1.70 
concen ethanol 0.08775 0.00618 25.3 1.69 
concen acetone 0.06822 0.00631 21.0 2.88 
concen isopropanol 0.07083 0.00629 18.1 1.66 
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All obtained particles were spherical with a porous structure (Fig 24). The surface of 
particles dried with methanol was rougher compared to the others. The diffusion of CO2 
and solvent into the droplet depended on the expansion of polar organic solvents and 
processing pressure. Polar organic solvents and solvents possessing low vapor pressure 
usually do not expand rapidly and/or completely in supercritical carbon dioxide at high 
pressure [66]. 
 
   
Figure 24: SEM pictures of supercritically spray-dried powders at 100 bar with methanol, acetone and 
isopropanol at a solvent flow rate of 20 ml/min using the concentric coaxial nozzle and 250 g/min carbon 
dioxide flow rates and a solvent flow rate of 0.5 ml/min. 
 
3.3.2 Particle size distribution 
The experiments revealed that incomplete expansion of the solvents influenced the 
saturation level of the solutions in the droplets and led to precipitates with larger particle 
size (Tab 13). When using methanol or ethanol as a co-solvent very small particles 
(d[4,3]= 20.9 µm and 16.9 µm) with the widest and the most narrow size distribution 
(span 4.2 and 1.9) were obtained. Both were fully soluble into water, which can help to 
enhance the extraction forces.  
Table 13: Particle size using the concentric coaxial nozzle with methanol, ethanol, acetone and isopropanol at a 
pressure as co-solvents dried at a pressure of 100 bar with 250 g/min carbon dioxide flow with a solvent flow 
rate of 20 ml/min and a solution rate of 0.5 ml/min. 
nozzle 
type 
CO2 
[g/min] 
solvent 
type 
solvent 
[ml/min] 
solution 
[ml/min] 
d[10] 
[µm] 
d[50] 
[µm] 
d[90] 
[µm] 
d[4,3] 
[µm] 
span 
concen. 250 methanol 20 0.5 3.3 12.1 54.5 20.9 4.2 
concen. 250 ethanol 20 0.5 4.5 12.2 27.7 16.2 1.9 
concen. 250 acetone 20 0.5 6.0 30.4 85.3 38.8 2.6 
concen. 250 isopropanol 20 0.5 6.2 43.5 120.8 54.1 2.6 
 
Methanol has the highest dielectric constant value (ε) of 33.0 and raised the solubility of 
water and lipids within CO2. Ethanol, with a dielectric constant value of 25.3, appeared to 
be most effective in reducing the particle size (d[4,3]= 16.2). Acetone also has a high 
100 bar, 250 g/min CO2, 0.5 ml/min sol. 
20 ml/min methanol 
100 bar, 250 g/min CO2, 0.5 ml/min sol. 
20 ml/min acetone 
100 bar, 250 g/min CO2, 0.5 ml/min sol. 
20 ml/min isopropanol 
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dielectric constant value of 21.0 comparable to isopropanol with 18.1. The medium size 
rose to 38.8 and 54.1 µm. From the results it can be concluded that the particle size 
increased with decreasing dielectric constant value. The higher the dielectric constant of 
the co-solvent the more improved was the capacity to form hydrogen bonds and the 
better was the miscibility with water. This favored the anti-solvent effect during swelling, 
and led to smaller particles.  
 
3.3.3 Yield and residual moisture 
With decreasing particle sizes the residual moisture was reduced (Tab 14). In 
correspondence with the evaporation rate of the co-solvents also the high methanol mole 
fraction-water ratio did not reduce the moisture content below 4.1 %. Isopropanol was 
also not able to enhance the evaporation forces compared to ethanol resulting in a 
residual moisture of 4.3 %. Acetone resulted in a moisture content of 3.4 % with the 
lowest mole fraction ratio solvent-water. The miscibility (phase equilibrium) of water in 
carbon dioxide was enhanced when using acetone compared to isopropanol. The resulting 
yield was increased by the efficient drying process (Tab 14). For the optimized ethanol 
conditions a residual moisture content of 1.9 with a yield of 95 % could be obtained.  
Table 14: Residual moisture and powder yield of particles obtained with different co-solvents.  
nozzle 
type 
pressure 
[bar] 
CO2 
[g/min] 
solvent 
type 
solvent 
[ml/min] 
solution 
[ml/min] 
residual 
moisture [%] 
yield 
[%] 
concen. 100 250 methanol 20 0.5 4.1 72 
concen. 100 250 ethanol 20 0.5 1.9 95 
concen. 100 250 acetone 20 0.5 3.4 84 
concen. 100 250 isopropanol 20 0.5 4.3 73 
 
3.3.4 Residual solvents 
Two factors mainly influenced the particle formation using the solvents methanol, 
ethanol, isopropanol and acetone, namely the dielectric constant value and the vapor 
pressure. After the addition of a polar co-solvent the zero net dipole moment of carbon 
dioxide changed and the solubility of water increased. This becomes obvious when 
comparing its solubility in methanol and acetone versus its solubility in isopropanol and 
ethanol (Fig 25, left). Methanol as co-solvent evaporates to a higher extent into the 
droplets and remains associated to the trehalose. This resulted in a high residual 
methanol content of 6500 ppm even higher compared to the concentration of ethanol 
(Fig 25, right).  
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Figure 25: The solubility of carbon dioxide in the mixtures of water and co-solvent (ethanol [50], isopropanol 
[50], methanol* [67], acetone* [68], (*mole fraction of the co-solvent within the CO2)) (left), and the residual 
solvent concentration of supercritically spray-dried particles using the concentric coaxial nozzle (right).  
 
This could be explained by the high mole fraction ratio of solvent-water (0.121 to 0.005) 
and the excellent solubility of methanol in carbon dioxide and water. The acetone-water 
ratio was lower (0.068 to 0.006) and resulted in residual acetone contents below 1000 
ppm. Drying with isopropanol-water at a ratio between 0.071 and 0.006 resulted in 
residual isopropanol concentrations below 2000 ppm. The solubility of the co-solvents 
and the carbon dioxide in the droplets were responsible for the residual solvent contents. 
The extraction of solvents via the final washing step could directly be correlated to the 
solubility of the co-solvents in the gaseous phase. The solubility behavior of the co-
solvents influences the mass transfer and reached the gaseous phase earlier with the 
consequence of having less residual solvent in the product. One should consider to select 
a co-solvent which exhibits an optimized solubility in supercritical carbon dioxide and at 
the same time provides a reduced solubility for the compounds. For the tested co-
solvents acetone was most appropriate. 
 
3.3.5 DSC and X-ray powder diffraction  
The particles dried with the co-solvents acetone, isopropanol and methanol were 
amorphous, although the residual moisture of about 4 % was relatively high. The local 
structure in the amorphous phase obvious by differences in the broad halo was affected 
by the selected solvent and indicated differences in swelling and evaporation behavior 
(Fig 26, left). DSC measurements reflected the influence of the co-solvent and the 
residual moisture content (Fig 26, right). Methanol as a co-solvent led to a residual 
moisture above 4 % and a Tg of 34.1°C for the dried particles. Using acetone and 
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isopropanol as co-solvent led to low moisture content around 3 % and resulted in a Tg of 
46.8 and 54.3°C.  
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Figure 26: Wide-angle X-ray diffraction pattern after supercritical spray-drying of liposomes using co-solvents 
at 100 bar and 250 g/min carbon dioxide (left), and DSC thermograms (right). 
 
3.3.6 Liposome size an lipid recovery  
The effect of the solubility of the co-solvents methanol, ethanol, isopropanol and acetone 
in CO2 on the liposome properties was tested. The liposome size was retained with a 
polydispersity of 0.1 when using acetone as co-solvent. The other co-solvents negatively 
affected the liposomal size distribution (Fig 27, left). Almost all lipids were extracted 
when using methanol as co-solvent. Methanol exhibits the highest dielectric constant, 
which makes it a good solvent also for the lipids, resulting in the low lipid recovery. When 
using ethanol the lipid recovery of DOTAP-Cl and DOPC differed because of the different 
solubility of the lipids within ethanol, as discussed before. For isopropanol a higher 
solubility of DOTAP compared to DOPC was observed, too. Furthermore, the declined lipid 
recovery of about 60 % pointed at a selective solubility of the lipids in isopropanol. The 
phase behavior and the potential ability of isopropanol to form four phases within 
supercritical carbon dioxide made any interpretation difficult. Only acetone exhibited no 
differences in lipid solubility for both liposome components with a high recovery 
(Fig 27, right).  
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Figure 27: Liposome size and polydispersity index (left) and lipid recovery (right) after supercritical spray-
drying of liposomes suspensions at 100 bar using different co-solvents with a flow rate of 20 ml/min and 
0.5 ml/min solution flow rate at a carbon dioxide flow-rate of 250 g/min. 
 
The further improved ratio between supercritical fluid and liquid feed rate, as well the 
solubility of carbon dioxide in the liquid phase is responsible for the results. The viscosity 
and thereby the solvating power of CO2 changed by the addition of co-solvents [69]. With 
increasing molecular mass of the co-solvent the attraction forces and their solubility in 
the supercritical fluid increases via hydrogen bonds [70]. 
 
3.4 PARTICLE FORMATION WITHOUT A CO-SOLVENT 
The mixing behavior of water in the compressed carbon dioxide phase is highly non-ideal 
[71]. The mutual solubility of water in the carbon dioxide rich phase is very low with 
4.280x10-3 mol % as described by Spycher et al. (2003) [39]. Based on the data 
obtained during the process development higher ratios of carbon dioxide to the liquid 
feed the phase behavior and limited solubility was adjusted. The influence of CO2 on the 
solubility of the compounds in the supercritical phase was further determined. By using 
the different carbon dioxide flow rates of 250, 350 and 416 g/min and a constant liquid 
feed of 0.25 ml/min the mole fractions of water in supercritical carbon dioxide were 
3.386x10-3, 2.418x10-3 and 2.035x10-3 mol %, respectively, which are below the critical 
mutual solubility of water in CO2. Based on this calculation a drying of the aqueous 
formulation was investigated.  
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3.4.1 Particle morphology 
The concentric coaxial nozzle, which has already shown optimized saturation levels by 
the addition of co-solvents to the carbon dioxide, was applied. For the chosen 
experimental conditions spherical, hollow and smooth particles were obtained for all 
water mole fractions in CO2 (Fig 28). Due to the selected mutual water solubility a 
supercritical drying was feasible without further co-solvents.  
 
   
Figure 28: SEM pictures of supercritically spray-dried powders without the addition of a co-solvent at 100 bar 
using the concentric coaxial nozzle and different carbon dioxide flow rates of 250, 350 and 416 g/min with a 
solution flow rates of 0.25 ml/min. 
 
3.4.2 Particle size distribution 
At a low mixing energy and a reduced allocated carbon dioxide concentration, in our case 
250 g/min CO2, the direct consequence of the mole fraction water was agglomeration, 
leading to increased particle sizes (Tab 15). At a carbon dioxide flow of 350 and 
416 g/min very small particles of about 6 µm with a narrow size distribution (span of 1.4 
and 1.3) were collected. Only slight swelling occurred due to the lack of co-solvents and 
the low solubility of carbon dioxide in water. The particle size distribution was mainly 
influenced by the initial droplet size, which is a result of the high atomizing energy of the 
larger CO2 flow rate compared to the reduced liquid feed rate. 
Table 15: Particle size diameter using the concentric coaxial nozzle without any co-solvent at a pressure of 
100 bar with 250, 350 and 416 g/min carbon dioxide flow with a solution rate of 0.25 ml/min. 
nozzle 
type 
pressure 
[bar] 
CO2 
[g/min] 
solution 
[ml/min] 
d[10] 
[µm] 
d[50] 
[µm] 
d[90] 
[µm] 
d[4,3] 
[µm] 
span 
concen. 100 250 0.25 3.3 12.6 46.2 20.1 3.3 
concen. 100 350 0.25 2.6 5.5 10.6 6.2 1.4 
concen. 100 416 0.25 2.7 5.2 10.2 6.3 1.3 
 
 
100 bar, 250 g/min CO2, 0.25 ml/min 100 bar, 350 g/min CO2, 0.25 ml/min 100 bar, 416 g/min CO2, 0.25 ml/min 
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3.4.3 Yield and residual moisture 
The moisture content was dependent on the mole fraction of carbon dioxide. With an 
increasing mole fraction of CO2 the droplet size was reduced and correspondingly the 
residual moisture decreased from 3.6 % at 250 g/min CO2 to 1.7 % at 416 g/min CO2 
(Tab 16). The particle yield above 80 % was indicative for a feasible drying procedure.  
Table 16: Residual moisture and powder yield of particles obtained at different carbon dioxide flow rates 
without any co-solvents. 
nozzle type pressure [bar] CO2 [g/min] 
solution 
[ml/min] 
residual 
moisture [%] 
yield 
[%] 
concen. 100 250 0.25 3.6 81 
concen. 100 350 0.25 2.5 80 
concen. 100 416 0.25 1.7 84 
 
3.4.4 DSC and X-ray powder diffraction  
As a reference the X-ray diffractogram pattern of crystalline dihydrate trehalose is shown 
in figure 29 together with the particles dried at 100 bar. The additional ethanol flow rate 
of 20 ml/min, which was used at the 1.0 ml/min solution feed, resulted in few low 
intensity peaks in the XRD diffraction pattern indicating a partially crystalline state. DSC 
revealed a Tg at 48.8°C followed by an exothermic crystallization peak at about 70°C and 
an endothermic peak around 100°C, which is indicative for the presence of amorphous 
trehalose in the sample. Without co-solvent and a higher mole fraction of carbon dioxide 
the drying process was feasible resulted in amorphous structure determined by XRD (Fig 
29, left). These findings were supported by DSC measurements with a Tg of 51.9°C (Fig 
29, right).  
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Figure 29: Wide-angle X-ray diffraction pattern after supercritical spray-drying of liposomes at 100 bar using 
416 g/min carbon dioxide (left) and the corresponding DSC thermograms (right).  
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3.4.5 Liposomes size and lipid recovery 
Without co-solvent in the supercritical carbon dioxide phase the drying procedure was 
feasible at reduced aqueous feed rate. A dry product was obtained and the liposome 
properties were preserved at different carbon dioxide flow rates. The polydispersity 
indices were comparable to those before processing (Fig 30, left). For low carbon dioxide 
flow rates they even could be improved to 0.12 with lipid recoveries of above 100 % for 
all investigated process conditions (Fig 30, right). At the low density and pressure of 
100 bar the evaporation forces of carbon dioxide were further improved by the reduction 
of the liquid feed to 0.25 ml/min. The ratio CO2-water must be increased because of the 
mutual solubility within CO2-water without addition of a co-solvent. Without a co-solvent 
the solubility of the lipids in carbon dioxide could be neglected. 
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Figure 30: Liposome size and polydispersity index (left) and lipid recovery (right) after supercritical–spray-
drying of liposome suspensions at 100 bar without co-solvents with a solution flow rate of 0.25 ml/min solution 
at different carbon dioxide flow-rates. 
 
3.5 PARTICLE FORMATION WITHOUT A CO-SOLVENT UNDER DIFFERENT PRESSURES 
The successful particle formation process without the addition of an organic co-solvent to 
the carbon dioxide was further investigated at different pressure. Previous studies 
revealed no significant differences in particle morphology and size distribution over a 
wide temperature range of 31 to 40°C as shown by Werling and Debenedetti (1999) 
[29]. Pressure has a more pronounced impact on particle morphology than temperature. 
By varying the pressure, the phase behavior of the supercritical fluid was changed. The 
mole fraction of water was predetermined and the water solubility in the carbon dioxide 
increased with density (Tab 17).  
 
 
 
  SUBCRITICAL- AND SUPERCRITICAL DRYING 
 
 
 
  
 
199
Table 17: Density and mole fraction water in CO2 used at different pressure and anti-solvent flow rates. 
nozzle 
type 
pressure 
[bar] 
CO2 
[g/min] 
solution 
[ml/min] 
density 
CO2 [g/ml] 
mol fraction 
water in CO2 
solubility of water in 
CO2 [mol %] [36] 
concen. 80 250 0.25 0.278 7.649 x 10-3 - 
concen. 100 250 0.25 0.628 3.384 x 10-3 4.28 x 10-3 
concen. 150 250 0.25 0.781 2.723 x 10-3 5.07 x 10-3 
concen. 100 416 0.25 0.628 2.035 x 10-3 - 
concen. 150 416 0.25 0.781 1.636 x 10-3 - 
concen. 170 416 0.25 0.808 1.581 x 10-3 5.80 x 10-3 
 
3.5.1 Particle morphology 
Figure 31 shows the influence of pressure on particle morphology. At a constant 
temperature the coexisting phases were reduced when the pressure increased. The 
solvent strength (miscibility and solubility) of carbon dioxide was raised when increasing 
the density of the supercritical fluid with pressure, which resulted in a wider working 
range. With increasing pressure the mutual solubility of water in the CO2 rich phase 
changed from 4.28x10-3 mol % at 100 bar to 5.07x10-3 mol % at 150 bar and to 
5.43x10-3 mol % at 170 bar, respectively.  
    
    
Figure 31: SEM pictures of supercritically spray-dried powders without the addition of a co-solvent at different 
pressure using the concentric coaxial nozzle and carbon dioxide flow rates of 250 and 416 g/min with a solution 
flow rates of 0.25 ml/min. 
 
At 80 bar just above the saturation pressure the particle formation process was 
depressed. The mole fraction of water (7.649x10-3) in the experiments was too high for 
sufficient evaporation and saturation levels of carbon dioxide in the droplets. The 
80 bar, 250 g/min CO2, 0.25 ml/min  
150 bar, 416 g/min CO2, 0.25 170 bar, 416 g/min CO2, 0.25 
150 bar, 250 g/min CO2, 0.25 
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probably existing two phase scenario with partial phase boundary between the carbon 
dioxide and the solution resulted in droplets and a mass transfer through the interface. 
After adjusting the pressure below the solubility level spherical and porous particles were 
obtained at 250 g/min CO2 flow rate at 150 bar. With increasing carbon dioxide flow rate 
and pressure particle morphology changed to golf ball-like structures. This might be 
induced by a high mass transfer rate of CO2 into the particles and by a faster water 
extraction out of the particles. Thereby, larger pores formed and after final extraction the 
capillary tension induced slight shrinkage resulting in this surface structure.  
 
3.5.2 Particle size distribution 
At a low mixing energy, in our case 250 g/min CO2 at 80 bar, no direct particle formation 
occurred. Fragments of particles and droplets dried partially and agglomerated at the 
filter plate. The low feed rate of carbon dioxide mainly condensed onto the droplet 
surfaces and their size increased (Tab 18). At higher pressure and the related density 
change, the spherical size of the particles was retained, but agglomeration could be 
observed as well. The carbon dioxide / water ratio was still too low, although the density 
change reduced the water mole fraction below the mutual solubility. At the higher 
pressure the improved mixing energies at CO2 flow rates of 350 and 416 g/min very 
small particles of about 11 µm with a narrow size distribution were collected. The 
evaporation ratio of the solvent became more important and the size of the droplets 
decreased.  
Table 18: Particle size diameter using the concentric coaxial nozzle without any co-solvent at pressures of 80, 
and 150 bar with 250 g/min carbon dioxide flow and at pressures of 150 and 170 bar with 416 g/min carbon 
dioxide flow with a solution rate of 0.25 ml/min. 
nozzle 
type 
pressure 
[bar] 
CO2 
[g/min] 
solution 
[ml/min] 
d[10] 
[µm] 
d[50] 
[µm] 
d[90] 
[µm] 
d[4,3] 
[µm] 
span 
concen. 80 250 0.25 3.1 13.8 63.3 24.3 4.4 
concen. 150 250 0.25 4.8 24.2 115.1 44.8 4.5 
concen. 150 416 0.25 2.9 8.6 19.3 11.5 1.9 
concen. 170 416 0.25 2.8 7.8 17.1 10.5 1.8 
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3.5.3 Yield and residual moisture 
Evaporation of water was affected by the pressure and the mixing energy of the fluids 
assigned by the mole fraction value. At a low pressure, especially close to the 
supercritical point of carbon dioxide, drying of the droplets resulted in high moisture 
contents of 9.8 % (Tab 19). An increased pressure on the other hand enhanced the 
evaporation of water. Higher mole fraction CO2 of 416 g/min and the reduced liquid feed 
rate favored the miscibility of water, because of higher atomization forces and smaller 
droplets. The product yield showed values around 60 % and could not be improved 
compared to lower pressures.  
Table 19: Residual moisture and powder yield of particles obtained at different pressure without any co-solvent. 
nozzle type 
pressure  
[bar] 
CO2  
[g/min] 
solution 
[ml/min] 
residual 
moisture [%] 
yield  
[%] 
concen. 80 250 0.25 9.8 49 
concen. 150 250 0.25 5.8 70 
concen. 150 416 0.25 2.8 59 
concen. 170 416 0.25 3.7 61 
 
3.5.4 Liposome size and lipid recovery 
With increased pressure the mutual water solubility in CO2 and the evaporation raised. 
Experiments were conducted by varying pressure between 80 and 170 bar. The liposome 
size and polydispersity were negatively affected at a low pressure of 80 bar. Just above 
the critical point the water solubility and drying performance were insufficient. However, 
at 150 and 170 bar the liposome properties and the lipid recovery were preserved at the 
tested conditions (Tab 20). A raised solubility of the lipids with increasing pressure and 
density, which was observed when adding organic co-solvents, could not be confirmed in 
pure carbon dioxide. 
Table 20: Liposome properties and lipid recovery obtained at different pressure without any co-solvents. 
nozzle 
type 
pressure 
[bar] 
CO2 
[g/min] 
z-average 
[nm] 
polydispersity 
index 
DOTAP-Cl 
[%] 
DOPC 
[%] 
concen. 80 250 176 +/- 1.5 0.44 +/- 0.03 63.3 64.9 
concen. 150 250 118 +/- 1.1 0.13 +/- 0.01 100.1 100.0 
concen. 150 416 117 +/- 1.5 0.10 +/- 0.01 108.0 107.7 
concen. 170 416 116 +/- 0.5 0.13 +/- 0.01 105.1 105.0 
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3.6 PARTICLE FORMATION USING SUBCRITICAL CONDITIONS 
3.6.1 Particle morphology 
It has been proposed that the hydrodynamic effect, the mixing of two miscible fluids, was 
generally the dominant factor for precipitation under subcritical conditions. Particles were 
generated by diffusion of CO2 into the droplets and jet break-up, followed by extraction 
of the solvent from the droplet resulting in dry powder formation [46]. In consideration 
of the phase behavior, the settings were adjusted to achieve sufficient nucleation by 
reducing the liquid feed rate to 0.11 ml/min and increasing the CO2 flow rate to 500 
g/min CO2. Spherical and hollow particles were obtained for the gravity nozzle and the 
concentric nozzle (Fig 32).  
 
     
Figure 32: SEM pictures of subcritically spray-dried powders without the addition of a co-solvent using the 
gravity and concentric coaxial nozzle at a carbon dioxide flow rate of 500 g/min with a solution flow rates of 
0.11 ml/min. 
 
3.6.2 Particle size distribution 
The concentric coaxial nozzle resulted in smaller particles with a medium size of 31.5 µm 
compared to 52.1 µm for the gravity coaxial nozzle (Tab 21). No strong agglomeration 
effects were detected, which was indicated by the low span value. An initially increased 
droplet diameter due the condensation of CO2 should be considered during subcritical 
drying [30]. The different atomization of CO2 and the liquid feed affected first of all the 
droplet size and finally the drying behavior of the droplets. 
Table 21: Particle size diameter using the gravity and concentric coaxial nozzle at subcritical conditions of 19 
and 20 bar with 500 g/min carbon dioxide flow and a solution rate of 0.11 ml/min. 
nozzle 
type 
pressure 
[bar] 
temp. 
[°C] 
CO2 
[g/min] 
solution 
[ml/min] 
d[10] 
[µm] 
d[50] 
[µm] 
d[90] 
[µm] 
d[4,3] 
[µm] 
span 
gravity 19 40 500 0.11 11.4 45.4 79.4 52.1 2.0 
concen. 21 40 500 0.11 5.0 25.6 66.5 31.5 2.4 
 
gravity nozzle<, 19 bar, temp. 40°C, 
500 g/min CO2, 0.11 ml/min sol. 
concentric nozzle, 21 bar, temp.40°C, 
500 g/min CO2, 0.11 ml/min sol. 
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3.6.3 Yield and residual moisture 
The nozzle configuration and therefore the droplet size distribution and the mass transfer 
properties resulted in different moisture contents. Higher mass transfer of water in the 
subcritical region due to optimized droplet distributions resulted in an evaporation 
strength high enough to reduce the moisture to 3 % (Tab 22). Particles produced with 
the concentric coaxial nozzle had a moisture content of 4.3 %. A further reduction is 
feasible by reducing the droplet size at higher atomization forces of carbon dioxide and 
reduced liquid feed rates. Both strategies consider the solubility of water in the gaseous 
phase. A sufficient yield between 77 and 80 % was found as the pressure drop between 
filter plate and outlet valve was prevented. Furthermore, small particles were not pressed 
through the filter. Also no residual ethanol was detectable.  
Table 22: Residual moisture and powder yield of particles obtained at subcritical conditions.  
nozzle  
type 
pressure  
[bar] 
CO2  
[g/min] 
solution 
[ml/min] 
residual 
moisture [%] 
yield 
[%] 
gravity 19 500 0.11 3.1 80 
concen. 21 500 0.11 4.3 77 
 
3.6.4 DSC and X-ray powder diffraction  
Under subcritical conditions at around 20 bar with relatively low water mole fractions and 
high carbon dioxide flows the amorphous structure of the powder was preserved (Fig 33, 
left). Drying levels were reached with residual moisture of about 3 to 4 % for particles 
produced by the concentric co-axial nozzle, which affected the glass transition 
temperature (Fig 33, right).  
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Figure 33: Wide angle X-ray diffraction pattern (left) and DSC thermograms (right) after subcritical spray-
drying of liposomes at 19 and 20 bar using 500 g/min carbon dioxide and the gravity and concentric coaxial 
nozzle. 
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3.6.5 Liposome size and lipid recovery 
At subcritical conditions at a pressure below the critical point the collection of dry 
particles with favorable liposome properties and lipid recoveries was feasible (Tab 23). 
The major advantages of drying with a subcritical gaseous phase were the low pressure 
and the reduced extraction forces of lipids. However, at such conditions the water-CO2 
ratio should be selected very low to overcome the mutual solubility.  
Table 23: Liposome properties and lipid recovery of particles obtained at subcritical conditions using a CO2 flow 
rate of 500 g/min with a solution feed of 0.11 ml/min.  
nozzle  
type 
pressure 
[bar] 
z-average 
[nm] 
polydispersity 
index 
DOTAP-Cl 
[%] 
DOPC 
[%] 
gravity 19 120 +/- 1.5 0.15 +/- 0.01 104.9 103.8 
concen. 21 118 +/- 0.1 0.15 +/- 0.02 101.6 101.3 
 
3.7 DRUG LOADING STUDIES 
The drug loading studies of liposomes were carried out with the model compounds 
Coumarin and Nile Red. According to literature solubility of Coumarin is depended on 
pressure and temperature (Fig 34, left) [72]. No solubility data are so far available for 
Nile Red. Due to the relatively low solubility of Coumarin within the supercritical carbon 
dioxide and due to the substantial hydrophobicity of Nile Red these two fluorescent dyes 
were chosen as model substances. These two model compounds were used as model 
substances for Paclitaxel, for which the solubility at our temperature and pressure 
conditions were significantly lower as compared to Coumarin (Fig 34, right) [73]. 
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Figure 34: Coumarin [72] and Paclitaxel [73] solubility in supercritical carbon dioxide at different temperatures.  
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3.7.1 Drug loading gravity feed nozzle  
After reconstitution of the particles produced by the coaxial feed nozzle the Coumarin 
recovery was 100 % for particles collected from the filter plate, while a slight reduction 
was measured for particles from the wall. Although the lipid extraction was pronounced 
at these conditions the Coumarin recovery was nearly completed (Tab 24).  
Table 24: Coumarin recovery for supercritically spray-dried particles using the coaxial gravity feed nozzle with 
different trehalose concentrations 5, 10.5 and 15 % [w/v] at a pressure of 170 bar with 350 ml/min carbon 
dioxide flow with an ethanol flow rate of 30 ml/min and a solution rate of 1.0 ml/min. 
trehalose 
[w/v] 
nozzle 
type 
particle 
collection 
pressure 
[bar] 
CO2 
[g/min] 
ethanol 
[ml/min] 
solution 
[ml/min] 
Coumarin 
recovery [%] 
5.0 gravity wall 170 350 30 1.0 94.0 
5.0 gravity filter 170 350 30 1.0 100.4 
10.5 gravity wall 170 350 30 1.0 97.0 
10.5 gravity filter 170 350 30 1.0 100.8 
15.0 gravity wall 170 350 30 1.0 97.9 
15.0 gravity filter 170 350 30 1.0 100.2 
 
3.7.2 Drug loading without co-solvents 
Without the addition of a co-solvent a significantly reduced Coumarin recovery of about 
60 % was found at 100 bar (Fig 35, left), although the lipid recovery revealed no distinct 
solubility of the lipids in the subcritical phase. Without co-solvent addition the extraction 
of Coumarin was raised due to changed evaporation mechanisms of the water. The 
drying procedure and saturation within the droplets was decelerated and extraction 
forces dissolved the fluorescent dye.  
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Figure 35: Coumarin recovery in supercritically spray-dried particles without any co-solvent at different carbon 
dioxide flow rates (left) and varied pressure (right).  
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However, with increased pressure the Coumarin content increased again and at 170 bar 
almost 90 % recovery was reached (Fig 35, right). At higher pressure the drying strength 
was reduced, because of an enlarged miscibility of water in the supercritical phase. 
The fluorescence intensity of Nile Red depends on the polarity of the environment, with a 
higher intensity measured in more hydrophobic environments [74,75,76]. Therefore, the 
fluorescence intensity of Nile Red is increased when it is interacting with the apolar lipids 
of the liposomes [77]. In the presence of a co-solvent and carbon dioxide mixture Nile 
Red was dissolved completely out of the liposomes for all investigated processes 
conditions. This was indicated by a decrease in the spectral intensity as compared to the 
intensity before the drying process (Fig 36, left). Nile Red was soluble in pure carbon 
dioxide and in polar mixtures of supercritical fluids and co-solvents [78]. When using 
acetone as co-solvent slight Nile Red fluorescence intensity after supercritical drying was 
measured (Fig 36, right). Only acetone preserved the lipids during supercritical drying, 
due to the weak interactions between the lipid molecules and the solvent. The same 
effect can be used to describe this effect here.  
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Figure 36: Fluorescence intensity of Nile Red loaded and empty liposomes after supercritical spray-drying at 
100 bar, 20ml/min ethanol flow rate using 0.5 and 1.0 ml/min solution flow rate and different carbon dioxide 
flow rates of 250, 350 and 416 g/min (left) and at 100 bar using different co-solvents (right). 
 
3.7.3 Drug loading at subcritical conditions 
As the lipid solubility decreased under supercritical drying without any co-solvent, Nile 
Red was partially preserved as well (Fig 37, left). The evaporation of the carbon dioxide 
and hence the saturation was influenced by the droplet size induced by atomization force 
of the carbon dioxide. Without any additional co-solvent to the carbon dioxide the 
solubility was affected by the former described process. 350 g/min CO2 showed optimum 
process conditions with respect to particle size distribution, liposome size and lipid 
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recovery. The particle formation process was fast enough and the extraction forces were 
reduced with minor miscibility of Nile Red. At subcritical conditions, the fluorescence 
intensity of Nile Red was preserved for both tested nozzles (Fig 37, right). The solubility 
of the fluorescent dye in the fluidized CO2 could therefore be assigned as very low.  
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Figure 37: Fluorescence intensity of Nile Red loaded and empty liposomes after supercritical spray-drying at 
100 bar without any co-solvent (left) and after subcritical spray-drying at 19 and 20 bar (right). 
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4. CONCLUSIONS 
In the presented study different technical modifications using subcritical and supercritical 
carbon dioxide (CO2), with and without co-solvents were carried out. The use of 
supercritical fluids to dry aqueous formulations containing liposomes was investigated 
because of the very gentle drying temperature around the critical point at 31°C and a 
pressure of 74 bar. The major limitation of this technique is the very low water solubility 
in supercritical CO2. With a comprehensive particle formation and drying study, working 
conditions should be identified where the preservation of the liposomes was given. The 
major consideration was to increase the water solubility in the supercritical phase without 
affecting lipid recovery and liposome integrity. To overcome these limitations several 
factors, such as mass transfer of carbon dioxide and its thermodynamical behavior had to 
be optimized by selecting different flow rates, pressure and co-solvents. The addition of 
co-solvents to the supercritical CO2 enhanced the solubility of water and allowed a more 
efficient drying process, but in contrast directly affected the liposomes due to the 
solubility of the lipids in the co-solvents. The comprehensive particle formation study was 
necessary, because of the difficult prediction for working regions suitable for aqueous 
suspensions. Only experimental drying studies based on the knowledge using organic 
solvents were available so far. Therefore, the addition of organic solvents to CO2 was 
studied first, followed by the change and the omitting of co-solvents at supercritical and 
subcritical conditions.  
To investigate the optimum mass transfer and spraying conditions from the various 
tested nozzle types and set-ups, only the concentric coaxial nozzle offered a sufficient 
high mass transfer of CO2 into the liquid feed. The other nozzle types, co-solvent flow 
rates and pressures revealed either unsatisfactory particle formation properties or high 
lipid extraction capacities. This resulted always in a reduction of liposome quality, loss of 
material and high residual moisture content of the particles. For all further experiments 
only the concentric coaxial nozzle was used.  
With the addition of the co-solvents methanol, ethanol, isopropanol and acetone the 
drying capacity increased, but only for acetone optimized liposome properties were 
obtained. The reduced solubility of lipids in acetone made this co-solvent a feasible 
alternative for working at higher liquid feed rates. On the other hand, without co-solvent 
the mass transfer of carbon dioxide must be enhanced by the reduction of liquid feed 
rate. Without co-solvent particle formation and liposome properties were exceptional 
whereby the lipid solubility in CO2 can be completely neglected. The expected variation of 
lipid solubility at higher pressures was not present without co-solvent. 
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A new approach of subcritical drying at pressures around 20 bar, resulted in very 
homogenous liposomes and a narrow particle size distribution. Contrary to supercritical 
gases the subcritical condition allowed drug loading and full recovery of lipophilic model 
compounds. The drawback of such a technology is the very high carbon dioxide feed rate 
compared to a relatively low liquid flow rate, which is at least factor 2 slower than during 
supercritical drying. 
Overall, the use of subcritical and supercritical CO2 is an alternative drying approach at 
very gentle conditions method. As soon as appropriate working conditions are identified 
the process is a robust and consistent. Although Paclitaxel solubility data indicated a 
reduced solubility in CO2 we were not able to confirm this data due to technical 
limitations. The loading of Paclitaxel followed by an economical assessment should be the 
next steps to finally evaluate this technique. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CHAPTER 9   
 
 
 
  
 
210 
5. REFERENCES 
                                                
[1] Jung, J., Perrut, M., Particle design using supercritical fluids: literature and patent survey, J. Supercrit. 
Fluids, 20(3): 179-219, (2001). 
[2] Ribeiro Dos Santos, I., Richard, J., Pech, B., Thies, C., Benoit, J.P., Microencapsulation of protein 
particles within lipids using a novel supercritical fluid process, Int. J. Pharm., 242(1-2): 69-78, (2002). 
[3] Bristow, S., Shekunov T., Shekunov, B.Y., York, P., Analysis of the supercritical and precipitation process 
with supercritical CO2, J. Supercrit. Fluids, 21(3): 257-271, (2001). 
[4] Baldyga, J., Henczka, M., Shekunov, B.Y., Fluid dynamics, mass transfer, and particle formation, in 
supercritical fluids, in Supercritical Fluid Technology for Drug Product Development, (Eds, York. P., 
Kompella, U.B., Shekunov, B.Y.), vol 138: 91-158 (Marcel Dekker) (2004). 
[5] Debenedetti, P.G., Reid, R.C., Diffusion and mass transfer in supercritical fluids, Amer. Inst. Chem. Eng. 
J., 32(12): 2034-2046 (1984). 
[6]  Bustami, R.T., Chan, H-K., Dehghani, F., Foster, N.R., Recent applications of supercritical fluid 
technology to pharmaceutical powder systems, Kona, 19:57-69 (2001).  
[7] Clavier, J-Y., Perrut, M., Scale-up issues for supercritical fluid processing in compliance with GMP, in 
supercritical fluids, in Supercritical Fluid Technology for Drug Product Development, (Eds, York. P., 
Kompella, U.B., Shekunov, B.Y.), vol 138: 615-651 (Marcel Dekker) 2004. 
[8] Dixion, D.J., Johnston, K.P., Molecular thermodynamics of solubilities in gas antisolvent crystallization, 
Amer. Inst. Chem. Eng. J., 37(10): 1441-1440 (1991). 
[9] Yeo, S.D., Lim, G.B., Debenedetti, P.G., Bernstein, H., Formation of microparticulate protein powders 
using a supercritical fluid antisolvent, Biotechnol. Bioeng., 41(3): 341-346 (1993). 
[10] Kompella, U.B., Koushik, K., Preparation of drug delivery systems using supercritical fluid technology, 
Crit. Rev. Ther. Drug Carrier System, 18(2): 173-199, (2001). 
[11] Shekunov, B.Y., Chattopadhyay P., Seitzinger, J., Huff, R., Nanoparticle of poorly soluble drugs prepared 
by supercritical fluid extraction of emulsions, Pharm. Res., 23(1): 196-204 (2005). 
[12] Randolph, T.W., Randolph, A.D., Mebes, M., Yeung, S., Sub-micrometersized biodegradable particles of 
poly(L-lactic acid) via the gas antisolvent spray precipitation process, Biotechnol. Prog., 9(4): 429-435 
(1993). 
[13] Dixion, D.J., Johnston, K.P., Bodmeier, R.A., Polymeric materials formed from precipitation with a 
compressed fluid antisolvent, Amer. Inst. Chem. Eng. J., 39(1): 127-139 (1993). 
[14] Gallagher, P.M., Coffey, M.P., Krukonis, V.J., Hillstrom, W.N., Gas antisolvent recrystallization of RDX: 
Formation of ultra-fine particles of a difficult-to-comminute explosive, J. Supercrit. Fluids, 5(2): 130-142 
(1992). 
[15] Altunin, V., Sakhabetdinov, M., Viscosity of liquid and gaseous carbon dioxide at temperatures 220-1300 
K and pressures up to 1200 bar, Teploenergetika, 8: 85-89 (1972). 
[16] McHugh, M.A., Kurkonis, V.J., Supercritical fluid extraction: principles and practice, 2nd edition, Newton, 
Butterworth-Heinemann, (1994). 
[17] Palakodaty, S., York, P., Pritchard, J., Supercritical Fluid Processing of Materials from Aqueous Solutions: 
The Application of SEDS to Lactose as a Model Substance, Pharm. Res., 15(12): 1835-1843, (1998). 
[18] King, M.B., Mubarak, A., Kim, J.D., Bott, T.R., The mutal solubilities of water in supercritical and liquid 
carbon dioxide, J. Supercrit. Fluids, 5(4): 296-302 (1992). 
[19] Bouchard, A., Jovanovic, N., Jiskoot, W., Mendes, E., Witkamp, G-J., Crommelin, D.J.A., Hofland, G.W., 
Lysozyme particle formation during supercritical fluid drying: Particle morphology and molecular 
integrity, J. Supercrit. Fluids, 40(2): 293-307 (2007). 
 
  SUBCRITICAL- AND SUPERCRITICAL DRYING 
 
 
 
  
 
211
                                                                                                                                                     
[20] Ting, S.S.T., Tomasko, D.L., Foster, N.R., Macnaughton, S.J., Solubility of naproxen in supercritical 
carbon dioxide with and without cosolvents, Ind. Eng. Chem. Res., 32(7). 1471-1481 (1993). 
[21] Krukonis, V.J., Kurnik, R.T., Solubility of solid aromatic isomers in carbon dioxide, J. Chem. Eng. Data, 
30(3): 247-249 (1985). 
[22] Sacha, G.A., Schmitt, W.J., Nail, S.L., Identification of Physical-Chemical Varaible Affecting Particle Size 
Following Precipitation using a Supercritical Fluid, Pharm. Dev. Tech., 11(2): 195-205 (2006).  
[23] Durling, N.E., Catchpole, O.J., Tallon, S,J., Grey, J.B., Measurement and modelling of the ternary phase 
equilibria for high pressure carbon dioxide-ethanol-water mixtures, Fluid Phase Equilibria, 252(1-2): 
103-113 (2007). 
[24] Yao, S., Guan, Y., Zhu, Z., Investigation of phase equilibrium for ternary systems containing ethanol, 
water and carbon dioxide at elevated pressures, Fluid Phase Equilibria, 99(1-2): 249-259 (1994). 
[25] Shoyele, S.A., Cawthorne, S., Particle engineering techniques for inhaled biopharmaceuticals, Adv. Drug 
Delivery Rev., 58(9-10): 1009-1029 (2006). 
[26] Eckert, C.A., Knutson, B.L., Debenedetti, P.G., Supercritical fluids as solvents for chemical and materials 
processing, Nature, 383(6598): 313-318 (1996). 
[27] Moshashaee, S., Bisrat, M., Forbes, R.T., Quinn, E.A., Nyqvist, H., York, P., Supercritical fluid processing 
of proteins: lysozyme precipitation from aqueous solution, J. Pharm. Pharmacol., 55(2): 185-192 
(2003). 
[28] Fages, J., Lochard, H., Letourneau, J-J., Sauceau, M., Rodier, E., Particle generation for pharmaceutical 
applications using supercritical fluid technology, Powder Tech., 141(3): 219-226, (2004). 
[29] Werling, J.O., Debenedetti, P.G., Numerical modelling of mass transfer in the supercritical anti-solvent 
process, J. Supercrit. Fluids, 16(1):167-181 (1999). 
[30] Martin, A, Bouchard, A., Hofland, G.W., Witkamp, G-J., Cocero, M.J., Mathematical modelling of the 
mass transfer from aqueous solutions in a supercritical fluid during particle formation, J. Supercrit. 
Fluids, 41(1): 68-73 (2007).  
[31] Subramaniam, B., Rajewski, R.A., Snavely, K., Pharmaceutical Processing with Supercritical Carbon 
Dioxide, J. Pharm. Sci., 86(8): 885-890, (1997). 
[32] Frederiksen, L., Anton, K., van Hoogvest, P., Keller, H.R., Leuenberger, H., Preparation of liposomes 
encapsulating water-soluble compounds using supercritical carbon dioxide, J. Pharm. Sci., 86(8): 921-
928 (1997). 
[33] Walde, P., Preparation of Vescicles (Liposomes), Encycl. Nanosci. Nanotech., 9: 43-79 (2004).  
[34] Brandt, R., Fricke, J., Acetic-acid-catalyzed and subcritically dried carbon aerogels with a nanometer-
sized structure and a wide density range, J. of Non-Crystalline Solids, 350: 131-135 (2004). 
[35] Haereid, S., Nilsen, E., Einarsrud, M-A., Subcritical drying of silica gels, J. of Porous Materials, 2(4): 315-
324 (1996). 
[36] Aravind, P.R., Mukundan, P., Krishna Pillai, P., Warrier, K.G.K., Mesoporous silica-alumina aerogels with 
high thermal pore stability through hybrid sol-gel route followed by subcritical drying, Microporous 
Mesoporous Mat., 96(1): 14-20 (2006).  
[37] Winters, M. A., Knutson, B. L., Debenedetti P.G., Sparks, H.G., Przybycien, T.M., Stevenson, C.L., 
Prestrelski, S.J, Precipitation of proteins in supercritical carbon Dioxide. J. Pharm. Sci. 85(6):586–594 
(1996). 
[38] Heinrich, T., Kleit, U., Fricke, J., Aerogels-Nanoporous Materials Part I: Sol-Gel Process and Drying of 
Gels, J. Porous Mat., 1(1): 7-17 (1995). 
 
CHAPTER 9   
 
 
 
  
 
212 
                                                                                                                                                     
[39] Spycher, N., Pruess, K., Ennis-King, J., CO2-H2O mixtures in the geological sequestration of CO2. I. 
Assessment and calculation of mutual solubilities from 12 to 100°C and up to 600 bar. Geochim. et 
Cosmochim. Acta, 67(16): 3015-3031 (2003). 
[40] Sabirzyanov, A.N., Shagiakhmetov, R.A., Gabitov, F.R., Tarzimanov, A.A., Gumerov, F.M., Water 
Solubility of Carbon Dioxide under Supercritical and Subcritical Conditions, Theoretical Foundations of 
Chem. Eng., 37(1): 51-53 (2003).  
[41] Wubbolts, F.E., Bruinsma, O.S.L., van Rosmalen, G.M., Dry - spraying of ascorbic acid or acetaminophen 
solutions with supercritical carbon dioxide, J. of Crystal Growth 198/199 (Pt. 1): 767-772 (1999). 
[42] Perez de Diego, Y., Pellikaan, H.C., Wubbolts, F.E., Witkamp, G.J., Jansens, P.J., Operating regimes and 
mechanism of particle formation during the precipitation of polymers using the PCA process, J. of 
Supercritical Fluids, 35(2): 147-156 (2005). 
[43] Perez de Diego, Y., Wubbolts, F.E., Witkamp, G.J., Jansens, P.J., Improved PCA Process for the 
Production of Nano- and Micro particles of Polymers, AIChE Journal, 50(19): 2408-2417 (2004). 
[44] Hofland, G.W.; Van Es, M., Van der Wielen, L.A.M., Witkamp, G-J., Isoelectric Precipitation of Casein 
Using High - Pressure CO2, Industrial & Engineering Chemistry Res., 38(12): 4919-4927 (1999). 
[45] Jackson, M., Mantsch, H.H., Beware of proteins in DMSO. Biochimica et Biophysica Acta, Protein 
Structure and Molecular Enzymology, 1078(2), 231-235 (1991). 
[46] Palakodaty, S., York, P., Phase behavioral effects on particle formation processes using supercritical 
fluids. Pharm. Res., 16(7): 976-985 (1999). 
[47] Hanna, M., York, P., Method and apparatus for the formation of particles, WO9401426 (1998). 
[48] Lengsfeld, C.S., Delplanque, J.P., Barocas, V.S., Randolph, T.W., Mechanism Governing Microparticle 
Morphology during Precipitation by a Compressed Antisolvent: Atomization vs. Nucleation and Growth, J. 
Phys. Chem. B, 104(12): 2725-2735 (2000). 
[49] Duhkin, S.S., Shen, Y., Pfeffer, D.R., Droplet mass transfer, intradroplet nucleation and submicron 
particle production in two-phase flow of solvent-supercritical anti-solvent emulsion, Coll. Surf. A, 261(1-
3): 163-176 (2005). 
[50] Lim, J.S., Lee, Y.Y, Phase equilibria for carbon dioxide-ethanol-water system at elevated pressures, J. 
Supercritical Fluids, 7(4): 219-230 (1994). 
[51] Jovanovic, N., Bouchard, B., Hofland, G.W., Witkamp, G-J., Crommelin, D.J.A., Jiskoot, W., Stabilization 
of proteins in dry powder formulations using supercritical fluid technology, Pharm. Res., 21(11): 1955-
1969 (2004). 
[52] Thiering, R., Dehghani, F., Dillow, A., Foster, N.R., The influence of operating conditions on the dense 
gas precipitation of model proteins, J. Chem. Technol. Biotech., 75(1): 29-41 (2000). 
[53] Chavez, F., Debenedetti, P.G., Luo, J.J., Dave, R.N., Pfeffer, R., Estimation of the Characteristic Time 
Scales in the Supercritical Antisolvent Process, Ind. Eng. Chem. Res., 42(13): 3156-3162 (2003). 
[54] European Medicines Agency, Impurities: Residual Solvents, CMPM/ICH/283/95 (1998). 
[55] Taylor, L.S., York, P., Characterization of the phase transitions of trehalose dihydrate on heating and 
subsequent dehydration, J. Pharm. Sci., 87(3): 347-355 (1998). 
[56] Castor, T.R., Phospholipid Nanosomes, Current Drug Delivery, 2(4): 329-340 (2005). 
[57] Adrian, T., Wendland, M., Hasse, H., Maurer, G., High-pressure multiphase behavior of ternary systems 
carbon dioxide-water-polar solvent: Review and modelling with the Peng-Robinson equation of state, J. 
Supercrit. Fluids, 12(3): 185-221 (1998). 
[58] Chrastil, J., Solubility of solids and liquids in supercritical gases, J. Phys. Chem., 86(15): 3016-3021 
(1982). 
 
  SUBCRITICAL- AND SUPERCRITICAL DRYING 
 
 
 
  
 
213
                                                                                                                                                     
[59] Bamberger, T., Erickson, J.C., Cooney, C.L., Kumar, S.K., Measurement and model prediction of 
solubilities of pure fatty acids, pure triglycerides, and mixtures of triglycerides in supercritical carbon 
dioxide, J. Chem. Eng. Data 33(3): 327-333 (1988). 
[60] Hamman, H., Solubilities of pure lipids in supercritical carbon dioxide, J. Supercrit. Fluids, 5(2): 101-106 
(1992). 
[61] Reverchon, E., Caputo, G., De Marco, I., Role of Phase Behavior and Atomization in the Supercritical 
Antisolvent Precipitation, Ind. Eng. Chem. Res., 42(25): 6406-6414 (2003). 
[62] Adrian, T., Wendland, M., Hasse, H., Maurer, High-pressure multiphase behavior of ternary systems 
carbon dioxide-water-polar solvent: Review and modeling with the Peng-Robinson equation of state, J. 
Supercrit. Fluids, 12(3): 185-221 (1998). 
[63] Xia, J., Joedecke, M., Perez-Salado Kamps, A., Maurer, G., Solubility of CO2 in (CH3OH + H2O), J. 
Chem. Eng. Data, 49(6): 1756-1759 (2004). 
[64] Lazzaroni, M.J., Bush, D., Brown, J.S., Eckert, C.A., High - pressure vapor -liquid equilibria of some 
carbon dioxide + organic binary systems, J. Chem. Eng. Data, 50(1): 60-65 (2005). 
[65] Bamberger, A., Mauer, G., High-pressure (vapour + liquid) equilibria in (carbon dioxide + acetone or 2-
propanol) at temperatures from 293 K to 333 K, J. Chem. Thermodyn., 32(5): 685-700 (2000). 
[66] Reverchon, E., Della Porta, G., Di Trolio, A., Pace, S., Supercritical antisolvent precipitation of 
nanoparticles of superconductor precursors, Ind. Eng. Chem. Res., 37(3): 952-958 (1998). 
[67] Xia, J., Joedecke, M., Perez-Salado Kamps, A., Maurer, G., Solubility of CO2 in (CH3OH + H2O), J. 
Chem. Eng. Data, 49(6): 1756-1759 (2004). 
[68] Jödecke, M., Perez-Salado Kamps, A., Maurer, G., Experimental Investigation of the Solubility of CO2 in 
(Acetone and Water), J. Chem. Eng. Data, 52(3): 1003-1009 (2007). 
[69] Zhang, X., Zhand, X., Han, B., Shi, L., Li, H., Yang, G., Determination of constant volume heat capacity 
of mixed supercritical fluids and study on the intermolecular interaction, J. Supercrit. Fluids, 24(3): 193-
291 (2002).  
[70] Fulton, J.L., Yee, G.G., Smith, R.D., Hydrogen bonding of simple alcohols in supercritical fluids. An FTIR 
study, ACS Symposium Series, 514 (Supercritical Fluid Engineering Science): 175-187 (1993). 
[71] Yao, S., Guan, Y., Zhu, Z., Investigation of phase equilibrium for ternary systems containing ethanol, 
water and carbon dioxide at elevated pressures, Fluid Phase Equilibria, 99(1-2): 249-259 (1994). 
[72] Choi, Y.H., Kim, J., Noh, M.J., Choi, E.S., Yoo, K.P., Effect of functional groups on the solubilities of 
coumarin derivatives in supercritical carbon dioxide, Chromatographia, 47(1/2): 93-97 (1998). 
[73] Gupta, R.B., Solubility in Supercritical Carbon Dioxide, p: 735, CRC Press (1996). 
[74] Sackett, D.A., Wolff, J., Nile Red as A Polarity-Sensitive Fluorescence Probe of Hydrophobic Protein 
Surfaces, Anal. Biochem., 167(2): 228-234 (1987). 
[75] Krishnamoorthy, I., Krishnamoorthy, G., Probing the link between proton transport and water content in 
lipid membranes, J. of Phys. Chem. B, 105(7): 1484-1488 (2001). 
[76] Hungerford, G., Castanheira, E.M.S., Baptista, A.L.F., Coutinho, P.J.G., Real Oliveira, E.C.D., Domain 
Formation in DODAB–Cholesterol Mixed Systems Monitored via Nile Red Anisotropy, J. of Fluorescence, 
15(6): 835-840 (2005). 
[77] Hungerford, G., Ferreira, J.A., The effect of the nature of retained solvent on the fluorescence of Nile 
Red incorporated in sol-gel-derived matrices, J. of Luminescence, 93(2): 155-165 (2001). 
[78] Berger, T.A., Deye, J.F., Anderson, A.G., Nile Red as A Solvatochromic Dye for Measuring Solvent 
Strength in Normal Liquids and Mixtures of Normal Liquids with Supercritical and Near Critical Fluids, 
Anal. Chem., 63(6): 615-622 (1990). 
 
 
 
 
 
 
 
 
 
 
 
Chapter 10 
 
Summary of the Evaluated Drying Technologies  
 
 
 
Abstract: 
Formulation research always has to focus on the stability of the active compound within 
a new formulation. For market approval a product ideally has to be stable for at least 
two years at the selected storage conditions. If the stability of a liquid formulation is not 
sufficient numerous pharmaceutical drying processes are available each with 
advantages and disadvantages. In this thesis several technologies were evaluated for 
drying the liposomal product EndoTAG®-1. This chapter provides an overview and a 
comparison of the evaluated techniques.  
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1. NEW LIPOSOME FORMATION TECHNIQUE  
The currently used liposome formation techniques are considered as time consuming, as 
they are composed of several complex production steps. In this thesis various techniques 
for liposome preparation were compared. We investigated a new single pass extrusion 
technique (Chapter 6), to adjust large polydisperse vesicles in a single step to liposomes 
with a smaller size and a narrow homogenous size distribution. The idea of using the 
shear forces within the nozzle for the preparation of homogenous liposomes out of of 
multi-lamellar vesicles (MLV) without a consecutive extrusion process originated during 
the spray-drying experiments. Based on this assumption we developed a new liposomal 
preparation technique to obtain small liposomes with homogenous size distribution in a 
single step by an inline extrusion at high pressure followed by an atomization step. The 
technique was implemented into a spray-drying (Chapter 7), inert spray-drying (Chapter 
8) or supercritical fluid-drying (chapter 9) set-up. 
 
2. SCALABILITY AND INDUSTRIAL USE OF THE EVALUATED DRYING TECHNIQUES 
Figure 1 provides a classification of the techniques evaluated in the context of the thesis 
to dry liposomal placebo formulations and the Paclitaxel containing EndoTAG®-1 
formulation according to their employment for industrial production and scalability. 
Freeze-drying, spray-drying and spray freeze-drying are already approved by regulatory 
authorities and there are products on the market available stabilized by these 
techniques. In this context, freeze-drying and spray-drying are the prevalent and most 
advanced techniques for industrial production. 
 
Figure 1: Classification of drying techniques for liposomal formulations in respect of scalability and employment 
for industrial production.  
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The scale-up is thereby less problematic and easier to perform for the continuous spray-
drying as compared to freeze-drying, which is typically run in the batch mode. The spray 
freeze-dried products exhibit several advantages e.g. the liposomal integrity after the 
process and the properties of the freely flowable bulk material, but the scalability as an 
industrial process is more complex as compared to spray-drying. The handling of liquid 
nitrogen and transfer of particles into the drying chamber is complicated and requires 
special technical equipment. Inert spray-drying and supercritical fluid-drying can be 
classified between academic interest and approved techniques. Up to now, no 
pharmaceutical product is prepared by these methods and the technical requirements 
are, especially for the supercritical fluid-drying, more complex as compared to freeze-
drying or spray-drying. Although the supercritical fluid technique is frequently used for 
extraction processes in food industry, like decaffeination, the acceptance in 
pharmaceutical production is still very low. The limited number of available commercial 
plants, the compliance of good manufacturing processes (GMP) and sterility impeded a 
faster development. The newly developed percolative vacuum-drying, which is on the 
basis of the vacuum fluidized be drying proposed by the group of Leuenberger, is just at 
the beginning and needs further investigations.  
 
3. COMPARISON OF THE EVALUATED DRYING TECHNOLOGIES 
Table 1 provides a comparison of the used drying technologies concerning product and 
process parameters.  
 
3.1 FREEZE-DRYING 
Although freeze-drying is the appropriate stabilization technique for many products 
several drawbacks are evident. The time consuming process, limited batch sizes and the 
difficulties related to each drying step make this technology rather complicated for the 
EndoTAG®-1 formulation. The cake structure and the lack to obtain bulk material like 
particles make freeze-drying inconvenient for the production of bulk material for flexible 
dosing. However, the preservation of liposomes and the drug loading are the major 
advantages of freeze-drying. An optimization of the so far used freeze-drying process for 
the production of the EndoTAG®-1 formulation resulted in a reduction of the primary 
drying time of at least 20 %. For this optimization, the freezing temperature was reduced 
from -40 to -50°C. A further approach to increase the productivity lyophilization was an 
increase of the filling volume from 25 to 50 ml.  
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Table 1: Comparison of the drying technologies evaluated in the context of the thesis. 
technique 
one step 
process  
optimum 
size/PI 
used 
drugs 
freezing 
stress 
min heat 
exposure  
process 
time/liter  
freeze-drying not possible 
110 nm 
0.25 
PXL -50°C - 
120 h 
60* h 
spray-drying 
(two-fluid nozzle) 
not possible 
168 nm 
0.17 
PXL - 50°C 6 h 
spray-drying 
(orifice nozzle) 
possible 
140 nm 
0.16 
C 
NR 
- 45°C 10 min 
inert spray-drying 
(orifice nozzle) 
possible 
130 nm 
0.15 
C 
NR 
- 40°C 50 min 
subcritical fluid-
drying 
possible 
118 nm 
0.15 
NR - 35°C 151 h 
supercritical fluid-
drying 
possible 
121 nm 
0.13 
C 
NR 
- 35°C 66 h 
supercritical fluid-
drying (co-solvent) 
possible 
125 nm 
0.10 
NR - 35°C 33 h 
spray freeze-drying not possible 
125 nm 
0.18 
PXL -196°C - 60 h 
percolative drying not possible 
150 nm 
0.22 
C -196°C - 4 h 
NR: Nile Red, C: Coumarin, PXL: Paclitaxel              * increased filling volume of 50 ml  
 
3.2 SPRAY FREEZE-DRYING 
Spray freeze-drying combines the spraying approach to form particles by freezing in 
liquid nitrogen with a conventional freeze-drying process. Although the spray freeze-
drying process revealed no faster drying performance, the advantage of this technique is 
the obtained particle structure and the very gentle conditions. The liposomal properties 
and the Paclitaxel recovery were preserved for small and large particles. The product can 
be handled as bulk material and a broad range of particles sizes can be produced by 
varying the nozzle type and the freezing conditions.  
 
3.3 PERCOLATIVE VACUUM-DRYING 
The newly developed percolative vacuum-drying step, which combines several aspects of 
spray freeze-drying, vacuum-drying and atmospheric freeze-drying allowed reducing the 
drying time of spray-frozen particles. To increase the driving force for heat and mass 
transfer a percolation gas was streamed though the particle layer during PVD resulting in 
drying times below four hours. Trehalose crystallization during the process is a 
disadvantage of the method, although the liposomal integrity was preserved. For the 
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percolative vacuum-drying process further investigations on the control of the process 
parameters and the impact on the product are necessary. 
 
3.4 SPRAY-DRYING USING A TWO-FLUID NOZZLE 
During the spray-drying process with a two-fluid nozzle the liposomal formulations are 
subjected to thermal stress by a heat exposure of at least 50°C. Although Paclitaxel is 
known to be heat sensitive, the liposomal stability and Paclitaxel loading could be 
preserved to a great extent under these conditions. The fast drying process and the 
obtained dry flow powder make this technology to a feasible alternative for the time 
consuming freeze-drying process.  
 
3.5 SPRAY-DRYING WITH AN ORIFICE NOZZLE 
A separate liposome formation process was still required in the so far described drying 
techniques prior to the drying step. Therefore, we aimed to combine the liposome 
formation and the drying step within one continuous process. The spray-drying concept 
using an online extrusion through a porous device and an orifice nozzle allowed the size 
adjustment of the liposomes and the consecutive drying in the same process. This 
combination simplifies the production process and circumvents the conventional filter 
extrusion process. The high liquid feed rates allowed an effective liposome formation and 
drying of up to 100 ml/min under preservation of the liposomal integrity. 
 
3.6 INERT SPRAY-DRYING WITH AN ORRIFICE NOZZLE 
Experience from spray-drying revealed that the temperature exposure during the drying 
step led to a degradation of the heat sensitive drug Paclitaxel under some conditions. 
With the addition of organic solvents to the aqueous formulation a reduced heat capacity 
and therefore lower temperatures were sufficient to dry the product. The closed inert 
loop spray-drying system allows the spray-drying of organic solvents in a wider 
temperature range. Variations of solvents and solvent concentrations enabled a reduction 
of the drying temperature down to 35°C. The idea of the single-step liposome formation 
was tested in this set-up, as well. Furthermore, first evaluation studies were performed 
using a molecular disperse solution of lipids and excipients to overcome the MLV 
preparation step by ethanol injection and to simplify the production method.  
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3.7 SUBCRITICAL AND SUPERCRITICAL FLUID-DRYING 
For setting up the subcritical and supercritical fluid-drying long process development 
times were necessary for finding optimum drying conditions. At working conditions above 
the critical point the drying process was maintained at low temperature of 40°C. 
Supercritical drying of aqueous liposomal formulation without the addition of co-solvents 
to the supercritical CO2 was possible, but only at reduced liquid flow rates prolonging the 
process times. Drying became more effective by the addition of organic co-solvents, with 
best results concerning liposomal properties for acetone. Organic co-solvents are related 
to the risk of a reduced lipid and drug recovery, as they increase the solubility of these 
compounds in the supercritical phase. To overcome this, subcritical conditions were used 
by reducing the pressure in the system with the consequence that the mass transfer of 
carbon dioxide has to be significantly increased to compensate the reduced water 
solubility. The advantage is the preservation of both, hydrophilic and hydrophobic 
compounds by the subcritical approach. 
 
 
4. CONCLUSIONS 
The study provides a comprehensive overview on different stabilization techniques for 
liposomal formulations. The selection of the appropriate technology for a particular 
formulation can thereby be based on several considerations. If free flowable particulate 
bulk material is desired the spraying-technologies are preferred over lyophilization. 
Another advantage of spraying-based technologies is the possibility to combine the 
liposome formation step and the drying step within the same process. It is a prerequisite 
for the selection of the stabilization technique that the integrity of the liposomes is 
preserved with the incorporated drug after the process. Spray-drying is related to a 
thermal stress for the formulation but only for a short time. For heat labile drugs 
processes with low process temperatures, e.g. freeze-drying, spray freeze-drying, inert-
spray drying or supercritical drying are most adequate. However, for technologies with a 
freezing step a sufficient stabilization against freezing induced stress e.g. by the selection 
of appropriate cryoprotectors is needed.  
 
The goal to circumvent the time-consuming lyophilization step for the Paclitaxel 
containing EndoTAG®-1 formulation could be achieved by selecting spray-drying with a 
two-fluid nozzle as alternative technique. The feasibility to dry Paclitaxel containing 
formulations needs to be proofed for spray-drying with an orifice nozzle, inert spray-
drying, sub- and supercritical drying, as well as percolative drying, which was so far 
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proofed only for selected model compounds. Alternatively, inert spray-drying or 
supercritical drying could be used as the drying temperature and with it the formation of 
degradation products can be significantly reduced as compared to conventional spray-
drying.  
 
 
 
 
 
   
 
 
 
ABBREVIATIONS 
 
DOPC  1,2-dioleoyl-sn-glycero-3-phosphocholine 
DOTAP-Cl  1.2-dioleoyl-3-trimethylammonium-propane-chloride  
DSC  differential scanning calorimetry 
HS-GC  static headspace gas chromatography 
Maa/lf  mass ratio of atomizing air to liquid feed 
MLV  multi-lamellar-vesicles 
NIBS  non invasive back-scatter technique 
Oh  Ohnesorge number 
PCA  precipitation with compressed anti-solvent 
PCS  photon correlation spectroscopy 
PI   polydispersity index 
PVD  percolative vacuum-drying 
PXL  Paclitaxel 
Re   Reynolds number 
RP-HPLC reversed phase high performance liquid chromatography  
SeD  secondary-drying 
SEM  scanning electron microscopy 
SCF  supercritical fluids 
Tc  collapse temperature  
Teu  eutectic temperature  
Tg  glass transition temperature 
Tg`  glass transition temperature of the maximally freeze-concentrated solution 
TICT  twisted intramolecular charge transfer 
Tinlet  inlet temperature 
Tnc   no collapse range 
Toutlet  outlet temperature 
vaa  atomizing air volumetric flow rate 
VD  vacuum-drying 
vda  drying air volumetric flow rate 
vlf  liquid feed volumetric flow rate  
We   Weber number 
XRD  X-ray powder diffraction 
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